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Introduction 
Pyrazolo[l,5-a]pyrimidines which are purine analogues 
proved to have wide varieties of useful pharmaceutical 
activities such as antitrypanisommal activity,1 
antischistosomal activity,2 activity as HMG-CoA   reductase   
inhibitors,3 COX-2 selective inhibitors,4 AMP 
phosphodiesterase inhibitors,5 KDR kinase inhibitors,6 
selective peripheral benzodiazepine receptor ligands7 and as 
antianxiety agents.8 Other pharmaceutical activities, such as 
agents for the treatment of sleep disorders9 and as 
oncological agents4,10 have been reported. Also, several 
pyrazolotriazines and triazolotriazines, as adenine analogues, 
were used as antagonists, antischistosomal and antitumor 
agents.15-17 Such utilities have stimulated recent interest in 
the synthesis of these ring systems. Also, A large number of 
heterocyclic compounds containing pyridine rings are 
associated with diverse pharmacological properties such as 
antimicrobial,18,19 anticancer,20 anticonvulsant,21 antiviral,22  
anti-HlV,23 antifungal and antimycobacterial activities.24  In 
continuation of our interest in the synthesis of 
heterocycles,25,26 we report herein a convenient general 
method for synthesis of various zoloazines namely 
pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines, ben-
zo[4,5]imidazo-[l,2-a]pyrimidines, pyrazolo[5,l-c]1,2,4-
triazines, l,2,4-triazolo[3,4-c]1,2,4-triazines, benzo[4,5]imi-
dazo[2,1-c]1,2,4-triazines containing furan moiety. 
EXPERIMENTALS 
All melting points were determined on an electrothermal 
apparatus and are uncorrected. IR spectra were recorded 
(KBr discs) on a Nicolet Avatar 370 CSL FT-IR 8201 PC 
spectrophotometer. 1H & 13C NMR spectra were recorded in 
CDCl3 and (CD3)2SO solutions on a Varian Gemini 300 
MHz and 400 MHz spectrometer and chemical shifts are 
expressed in δ units using TMS as an internal reference. 
Mass spectra were recorded on a GC-MS QP1000 EX 
Shimadzu. Elemental analyses were carried out at the Micro 
analytical Center of Cairo University. The calculation of 
heat of formation, ∆H, for compounds 19a and 22a was 
carried out by Hyper Chem. program. 
Sodium 3-(furan-2-yl)-3-oxoprop-1-en-1-olate (3)    
A solution of 2-acetylfurane (1) (5.25 g, 25 mmol) in ether 
(25 mL) was added dropwise to a mixture of sodium 
methoxide and ethyl formate (2) (25 mmol for each) in dry 
ether (50 mL) with stirring in ice-bath at 0-5 oC, for 2 h. The 
resulting solid collected to give 3 without crystallization.  
Pyrazolo[1,5-a]pyrimidines (8a, 8b), triazolo[1,5-a]pyrimidine 
(14) and imidazo[1,2-a]pyrimidine (15) 
General procedure 
A mixture of the sodium salt of 3 (1.6 g, 10 mmol) and the 
appropriate heterocyclic amines 5a-d (10 mmol for each), in 
a solution consisting of piperidene (2.5 mL), water (5 mL) 
and acetic acid (2 mL), were heated under reflux for about 
10 min, acetic acid (1.5 mL) was added to the reaction 
mixture while boiling, then the mixture was cooled and the 
resulting solid was collected and recrystallized from the 
proper solvent to give 8a , 8b, 14 and 15, respectively. 
Alternate synthetic route for 8a 
Method A: A mixture of 2-acetylfurane (1) (9.5 mmole) 
and N,N-dimethyl-N'-(3-phenyl-1H-pyrazol-5-yl)formami-
dine (13) (1.06 g, 5 mmol) in ethanol (10 mL) was heated 
under reflux for  3 h. The resulting solid was collected and 
recrystallized from ethanol gave product identical in all 
aspects (m.p., mixed m.p. and spectra) with 8a 
Method B: Equimolecular amounts of 3-(dimethylamino)-
1-(furan-2-yl)prop-2-en-1-one (12) (0.82 g, 5 mmole), the 
appropriate heterocyclic amines 5a-d (5 mmol) in acetic 
acid (10 mL) containing ammonium acetate (0.32 g, 5 
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mmole) were boiled under reflux for 4 h. The resulting solid 
was collected and recrystallized from the proper solvent to 
give 8a, 8b, 14 and 15, respectively. 
7-(Furan-2-yl)-2-phenylpyrazolo[1,5-a]pyrimidine (8a) 
This compound was obtained as pale yellow crystals 
from AcOH, Yield: 79 %, m.p.: 127-30 °C. FT-IR (KBr, cm-
1): 3059 ν(CH), 1611 ν(C=N), 1565 ν(C=C). 1H NMR (300 
MHz, DMSO-d6): δ = 5.99 (s, 1H, pyrazole H-5), 6.84 (d, 
1H, J = 4 Hz, furan H-4), 7.00 (d, 1H, J = 4Hz, furan H-3), 
7.42-7.99 (m, 7H, ArH’s and furan H-5), 8.75 (s, 1H, 
pyrimidine H-4). 13C NMR: δ = 100.89, 102.23, 120.12, 
125.90, 127.30, 128.85, 130.57, 132.68, 134.42, 144.49, 
146.21, 146.98, 149.18, 154.23. MS (EI, m/z (%)): 262 
(M+1, 34.2 %), 261 (M+, 100.0 %), 244 (21.9 %), 232 
(21.9 %), 207 (5.3 %), 142 (14.0 %), 130 (14.9 %), 103 
(22.8 %), 92 (20.2 %), 77 (76.3 %), 76 (42.1 %), 75 
(26.3 %), 64 (21.9 %). Calcd. for C16H11N3O (261.28) C, 
73.55; H, 4.24; N, 16.08 Found: C, 73.68; H, 4.35; N, 
16.16 %. 
7-(Furan-2-yl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile (8b) 
This compound was obtained as white crystals from EtOH, 
Yield: 70 %, m.p. 196-200 °C. FT-IR (KBr, cm-1): 3059 
ν(CH), 2228 ν(CN), 1632 ν(C=N), 1572 ν(C=C). 1H NMR 
(300 MHz, DMSO-d6): δ = 6.75 (d, 1H, J = 4 Hz, furan H-4), 
7.10 (d, 1H, J = 4Hz, furan H-3), 7.60 (d, 1H, ArH) 7.74 (d, 
1H, J = 4 Hz, furan H-5), 8.27 (s, 1H, pyrazole H-4), 9.12 (d, 
1H, J = 4 Hz, pyrimidine H-4). 13C NMR: δ = 82, 101, 113, 
119, 125, 133, 135, 145, 146, 149, 153. MS (EI, m/z ( %)): 
210 (M+, 100.0 %), 181 (29.9 %), 104 (11.5 %), 94 (13.8 %), 
76 (23.0  %), 65 (33.3 %). Calcd. for C11H6N4O (210.19) C, 
62.86. H, 2.88; N, 26.66 Found: C, 63.00; H, 2.71; N, 
26.75 %. 
5-(Furan-2-yl)-[1,2,4]triazolo[4,3-a]pyrimidine (14) 
Brown crystals from EtOH, yield: 70 %, m.p.: 181-84 °C. 
FT-IR (KBr, cm-1): 3059 ν(CH), 1616 ν(C=N), 1570 
ν(C=C). 1H NMR (300 MHz, DMSO-d6): δ = 6.73 (d, 1H, J 
= 4 Hz, furan H-4), 7.51 (d, 1H, J = 4Hz, furan H-3), 7.75(d, 
1H, ArH), 8.18 (d, 1H, J = 4 Hz, furan H-5), 8.57 (s, 1H, 
pyrazole H-4), 8.82 (d, 1H, J = 4 Hz, pyrimidine H-4). 13C 
NMR: δ = 111, 112, 131, 135, 142, 144, 146, 152, 159. MS 
(EI, m/z (%)): 186 (M+, 33.3 %), 130 (60.0 %), 75 (53.0%), 
64 (40.0%), 62 (35.3%). Calcd. for C9H6N4O (186.17) C, 
58.06; H, 3.25; N, 30.09 Found: C, 58.18; H, 3.34; N, 
29.85 %.   
4-Furan-2-yl-benzo[4,5]imidazo[1,2-a]pyrimidine (15) 
Dark brown crystals from AcOH, yield: 75 %, m.p.: 
>300 °C. FT-IR (KBr, cm-1): 3059 ν(CH), 1635 ν(C=N), 
1579 ν(C=C). 1H NMR (300 MHz, DMSO-d6): δ = 6.75 (d, 
1H, J = 4 Hz, furan H-4), 7.10 (d, 1H, J = 4Hz, furan H-3), 
7.60 (d, 1H, ArH) 7.74 (d, 1H, J = 4 Hz, furan H-5), 8.27 (m, 
4H, ArH's), 9.12 (d, 1H, J = 4 Hz, pyrimidine H-4);.13C 
NMR: δ = 109, 111, 113, 115, 121, 123, 126, 129, 131, 140, 
144, 146, 157, 159; MS (EI, m/z (%)): 235 (M+, 13.2 %), 
234 (M-1, 21.1 %), 148 (26.3%), 133 (26.3 %), 112 
(34.2 %), 100 (23. 7%), 95 (73.7 %), 84 (36.8 %), 78 
(34.2 %), 64 (100.0%). Calcd. for C14H9N3O (235.24) C, 
71.48; H, 3.86; N, 17.86 Found: C, 71.36; H, 4.00; N, 
17.77 %. 
Pyrazolo[5,1-c]1,2,4-triazines (22a and 22b) 
General procedure 
A solution of the appropriate diazonium salt of 
heterocyclic 5-amino-3-phenylpyrazole (16a) and 5-amino-
4-cyanopyrazole (16b) was added to a cold mixture of the 
appropriate 3 or 12 (5 mmol for each) and sodium acetate 
(0.41 gm, 5mmole) in ethanol (40 mL) at 0-5 °C, while 
stirring for 30 min. The reaction mixture was stirred for 3 h. 
The resulting solid was collected and recrystallized from the 
proper solvent to give 22a and 22b, respectively. 
4-(Furan-2-yl)-7-phenylpyrazolo[5,1-c]1,2,4-triazine (22a) 
This compound was obtained as yellowish brown crystals 
from AcOH, Yield: 80%, m.p.: 248-51 °C. FT-IR (KBr, cm-
1): 3059 ν(CH), 1638 ν(C=N), 1569 ν(C=C). 1H NMR (300 
MHz, DMSO-d6): δ = 6.75 (d, 1H, J = 4 Hz, furan H-4), 
7.45-7.62 (m, 4H, ArH's and pyrazole H-4), 7.74 (d, 1H, J = 
4 Hz, furan H-3), 7.90-7.93 (m, 2H, ArH's), 8.10 (d, 1H, J = 
4 Hz, furan H-5), 9.20 (s, 1H, ArH). 13C NMR: δ = 102.23, 
114.89, 121.19, 124.21, 125.96, 127.40, 128.53, 129.88, 
134.34, 144.98, 146.67, 154.58, 154.67; MS (EI, m/z (%)): 
262 (M+, 68.4 %), 131 (36.8 %), 129 (52.6 %), 115 (26.3 %), 
104 (31.6 %), (77 (68.4 %), 72 (94.7 %), 69 (63.2 %), 55 
(100 %). Calcd. for C15H10N4O (262.27) C, 68.69; H, 3.84; 
N, 21.36 Found: C, 68.74; H, 4.00; N, 21.52 %. 
4-(Furan-2-yl)pyrazolo[5,1-c]1,2,4-triazine-8-carbonitrile (22b) 
This compound was obtained as pale brown crystals from 
EtOH, Yield: 77 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 
3059 ν(CH), 2235 ν(CN), 1635 ν(C=N), 1569 ν(C=C). 1H 
NMR (300 MHz, DMSO-d6): δ = 6.75 (d, 1H, J = 4 Hz, 
furan H-4), 7.10 (d, 1H, J = 4Hz, furan H-3), 7.96 (d, 1H, J 
= 4 Hz, furan H-5), 8.27 (s, 1H, pyrazole H-4), 9.12 (d, 1H, 
J = 4 Hz, pyrimidine H-4). 13C NMR: δ = 82, 114, 115, 123, 
125, 126, 143, 145, 146, 148. MS (EI, m/z (%)): 211 (M+, 
3.6 %), 210 (M-1, 14.5 %), 150 (7.3 %), 149 (32.7 %), 141 
(14.5 %), 122 (14.5 %), 112 (10.9 %), 110 (40.0 %), 108 
(47.3 %),94 (54.5 %), 85 (36.4 %), 77 (38.2 %), 73 (30.9 %), 
64 (38.2 %), 53 (100.0 %). Calcd. for C10H5N5O (211.18) C, 
56.87; H, 2.39; N, 33.16 Found: C, 56.94; H, 2.45; N, 
33.38 %.  
4-(Furan-2-yl)-1,2,4-triazolo[5,1-c]1,2,4-triazine (24)    
A solution of 1,2,4-triazol-3-diazonium nitrate (16c) (5 
mmol) (which is prepared from 3-amino-1,2,4-triazol and 
sodium nitrite in nitric acid at 0-5 °C), was added to a 
mixture of the appropriate 3 or 12 (5 mmol) and sodium 
acetate (0.41 gm, 5 mmol) in ethanol (40 mL) at 0-5 °C, 
during a period 30 min while stirring. The reaction mixture 
was stirred for further 3 h and was kept in a refrigerator 
overnight. The resulting solid was collected and 
recrystallized from ethanol as pale yellow crystals, Yield 
70 %, m.p.: > 300 °C; FT-IR (KBr, cm-1): 3055 ν(CH), 1631 
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ν(C=N), 1549 ν(C=C). 1H NMR (300 MHz, DMSO-d6): δ = 
6.75 (d, 1H, J = 4 Hz, furan H-4), 7.10 (d, 1H, J = 4Hz, 
furan H-3), 7.96 (d, 1H, J = 4 Hz, furan H-5), 9.12 (s, 2H, 
ArH's, tetrazole H-5 and triazine H-6). MS (EI, m/z (%)): 
187 (M+, 4.9%), 145 (6.7  %), 114 (75.7 %), 95 (11.6  %), 
88 (6.5%), 86 (98.9 %), 74 (5.6 %), 56 (100.0 %). Calcd. for 
C8H5N5O (187.16) C, 51.34; H, 2.69; N, 37.42 Found: C, 
51.41; H, 2.45; N, 37.38 %. 
4-Furan-2-yl-benzo[4,5]imidazo[2,1-c][1,2,4]triazine (25). 
A solution of benzimidazol-2-diazonium sulphate (16d) (5 
mmol) (which is prepared from 2-aminobenzimidazole and 
sodium nitrite in sulphuric acid at 0-5 °C), was added 
dropwise to a mixture of the appropriate 3 or 12 (5 mmol) 
and sodium acetate (0.41 gm, 5 mmol) in ethanol (40 mL) 
while stirring at 0-5 °C, over a period 30 min. The reaction 
mixture was stirred for another 3 h and was kept in a 
refrigerator overnight. The resulting solid was collected and 
recrystallized from ethanol as dark brown crystals, Yield 
74 %, m.p.: 151-54 °C. FT-IR (KBr, cm-1): 3055 ν(CH), 
1649 ν(C=N), 1562 ν(C=C). 1H NMR (300 MHz, DMSO-
d6): δ = 6.84 (d, 1H, J = 4 Hz, furan H-4), 7.32 (m, 2H, 
AreH's), 7.58 (m, 1H, ArH), 7.80 (d, 1H, J = 4 Hz, furan H-
5), 8.01 (d, 1H, J = 8Hz, ArH), 8.70 (d, 1H, J = 8 Hz, ArH), 
9.62 (s, 1H, triazine H-6). MS (EI, m/z (%)): 236 (M+, 
1.54 %), 181 (4.26 %), 95 (100.0 %), 66 (10.66 %); Calcd. 
for C13H8N4O (236.23) C, 66.10; H, 3.41; N, 23.72 Found: C, 
66.22; H, 3.53; N, 23.48 %. 
2-(2-Arylhydrazono)-3-(furan-2-yl)-3-oxopropanal 26a-d 
The appropriate of benzenediazonium chloride (25a), 4-
methylbenzenediazonium chloride (25b), 4-nitro-
benzenediazonium chloride (25c) or 2,4-dinitro-
benzenedizonium chloride (25d) (5 mmole) was added drop 
wise with continuous cooling and stirring to a solution of the 
sodium salt of 1-(furan-2-yl)-3-hydroxyprop-2-en-1-one (3) 
or 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-1-one (11) (5 
mmole), in ethanol (15 mL) at 0-5 °C. Sodium acetate was 
used as a buffer. The reaction mixture was stirred for 
another 3 h. Then, it was kept in a refrigerator overnight; the 
resulting solid was collected, washed with water and 
recrystallized from the proper solvent to give the 
corresponding 26a-d, respectively.   
2-(2-Phenylhydrazono)-3-(furan-2-yl)-3-oxopropanal (26a)  
This compound was obtained as yellow crystals from 
EtOH, Yield: 93 %, m.p.: 128-30 °C. FT-IR (KBr, cm-1): 
3127 ν(NH), 3059 ν(CH), 1642 ν(CO), 1500 ν(C=C). 1H 
NMR (300 MHz, CDCl3): δ = 6.61 (d, 1H, J = 4 Hz, furan 
H-4), 7.25-7.73 (m, 6H, ArH's and furans protons), 7.74 (d, 
1H, J = 4 Hz, furan H-3), 10.14  (s, 1H, CHO), 14.80 (s, br., 
1H, NH). MS (EI, m/z (%)): 242 (M+, 28.1 %), 241 (9.8 %), 
214 (10.1 %), 213 (13.3 %), 185 (7.3 %), 158 (10.5 %), 130 
(10.1 %), 122 (47.0 %), 95 (100 %), 77 (60.7 %), 65 
(61.6 %). Calcd. for C13H10N2O3 (242.23) C, 64.46; H, 4.16; 
N, 11.56 Found: C, 64.62; H, 4.27; N, 11.68 %. 
2-(2-p-Tolylhydrazono)-3-(furan-2-yl)-3-oxopropanal (26b)  
This compound was obtained as yellowish brown crystals 
from EtOH, Yield: 93 %, m.p.: 140-42 °C. FT-IR (KBr, cm-
1): 3125 ν(NH), 3058 ν(CH), 1667 ν(CO), 1615 ν(C=N) 
1589 (C=C). 1H NMR (300 MHz, CDCl3): δ = 2.27 (s, 3H, 
CH3), 6.61 (d, 1H, J = 4 Hz, furan H-4), 7.25-7.73 (m, 5H, 
ArH's and furans protons), 7.74 (d, 1H, J = 4 Hz, furan H-3), 
9.925  (s, 1H, CHO), 14.36 (s, br., 1H, NH). 13C NMR: δ = 
19.85, 112.20, 117.19, 128.48, 131.12, 137.35, 140.99, 
146.18, 149.28, 151.55, 179.85, 192.87. MS (EI, m/z (%)): 
256 (M+, 40.9 %), 149 (59.1 %), 148 (90.9 %), 94 (86.4 %), 
79 (54.6 %), 77 (27.3 %), 71 (40.9 %), 68 (27.3 %), 66 
(27.3 %), 65 (63.6 %), 55 (27.3 %). Calcd. for C14H12N2O3 
(256.26) C, 65.62; H, 4.72; N, 10.93 Found: C, 65.81; H, 
4.54; N, 11.12 %. 
2-(2-p-Nitrophenylhydrazono)-3-(furan-2-yl)-3-oxopropanal 
(26c)  
This compound was obtained as redish brown crystals 
from AcOH, Yield: 93 %, m.p.: 207-209 °C. FT-IR (KBr, 
cm-1): 3111 ν(NH), 3058 ν(CH), 1651 ν(CO), 1625 ν(C=N) 
1599 (C=C). 1H NMR (300 MHz, CDCl3): δ = 6.85 (d, 1H, J 
= 4 Hz, furan H-4), 7.25-7.73 (m, 5H, ArH's and furans 
protons), 7.74 (d, 1H, J = 4 Hz, furan H-3), 9.93  (s, 1H, 
CHO), 14.08 (s, br., 1H, NH). 13C NMR: δ = 112.50, 117.24, 
123.82, 128.39, 145.24, 146.38, 147.58, 149.21, 152.22, 
179.88, 192.54. MS (EI, m/z (%)): 286 (M-1, 30.0 %), 258 
(M-2, 100.0 %), 260 (50.0 %), 177 (25.0 %), 176 (45.0 %), 
163 (65.0 %), 137 (70.0 %), 122 (45.0 %), 108 (65 %), 91 
(80.0 %), 77 (55 %), 76 (60.0 %), 75 (65.0 %), 64 (40 %), 
62 (80 %). Calcd. for C13H9N3O5 (287.23) C, 54.36; H, 3.16; 
N, 14.63 Found: C, 54.57; H, 3.30; N, 14.48 %. 
2-(2-(2,4-Dinitrophenyl)hydrazono)-3-(furan-2-yl)-3-
oxopropanal (26d) 
This compound was obtained as yellowish brown crystals 
from AcOH, Yield: 96 %, m p.: 156-58 °C. FT-IR (KBr, cm-
1): 3111 ν(NH), 3058 ν(CH), 1651 ν(CO), 1625 ν(C=N) 
1599 (C=C). 1H NMR (300 MHz, CDCl3): δ = 6.83 (d, 1H, J 
= 4 Hz, furan H-4), 7.09-8.94 (m, 5H, ArH's and furans 
protons), 9.95  (s, 1H, CHO), 15.14 (s, br., 1H, NH). MS (EI, 
m/z (%)): 332 (M+, 0.2 %),  122 (27 %), 95 (100.0 %), 94 
(37.6 %), 83 (9.8 %), 77 (3.2 %), 76 (2.9 %). Calcd. for 
C13H8N4O7 (332.23) C, 47.00; H, 2.43; N, 16.86 Found: C, 
47.12; H, 2.28; N, 16.00 %. 
(4H-Pyrazol-4-ylidene)-2-phenylhydrazine (27a-d) 
Method A: Equimolecular amounts of the appropriate 
30a-d and the appropriate hydrazine hydrate, 4-
nitrophenylhydrazine (5 mmol of each) in ethanol (10 mL) 
were refluxed for 4 h. The resulting solid, so formed, after 
cooling was recrystallized from the proper solvent to give 
27a-g, respectively. 
Method B: Arenediazonium chloride was prepared by 
reacting 5 mmol of an aromatic amine (aniline, p-toluidine, 
4-nitroaniline, or 2,4-dinitroaniline) with HCl (6 M, 3 mL) 
and sodium nitrite (0.37 g, 5 mmol) at 0-5 °C. A solution of 
the appropriate arenediazonium chloride (5 mmole), was 
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added to a mixture of 3-(furan-2-yl)-1H-pyrazole (32) (0.67 
g, 5 mmol) and sodium acetate (0.41 gm, 5 mmole) in 
ethanol (30 mL) at 0-5 °C, while stirring.  The reaction 
mixture is stirred for 3 h and was kept in a refrigerator 
overnight. The resulting solid, was collected, washed with 
water and recrystallized to give identical products in all 
aspects (m.p., mixed m.p., and spectra) with those obtained 
by method A. 
1-(3-(Furan-2-yl)-4H-pyrazol-4-ylidene)-2-phenylhydrazine 
(27a) 
This compound was obtained as dark brown crystals from 
AcOH, Yield: 70 %, m.p.: 202-205 °C. FT-IR (KBr, cm-1): 
3132 ν(NH), 3055 ν(CH), 1511 ν(C=C). 1H NMR (300 
MHz, CDCl3): δ = 6.62 (d, 1H, J = 4 Hz, furan H-4), 7.27-
8.14 (m, 7H, ArH's and furans protons), 9.14  (s, 1H, ArH), 
15.14 (s, br., 1H, NH). 13C NMR: 104.52, 106.38, 114.28, 
120.45, 130.12, 131.47, 135.82, 144.35, 145.47, 147.56, 
151.37. MS (EI, m/z (%)): 238 (M+, 5.9 %),  211 (5.1 %), 
161 (18.7 %),105 (12.1 %), 77 (100.0 %), 76 (41.0 %), 65 
(11.0 %). Calcd. for C13H10N4O (238.24) C, 65.54; H, 4.23; 
N, 23.52 Found: C, 65.35; H, 4.34; N, 23.68 %. 
1-(3-(Furan-2-yl)-4H-pyrazol-4-ylidene)-2-p-tolylhydrazine 
(27b) 
This compound was obtained as yellow crystals from 
AcOH, Yield: 71 %, m.p.: 200-203 °C. FT-IR (KBr, cm-1): 
3139 ν(NH), 3055 ν(CH), 1601 ν(C=C). 1H NMR (300 
MHz, CDCl3): δ = 2.34 (s, 3H, CH3), 6.62 (d, 1H, J = 4 Hz, 
furan H-4), 7.27-8.14 (m, 6H, ArH's and furans protons), 
9.14  (s, 1H, ArH), 15.14 (s, br., 1H, NH). 13C NMR: δ = 
20.22, 103.88, 106.19, 118.43, 130.72, 131.88, 135.58, 
137.25, 139.66, 144.14, 145.28, 151.33. MS (EI, m/z (%)): 
252 (M+, 89.4 %),  251(M-1, 37.6 %), 161 (100.0 %),149 
(12.9 %), 133 (42.4 %), 106 (63.5 %), 91 (78.8 %), 77 
(35.3 %), 76 (40.1 %), 54 (74.5 %), 50 (61.2 %). Calcd. for 
C14H12N4O (252.27) C, 66.65; H, 4.79; N, 22.21 Found: C, 
66.52; H, 4.93; N, 22.36 %. 
1-(3-(Furan-2-yl)-4H-pyrazol-4-ylidene)-2-(4-
nitrophenyl)hydrazine (27c) 
This compound was obtained as pale brown crystals from 
AcOH, Yield: 73 %, m.p.: 208-210 °C. FT-IR (KBr, cm-1): 
3297 ν(NH), 3055 ν(CH), 1627 ν(C=N), 1589 ν(C=C). 1H 
NMR (300 MHz, CDCl3): δ =  6.62 (d, 1H, J = 4 Hz, furan 
H-4), 7.27-8.14 (m, 6H, ArH's and furans protons), 9.14  (s, 
1H, ArH), 15.14 (s, br., 1H, NH). MS (EI, m/z (%)): 283 
(M+, 50 %),  282 (M-1, 11.2 %), 273 (7.7 %), 203 (8.8 %), 
175 (16.8 %), 161 (100.0 %),149 (5.11 %), 133 (33.7 %), 
106 (59.2 %), 91 (17.9 %), 77 (34.2 %), 75 (38.8 %), 64 
(28.6 %), 54 (20.9 %), 50 (61.2 %). Calcd. for C13H9N5O3 
(283.24) C, 55.13; H, 3.20; N, 24.73 Found: C, 55.33; H, 
3.15; N, 24.86 %. 
1-(3-(Furan-2-yl)-4H-pyrazol-4-ylidene)-2-(2,4-
dinitrophenyl)hydrazine (27d) 
This compound was obtained as redish brown crystals 
from AcOH, Yield: 80 %, m.p.: 260-64 °C. FT-IR (KBr, cm-
1): 3297 ν(NH), 3055 ν(CH), 1627 ν(C=N), 1589 ν(C=C). 
1H NMR (300 MHz, CDCl3): δ =  6.62 (d, 1H, J = 4 Hz, 
furan H-4), 7.27-8.14 (m, 5H, ArH's and furans protons), 
9.14  (s, 1H, ArH), 15.14 (s, br., 1H, NH). MS (EI, m/z 
(%)): 328 (M+, 14.9 %),  311 (24.1 %), 310 (26.7 %), 295 
(18.2 %), 161 (100.0 %), 133 (29.7 %), 119 (11.9 %), 106 
(46.9 %), 92 (10.6 %), 78 (24.1 %), 77 (31.7 %), 76 
(43.2 %), 63 (14.9 %), 51 (69.3 %). Calcd. for C13H8N6O5 
(328.24) C, 47.57; H, 2.46; N, 25.60 Found: C, 47.79; H, 
2.35; N, 25.82 %. 
1-(3-(Furan-2-yl)-1-(4-nitrophenyl)-1H-pyrazol-4-yl)-2-
phenyldiazene (27e) 
This compound was obtained as redish brown crystals 
from AcOH, Yield: 85 %, m.p.: 284-86 °C. FT-IR (KBr, cm-
1): 3055 ν(CH), 1608 ν(C=N), 1562, 1372 ν(NO2). 1H NMR 
(300 MHz, CDCl3): δ =  6.62 (d, 1H, J = 4 Hz, furan H-4), 
7.02 (d, 1H, J = 4Hz, furan H-3), 7.42-8.25 (m, 11H, ArH's 
and furans protons). MS (EI, m/z (%)): 360 (M+1, 11.4 %),  
241 (20.0 %), 211 (26.7 %), 163 (34.3 %), 158 (28.6 %), 
126 (20.0 %), 114 (28.6 %), 94 (100 %), 88 (28.6 %), 75 
(37.1 %), 77 (82.9 %), 65 (31.4 %), 51 (28.6 %). Calcd. for 
C19H13N5O3 (359.34) C, 63.51; H, 3.65; N, 19.49 Found: C, 
63.63; H, 3.58; N, 19.65 %. 
1-(3-(Furan-2-yl)-1-(4-nitrophenyl)-1H-pyrazol-4-yl)-2-p-
tolyldiazene (27f) 
This compound was obtained as dark brown crystals from 
AcOH, Yield: 83 %, m.p.: 264-67 °C. FT-IR (KBr, cm-1): 
3058 ν(CH), 1615 ν(C=N), 1562, 1372 ν(NO2). 1H NMR 
(300 MHz, CDCl3): δ =  2.38 (s, 3H, CH3), 6.62 (d, 1H, J = 
4 Hz, furan H-4), 7.02 (d, 1H, J = 4Hz, furan H-3), 7.42-
8.25 (m, 10H, ArH's and furans protons). Calcd. for 
C20H15N5O3 (373.36) C, C, 64.34; H, 4.05; N, 18.76 Found: 
C, 64.48; H, 4.21; N, 18.55 %. 
1-(3-(Furan-2-yl)-1-(4-nitrophenyl)-1H-pyrazol-4-yl)-2-(4-
nitrophenyl)diazene (27g)  
This compound was obtained as yellowish brown crystals 
from DMf, Yield: 78 %, m.p.: 285-89° C. FT-IR (KBr, cm-
1): 3055 ν(CH), 1608 ν(C=N), 1562, 1372 ν(NO2). 1H 
NMR (300 MHz, CDCl3): δ =  6.62 (d, 1H, J = 4 Hz, furan 
H-4), 7.02 (d, 1H, J = 4Hz, furan H-3), 7.42-8.25 (m, 10H, 
ArH's and furans protons). MS (EI, m/z (%)): 405 (M+1, 
2.5 %),  284 (15.7 %), 217 (7.6 %), 203 (8.6 %), 157 
(7.6 %), 164 (5.1 %), 122 (15.7 %), 106 (10.7 %), 95 
(100.0 %), 76 (14.7 %), 63 (34.0 %), 51 (21.3 %). Calcd. for 
C19H12N6O5 (404.34) C, 56.44; H, 2.99; N, 20.78 Found: C, 
56.57; H, 3.12; N, 20.98 %. 
Pyrazoles 28a and 28b 
A mixture of 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-
1-one (11) (0.82 gm, 5 mmol) and hydrazine hydrate or 4-
nitrophenylhydrazine (5 mmol) in ethanol (15 mL) was 
boiled under reflux for 4 h. The resulting solid was collected 
and recrystallized from the proper solvent to give 28a and 
28b, respectively.  
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3-(Furan-2-yl)-1H-pyrazole (28a) 
This compound was obtained as white crystals from water, 
Yield: 51 %, m.p.: 101-103 °C. FT-IR (KBr, cm-1): 3149 
ν(NH), 3033 ν(CH), 1634 ν(C=N), 1165 ν(C=C). 1H NMR 
(300 MHz, CDCl3): δ =  6.49 (d, 1H, J = 4 Hz), 6.51 (d, 1H, 
J = 4Hz), 6.69 (d, 1H, J = 4 Hz), 7.48 (d, 1H, J = 4 Hz, CH), 
7.66 (s, 1H), 11.66 (s, br., 1H, NH). 13C NMR: δ = 103.25, 
108.54, 111.48, 132.45, 132.78, 138.25, 151.72. MS (EI, 
m/z (%)): 134 (M+, 57.1 %), 133 (M-1, 100.0 %), 51 (7.1 %). 
Calcd. for C7H6N2O (134.14) C, 62.68; H, 4.51; N, 20.88 
Found: C, 62.87; H, 4.62; N, 21.10 %. 
3-(Furan-2-yl)-1-(4-nitrophenyl)-1H-pyrazole (28b) 
This compound was obtained as red crystals from AcOH, 
Yield: 83 %, m.p.: 140-43 °C. FT-IR (KBr, cm-1): 3058 
ν(CH), 1615 ν(C=N), 1562, 1372 ν(NO2). 1H NMR (300 
MHz, CDCl3): δ =  6.49 (d, 1H, J = 4 Hz), 6.51 (d, 1H, J = 
4Hz), 6.69 (d, 1H, J = 4 Hz), 7.48 (d, 1H, J = 4 Hz, CH), 
7.96 (m, 3H, ArH's), 8.3 (m, 2H), ArH's). MS (EI, m/z (%)): 
256 (M+1, 100 %) , 255 (M+, 61 %), 254 (M-1, 98.9 %), 
253 (49.4 %), 175 (17.9 %), 146 (14.6 %), 102 (14 %), 74 
(9.8 %). Calcd. for C13H9N3O3 (255.23) C, 61.18; H, 3.55; N, 
16.46 Found: C, 61.25; H, 3.64; N, 16.38 %. 
Ethyl 6-(furan-2-yl)-2-methylpyridine-3-carboxylate (29) and 
1-(6-(furan-2-yl)-2-methylpyridin-3-yl)ethanone (30)  
General procedure: Equimolecular amounts of 3-
(dimethylamino)-1-(furan-2-yl)prop-2-en-1-one (11) and 
ethyl acetoacetate or acetylacetone (5 mmol, each) in acetic 
acid (10 mL) and ammonium acetate (5 mmol) were boiled 
under reflux for 4 h. The resulting solid, was collected and 
recrystallized from the proper solvent to give 32 and 33, 
respectively. 
Ethyl 6-(furan-2-yl)-2-methylpyridine-3-carboxylate (29)  
This compound was obtained as dark brown crystals from 
benzene, Yield: 77 %, m.p.: 78-81 °C. FT-IR (KBr, cm-1): 
3058, 2929 ν(CH), 1715 ν(CO, ester),1646 ν(C=N), 1582 
ν(C=C). 1H NMR (300 MHz, CDCl3): δ =  1.33 (t, 3H, J = 
7.5 Hz,  CH2CH3), 2.72 (s, 3H, CH3), 4.22 (q, 2H, J = 7.5 Hz,  
CH2CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 
4Hz, furan H-3), 6.69 (d, 1H, J = 4 Hz), furan H-5), 7.96 (d, 
2H, J = 4 Hz, ArH's) 13C NMR: δ = 14.84, 26.00, 61.66, 
107.29, 109.97, 116.78, 125.12, 141.64, 143.88, 155.48, 
166.27, 158.87, 165.12. MS (EI, m/z (%)): 231 (M+, 2.6 %), 
149 (4.1 %), 80 (5.5 %), 78 (100.0 %), 75 (5.9 %), 65 
(3.3 %). Calcd. for C13H13NO3 (231.25) C, 67.52; H, 5.67; N, 
6.06 Found: C, 67.68; H, 5.79; N, 6.12 %. 
1-(6-(Furan-2-yl)-2-methylpyridin-3-yl)ethanone (30)  
This compound was obtained as dark brown crystals from 
AcOH, Yield: 76 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 
3058, 2923 ν(CH), 1701 ν(CO), 1634 ν(C=N), 1563 
ν(C=C). 1H NMR (300 MHz, CDCl3): δ =  2.34 (s, 3H, CH3), 
2.42 (s, 3H, CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 
1H, J = 4Hz, furan H-3), 6.69 (d, 1H, J = 4 Hz, furan H-5), 
7.63-8.00 (m, 2H), ArH's). 13C NMR: δ = 25.85, 27.64, 
113.87, 114.25, 119.15, 131.57, 132.58, 143.82, 148.67, 
152.75, 158.17, 199.47. MS (EI, m/z (%)): 202 (M+1, 
36.4 %), 201 (M+, 45.5 %), 174 (54.5 %), 149 (54.5 %), 82 
(63.6 %), 72 (54.4 %), 60 (100.0 %), 57 (91 %), 55 (18.2 %). 
Calcd. for C12H11NO2 (201.22) C, 71.63; H, 5.51; N, 6.96 
Found: C, 71.78; H, 5.38; N, 7.14 %. 
6-(Furan-2-yl)-2-methylpyridine-3-carbohydrazide (31) 
A mixture of ethyl 6-(furan-2-yl)-2-methylpyridine-3-
carboxylate (29) (1.15 g, 5 mmol) and hydrazine hydrate (1 
mL) in ethanol (10 mL) were boiled under reflux for 4 h. 
The resulting solid, was cooled and recrystallized to give 31 
as dark brown crystals from AcOH, Yield: 97 %, m.p.: > 
300 °C. FT-IR (KBr, cm-1): 3429, 3317 ν(NH, NH2), 3064, 
2982 ν(CH), 1715 ν(CO), 1635 ν(C=N), 1583 ν(C=C). 1H 
NMR (300 MHz, CDCl3): δ =  2.52 (s, 3H, CH3), 6.49 (d, 
1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 4Hz, furan H-3), 
6.69 (d, 1H, J = 4 Hz, furan H-5), 7.63-8.00 (m, 2H, ArH's), 
9.75 (s, br., 3H, NH, NH2). Calcd. for C11H11N3O2 (217.22) 
C, 60.82; H, 5.10; N, 19.34 Found: C, 60.95; H, 5.32; N, 
19.57 % 
Azido(6-(furan-2-yl)-2-methylpyridin-3-yl)methanone (32) 
Saturated solution of sodium nitrite was added 
portionwise to a stirred solution of 6-(furan-2-yl)-2-
methylpyridine-3-carbohydrazide (31) (1.08 g, 5 mmol) in 
hydrochloric acid (15 mL, 6 M) at 0-5°C till effervescence 
ceased. The reaction mixture stirred for 1 h. The resulting 
solid, was filtered, washed with water and recrystallized 
from acetic acid to give the 32, as dark brown crystals, 
Yield: 80 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 3058 
ν(CH), 2116 ν(azide group), 1712 ν(CO), 1633 ν(C=N), 
1592 ν(C=C). 1H NMR (300 MHz, CDCl3): δ =  2.52 (s, 3H, 
CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 
4Hz, furan H-3), 6.69 (d, 1H, J = 4 Hz, furan H-5), 7.54 (d, 
1H, J = 8 Hz, ArH), 7.89 (d, 1H, J = 8 Hz, ArH). MS (EI, 
m/z (%)): 230 (M+2, 50 %), 186 (50 %), 65 (25 %), 61 
(45 %), 60 (65 %), 58 (25 %), 57 (100.0 %), 55 (45 %), 50 
(25 %).  Calcd. for C11H8N4O2 (228.21) C, 57.89; H, 3.53; N, 
24.55 Found: C, 58.00; H, 3.35; N, 24.68 % 
Synthesis of urea 33a-d 
A mixture of the azido 32 and appropriate aniline, p-
toluidine, p-nitoaniline or 2,4-dinitroaniline (5 mmol) in 
dioxane (20 mL) was refluxed for 4 h. The resulting solid, 
so formed, was collected and recrystallized to yield 33a-d, 
respectively. 
1-(6-(Furan-2-yl)-2-methylpyridin-3-yl)-3-phenylurea (33a) 
This compound was obtained as dark brown crystals from 
DMF, Yield: 79 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 3369 
ν(NH), 3058 ν(CH), 1712 ν(CO). 1H NMR (300 MHz, 
CDCl3): δ =  2.12 (s, 3H, CH3), 6.49 (d, 1H, J = 4 Hz, furan 
H-4), 6.51 (d, 1H, J = 4Hz, furan H-5), 6.13-7.17 (m, 3H, 
ArH's), 7.26 (d, 1H, J = 4 Hz), 7.29-7.85 (m, 4H, ArH's), 
8.49 (s, br., 2H, NH2). MS (EI, m/z (%)): 293 (M+, 0.45 %), 
Synthesis of new purine analogous containing furan nucleus        Section A-Research paper 
Eur. Chem. Bull., 2015, 4(2), 50-59   DOI: 10.17628/ecb.2015.4.50-59 55
203 (22.41 %), 186 (100.0 %);), 158(23.33 %), 130 
(16.81 %), 107 (37.07 %), 103 (40.36 %), 94 (11.84 %), 91 
(19.42 %), 77 (29.39 %), 60 (26.39 %). Calcd. for 
C17H15N3O2 (293.32) C, 69.61; H, 5.15; N, 14.33 Found: C, 
69.72; H, 5.30; N, 14.45 %. 
1-(6-(Furan-2-yl)-2-methylpyridin-3-yl)-3-p-tolylurea (33b) 
This compound was obtained as dark brown crystals from 
DMF, Yield: 91 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 3396 
ν(NH), 3058 ν(CH), 1704 ν(CO, 1600 ν(C=C)). 1H NMR 
(300 MHz, CDCl3): δ =  2.12 (s, 3H, CH3), 2.35 (s, 3H, 
CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 
4Hz, furan H-5), 6.13-7.17 (m, 3H, ArH's), 7.26 (d, 1H, J = 
4 Hz), 7.29-7.85 (m, 3H, ArH's), 8.49 (s, br., 2H, NH2). 13C 
NMR: δ = 19.37, 20.88, 108.27, 106.44, 114.11, 121.22, 
129.98, 132.44, 137.18, 140.24, 143.51, 145.27, 147.67, 
154.18, 154.89. MS (EI, m/z (%)): 307 (M+, 0.33 %), 305 
(15.09 %), 231 (11.14 %);), 210 (5.40 %), 192 (11.01 %), 
186 (19.69 %), 181 (13.32 %), 167 (18.16 %), 154 
(17.29  %), 145 (16.95 %), 134 (12.90 %), 119 (27.03 %), 
109 (14.00 %), 92 (100.0 %), 82 (13.35 %), 64 (39.84 %). 
Calcd. for C18H17N3O2 (307.35) C, 70.34; H, 5.58; N, 13.67 
Found: C, C, 70.45; H, 5.71; N, 13.85 %. 
1-(6-(Furan-2-yl)-2-methylpyridin-3-yl)-3-(4-nitrophenyl)urea 
(33c) 
This compound was obtained as deep red crystals from 
AcOH, Yield: 82 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 
3365 ν(NH), 3058 ν(CH), 1708 ν(CO), 1615 ν(C=N), 1562, 
1370 ν(NO2). 1H NMR (300 MHz, CDCl3): δ =  2.12 (s, 3H, 
CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 
4Hz, furan H-3), 7.21-7.28 (m, 5H, ArH's and furan H-5), 
7.92 (d, 1H, J = 8 Hz, ArH), 8. (d, 1H, J = 8 Hz, ArH),  9.13 
(s, br., 2H, NH). Calcd. for C17H14N4O4 (338.32) C, 60.35; H, 
4.17; N, 16.56 Found: C, 60.52; H, 4.25; N, 16.68 %. 
1-(6-(Furan-2-yl)-2-methylpyridin-3-yl)-3-(2,4-dinitrophenyl)-
urea (33d) 
This compound was obtained as yellowish brown crystals 
from AcOH, Yield: 83 %, m.p.: > 300 °C. FT-IR (KBr, cm-
1): 3442 ν(NH), 3058 ν(CH), 1705 ν(CO), 1615 ν(C=N), 
1521, 1384 ν(NO2). 1H NMR (300 MHz, CDCl3): δ = 2.12 
(s, 3H, CH3), ), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 
1H, J = 4Hz, furan H-3), 7.21-7.29 (m, 2H, ArH and furan 
H-5), 7.88 (d, 1H, J = 8 Hz, ArH), 8.42-8.65 (m, 2H, ArH's), 
8.92 (s, 1H, ArH), 10.35 (s, br. 2H, NH). Calcd. for 
C17H13N5O6 (383.32) C C, 53.27; H, 3.42; N, 18.27 Found: 
C, 53.27; H, 3.42; N, 18.27 %. 
Synthesis of aryl  carbamates 34a-c 
A mixture of 32 (5 mmol) and phenol (0.5 g, 5 mmol) in 
dry benzene (20 mL) was refluxed for 4 h. The resulting 
solid, so formed, was collected and recrystallized to give 
34a-c.  
Phenyl 6-(furan-2-yl)-2-methylpyridin-3-ylcarbamate (34a) 
This compound was obtained as dark brown crystals from 
AcOH, Yield: 82 %, m.p.: > 300 °C. FT-IR (KBr, cm-1): 
3361 ν(NH), 3058 ν(CH), 1708 ν(CO), 1615 ν(C=N). 1H 
NMR (300 MHz, CDCl3): δ =  2.12 (s, 3H, CH3), 6.49 (d, 
1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 4Hz, furan H-3), 
6.392-7.35 (m, 7H, ArH's and furan H-5), 7.92 (d, 1H, J = 8 
Hz, ArH), 9.56 (s, br., 1H, NH). 13C NMR: δ = 19.32, 
105.77, 110.27, 114.51, 121.87, 124.83, 130.24, 130.87, 
136.74, 143.57, 146.59, 147.99, 153.34, 153.87, 154.28. 
Calcd. for C17H14N2O3 (294.3) C, 69.38; H, 4.79; N, 9.52 
Found: C, 69.52; H, 4.95; N, 9.68 %. 
4-Nitrophenyl 6-(furan-2-yl)-2-methylpyridin-3-ylcarbamate 
(34b) 
This compound was obtained as dark brown crystals from 
DMF, Yield: 77 %, m.p.: 184-87 °C. FT-IR (KBr, cm-1): 
3442 ν(NH), 3058 ν(CH), 1708 ν(CO), 1615 ν(C=N), 1562, 
1370 ν(NO2). 1H NMR (300 MHz, CDCl3): δ =  2.12 (s, 3H, 
CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 
4Hz, furan H-3), 6.39-7.35 (m, 6H, ArH's and furan H-5), 
7.92 (d, 1H, J = 8 Hz, ArH), 9.56 (s, br., 1H, NH). MS (EI, 
m/z (%)): 339 (M+, 62.2 %), 247 (100.0 %), 158 (19.6 %);), 
152 (24.5 %), 131 (14.0 %), 130 (23.2 %), 118 (18.1 %), 
109 (6.7 %), 93 (14.2 %), 77 (30.3 %), 67 (21.3 %), 51 
(8.3 %). Calcd. for C17H13N3O5 (339.3) C, 60.18; H, 3.86; N, 
12.38 Found: C, 60.25; H, 4.00; N, 12.45 %. 
2,4,6-trinitrophenyl 6-(furan-2-yl)-2-methylpyridin-3-ylcarba-
mate (34c) 
This compound was obtained as yellowish brown crystals 
from AcOH, Yield: 83 %, m.p.: > 300 °C. FT-IR (KBr, cm-
1): 3438 ν(NH), 3090 ν(CH), 1716 ν(CO), 1612 ν(C=N), 
1561, 1384 ν(NO2). 1H NMR (300 MHz, CDCl3): δ =  2.12 
(s, 3H, CH3), 6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, 
J = 4Hz, furan H-3), 7.20 (d, 1H, J = 4Hz, furan H-5), (6.39 
(d, 1H, J = 8Hz, ArH), 7.92 (d, 1H, J = 8 Hz, ArH), 9.15 (s, 
2H, ArH's), 9.56 (s, br., 1H, NH). MS (EI, m/z (%)): 429 
(M+, 12.5 %), 389 (86.7 %), 134 (13.4 %);), 127 (10.1 %), 
121 (100.0 %). Calcd. for C17H11N5O9 (429.3) C, 47.56; H, 
2.58; N, 16.31 Found: C, 47.67; H, 2.62; N, 16.55 %. 
Ethyl 2-amino-6-(furan-2-yl)pyridine-3-carboxylate (35) 
A mixture of 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-
1-one (11) (0.83, 5 mmol), ethyl cyanoacetate (0.56 g, 5 
mmol) and ammonium acetate (0.35 g 5 mmol) in acetic 
acid (10 mL) was refluxed for 4 h. The solid resulting after 
cooling was collected and recrystallized from diluted acetic 
acid to give 35 as white crystals from AcOH, Yield: 69 %, 
m.p.: 333-36 °C. FT-IR (KBr, cm-1): 3378 ν(NH), 3058 
ν(CH), 1694 ν(CO), 1644 ν(C=N), 1562 ν(C=C). 1H NMR 
(300 MHz, CDCl3): δ =  1.27 (t, 3H, J = 7.5 Hz, CH2CH3), 
2.12 (q, 2H, J = 7.5 Hz, CH2CH3), 6.49 (d, 1H, J = 4 Hz, 
furan H-4), 6.51 (d, 1H, J = 4Hz, furan H-3), 7.20 (d, 1H, J 
= 4Hz, furan H-5), 7.25 (d, 1H, J = 8Hz, ArH), 7.92 (d, 1H, 
J = 8 Hz, ArH), 12.58 (s, br., 1H, NH2). MS (EI, m/z (%)): 
232 (M+, 5.9 %), 203 (64.4.7 %), 189 (13.9 %);), 187 
(28.9 %), 160 (13.9 %), 132 (12.8 %), 105 (25 %), 77 
(23.3 %), 65 (12.8 %). Calcd. for C12H12N2O3 (232.24) C, 
62.06; H, 5.21; N, 12.06 Found: C, 61.92; H, 4.83; N, 
5.89 %.  
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(2-Amino-6-(furan-2-yl)pyridin-3-yl)(phenyl)methanone (36) 
A mixture of 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-
1-one (11) (0.83, 5 mmol), benzoylacetonitrile (0.74 g, 5 
mmol) and ammonium acetate (0.35 g 5 mmol) in acetic 
acid (10 mL) was refluxed for 4 h. The solid resulting on 
cooling was collected and recrystallized from diluted acetic 
acid to give 36 as pale brown crystals from AcOH, Yield: 
80 %, m.p.: 210-14 °C. FT-IR (KBr, cm-1): 3370, 3167 
ν(NH2), 3058 ν(CH), 1648 ν(CO, conjugated), 1615 ν(C=N), 1571 ν(C=C). 1H NMR (300 MHz, CDCl3): δ =  
6.49 (d, 1H, J = 4 Hz, furan H-4), 6.51 (d, 1H, J = 4Hz, 
furan H-3), 7.20 (d, 1H, J = 4Hz, furan H-5), 7.61-7.85 (m, 
7H, ArH's), 9.85 (s, br., 2H, NH2) MS (EI, m/z (%)): 264 
(M+, 73.1 %), 256 (100.0 %), 248 (42.3 %);), 218 (26.9 %), 
185 (42.3 %), 161 (26.9 %), 105 (19.2 %), 77 (88.2 %), 66 
(42.3 %) Calcd. for C16H12N2O2 (264.28) C, 72.72; H, 4.58; 
N, 10.60 Found: C, 72.95; H, 4.67; N, 10.84 %. 
Results and Discussion 
Treatment of sodium 3-(furan-2-yl)-3-oxoprop-1-en-1-
olate (3), which was prepared by reacting 2-acetylfuran (1) 
and ethyl formate (2) in methanolic sodium methoxide, 
followed by 5-amino-3-phenylpyrazole (5a) in acetic acid, 
in the presence of piperidenium acetate yielded 7-(furan-2-
yl)-2-phenylpyrazolo[1,5-a]pyrimidine (8a) (Scheme 1). 
The structure of 8a was established by elemental analysis, 
spectral data and alternative synthesis. For example, its 1H-
NMR spectrum revealed multiplet signal at δ 5.99 (s, 1H, 
pyrazole H-5), 6.84 (d, 1H, J = 4 Hz, furan H-4), 7.00 (d, 1H, 
J = 4Hz, furan H-3), 7.42-7.99 (m, 7H, ArH’s and furan H-
5), 8.75 (s, 1H, pyrimidine H-4). 
 
 
 
 
 
 
The formation of compounds 8a is assumed to take place 
via an initial Michael addition of the exocyclic amino group 
in compound 5a to the formyl group of 4 to give the acyclic 
non-isolable intermediate 6 which undergoes cyclization and 
aromatization via loss one molecule of water to give 8a as 
end product. Structure of 8a was further confirmed by its 
independent synthesis by reacting equimolecular amounts of 
N,N-dimethyl-N'-(3-phenyl-1H-pyrazol-5-yl)formamidine 
(13) with 2-acetylfuran (1) in refluxing ethanol or treatment 
of 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-1-one [27] 
(12) with 5a in boiling acetic acid. The product isolated, in 
each case, proved identical in all aspects (m.p., mixed m.p. 
and spectra) with those of the assigned structure 8a (Scheme 
1).  
Analogously, reaction of compound 3 or 11 reacted with 
each of 5-amino-4-cyanopyrazole (5b), 3-aminotriazole (5c) 
or 2-aminbenzoimidazole (5d) in acetic acid in the presence 
of piperidenium acetate or ammonium acetate afforded 7-
(furan-2-yl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile (8b), 
7-(furan-2-yl)-1,2,4-triazolo-[1,5-a]pyrimidine (14) and 4-
furan-2-yl-benzo[4,5]imidazo[1,2-a]pyrimidine (15), 
respectively  (Scheme 2). 
Treatment of diazotized 5-amino-3-phenylpyrazole (16a) 
with the sodium 3-(furan-2-yl)-3-oxoprop-1-en-1-olate (3) 
in ethanol containing sodium acetate gave 4-(furan-2-yl)-7-
phenylpyrazolo[5,1-c]1,2,4-triazine (22a) in a good yield 
(Scheme 3). 
Structure of 22a was elucidated by elemental analysis, 
spectral data and alternative synthetic route.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.  Synthesis of 7-(furan-2-yl)-2-phenylpyrazolo[1,5-a]pyriminidine (8a) 
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Scheme 2. Synthesis of pyrazolo[1,5-a]pyrimidine (8b), 1,2,4-
triazolo-[1,5-a]pyrimidine (14) and benzo[4,5]imidazo[1,2-
a]pyrimidine (15). 
For example, its infrared spectrum revealed no bands 
between in the region 1650-2000 cm-1 due to the absence of 
any carbonyl group. Its mass spectrum showed m/z = 262. 
On the basis of these results, the structure 19 was ruled out.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The formation of 22a seems to occur via coupling of 
diazonium chloride 16a with 3 to form the intermediate 20 
which then cyclized to give intermediate 21, which in turn 
undergoes elimination of formic acid to give 22a as the end 
product. Also, the formation of 22a rather than 19a is also 
evidenced by our finding that the calculated heat of 
formation of 22a (∆H = 170.581 kcal mol-1) is higher than 
of 19a (∆H = 145.961 kcal mol-1). 
Reaction of 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-1-
one (12) with 16a in ethanolic sodium acetate solution gave 
a product identical in all aspects (m.p., mixed m.p. and 
spectra) with 22a isolated above from the reaction of 16a 
with 3 (Scheme 3).  
Analogously, coupling of the diazotized 5-amino-4-
cyanopyrazole (16b), 3-amino-1,2,4-triazole (16c) and 2-
aminobenzimidazole (16d) with the appropriate 3 or 12 in 
ethanolic sodium acetate afforded 4-(furan-2-
yl)pyrazolo[5,1-c]1,2,4-triazine-8-carbonitrile (22b), 4-
(furan-2-yl)-1,2,4-triazolo[5,1-c]1,2,4-triazine (24) and 4-
furan-2-yl-benzo[4,5]imidazo[2,1-c]1,2,4-triazine (25), 
respectively (cf. Scheme 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Synthesis of 4-(furan-2-yl)pyrazolo[5,1-c]1,2,3-triazine-8-carbonitrile (21b), 4-(furan-2-yl)-1,2,4-triazolo[5,1-c]1,2,4-triazine 
(24) and 4-furan-2-yl-benzo[4,5]imidazo[2,1-c]1,2,4-triazine (25). 
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Reactions of 3 or 11 with benzenediazonium chloride 
(25a) in ethanol containing sodium acetate as a buffer 
solution yielded 2-(2-phenylhydrazono)-3-(furan-2-yl)-3-
oxopropanal (26a) (Scheme 4). Structure of 26a was 
confirmed by elemental analysis, spectral data and chemical 
transformations. 1H-NMR spectrum of 26a showed signal at 
δ = 6.61 (d, 1H, J = 4 Hz, furan H-4), 7.25-7.73 (m, 6H, 
ArH's and furans protons), 7.74 (d, 1H, J = 4 Hz, furan H-3), 
10.14  (s, 1H, CHO), 14.80 (s, br., 1H, NH). Compound 26a 
was refluxed with hydrazine hydrate in ethanol to give 1-(3-
(furan-2-yl)-4H-pyrazol-4-ylidene)-2-phenylhydrazine (27a). 
Further, compound 11 reactes with hydrazine hydrate to 
give 3-(furan-2-yl)-1H-pyrazole (28). The compound 28 
reacted with benzenediazonium chloride in ethanolic sodium 
acetate solution to afford a product identical in all aspect 
(m.p., mixed m.p. and spectra) with 27a which was prepared 
as described in Scheme 4. Similarly, treatment of the 
appropriate aryenediazonium chlorides (25b-d) with 3 or 11 
in cold ethanolic sodium acetate solution gave the 
corresponding (26b-f) respectively. 
Reaction of 3-(dimethylamino)-1-(furan-2-yl)prop-2-en-1-
one (11) with ethyl acetoaetate or acetylacetone in boiling 
acetic acid containing ammonium acetate under reflux gave 
ethyl 6-(furan-2-yl)-2-methylpyridine-3-carboxylate (29) 
and 1-(6-(furan-2-yl)-2-methylpyridin-3-yl)ethanone (30), 
respectively (Scheme 5). Structures of (29) and (30) were 
confirmed by elemental analysis, spectral data and chemical 
transformation. 1HNMR spectrum of 29 showed signals at δ 
= 1.33 (t, 3H, J = 7.5 Hz, CH2CH3), 2.72 (s, 3H, CH3), 4.22 
(q, 2H, J = 7.5 Hz, CH2CH3), 6.49 (d, 1H, furan H-4), 6.51 
(d, 1H, furan H-3), 6.69 (d, 1H, Furan H-5), 7.96 (s, 2H, 
ArH's). Thus, treatment of compound (29) with hydrazine 
hydrate gave 6-(furan-2-yl)-2-methylpyridine-3-carbo-
hydrazide (31), which is converted to azido(6-(furan-2-yl)-
2-methylpyridin-3-yl)methanone (32) by aqueous sodium 
nitrite in hydrochloric acid (6 M) in an ice-bath.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Synthesis of hydrazones (26) and pyrazoles (27) and 
(28)  
Structure of 32 was confirmed by elemental analysis, 
spectral data and chemical transformation.  Frther, 
compound 32 reacted separately with the appropriate 
aromatic amines (aniline, p-toluidine, 4-nitroaniline, 2,4-
dinitroaniline) in dry dioxan or with phenols (phenol, 4-
nitrophenol, 2,4,6-trinitrophenol) in  dry benzene to afford 
substituted urea (33a-d) and aryl carbamates (34a-c) 
respectively. 
Finally, treatment of the enaminone 11 separately with 
ethyl cyanoacetate and benzoylacetonitrile gave ethyl 2-
amino-6-(furan-2-yl)pyridine-3-carboxylate (35) and (2-
amino-6-(furan-2-yl)pyridin-3-yl)(phenyl)methanone (36), 
respectively (Scheme 5). 
 
 
 
 
 
 
 
 
 
 
Scheme 5. Synthesis of hydrazides (31), azides (32), urea 
derivatives (33 a-d), aryl carbamates (34) and pyridines (35 and 
36). 
Conclusion 
In conclusion, compounds of type 3 and 12 proved to be 
useful precursors for synthesis of various fused heterocycles 
via their reactions with 5-aminopyrazoles, 3-aminotriazole, 
2-aminobenzoimidazole and diazotized heterocyclic amines. 
The structures of the newly synthesized compounds were 
confirmed by spectral data, alternate synthesis and elemental 
analyses. 
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CLOUD POINT EXTRACTION FOR PRE-CONCENTRATION 
AND DETERMINATION OF PALLADIUM IN WATER AND 
FOOD SAMPLES BY VISUAL AND FLAME ATOMIC 
ABSORPTION SPECTROMETRY 
Fadl A. Elgendy,[a] Magdi E. Khalifa,[b] and Ayman H. Kamel[c]* 
 
 
Keywords: palladium; cloud point; spectrometry; pre-concentration 
The cloud point extraction (CPE) method was successfully employed for the separation and pre-concentration of trace amounts of
palladium prior to its determination either by flame atomic absorption spectrometry (FAAS) or using visual spectrophotometry.
Palladium(II) reacts with 2-Hydroxyimino-3-(2-hydrazonopyridyl)-butane (HHB) as chelating agent in the presence of p-octyl poly 
ethylene glycol phenyl ether (Triton X-100) as a nonionic surfactant giving a purple to pink  surfactant rich phase chelate which could be 
used for CPE. The effects of experimental conditions such as pH, chelating agent and surfactant concentrations, equilibration temperature
and time on CPE were studied. The performance characteristics of the method such as linearity, detection limit, pre-concentration and 
improvement factors were evaluated. Linearity was obeyed in the range of 0.5−15  and 0.4-18.0 ng mL−1 of Pd(II) with a detection limit of 
0.08 and 0.035 ng mL−1 using FAAS and visual spectrometry, respectively. Validation of the method revealed good performance 
characteristics including good selectivity for Pd2+ over a wide variety of other diverse cations and anions, high reproducibility, low
detection limit, acceptable accuracy and precision. The proposed method was successfully applied for the assessment of palladium (II)
traces in water and food samples with satisfactory results. 
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Introduction 
Monitoring of trace levels of heavy metal ions in 
environmental samples is an important task of analytical 
chemistry due to their positive and/or negative influences on 
the human life.1–3 Palladium metal has an increasing 
importance in today's industries because of its catalytic 
functions, conductivity and resistance to corrosion.4 It is 
essential in key manufacturing processes in the automobile, 
chemical petroleum refining, pharmaceutical and electronics 
industries.5,6 The toxicity of palladium compounds to 
mammals, fish and higher plants are causes for 
environmental concerns. Therefore, these compounds 
usually considered as environmental pollutants 7. Moreover, 
some of Pd(II) compounds have been reported as potential 
health risks to humans, causing asthma, allergy, rhino 
conjunctivitis and other serious health problems.8–10 Several 
analytical techniques have reported for the determination of 
trace elements in natural water, however, the determination 
of palladium under microgram concentration levels is 
generally hampered by insufficient sensitivity of the 
techniques used and or by a matrix effect.11-16 To overcome 
the above drawbacks it requires previously separation and 
pre-concentration technique for enrichment of Pd(II) traces 
prior to its determination.  
Various methods for the separation and pre-concentration 
of Pd(II) ions, such as co-precipitation, fire-assay, sorption 
and ion exchange, liquid–liquid micro-extraction, solid 
phase extraction, and cloud point extraction have been 
developed and applied.17–21 Some advantages of CPE 
extraction are low cost, safety, simplicity, fast operation, no 
need for large amounts of toxic organic solvent, high pre-
concentration factor, and ease of coupling to analytical 
instruments.22-24 This method is based on the property that 
an aqueous solution of surfactants forms micelles and 
becomes turbid above a temperature defined as cloud point 
temperature. Above the cloud point temperature, the original 
surfactant solution separates into a small volume of 
surfactant rich phase and a bulk of diluted aqueous phase, in 
which the concentration of surfactant is close to the critical 
micellar concentration (CMC). Any analyte solubilized in 
the hydrophobic core of the micelles will be concentrated 
into the small volume of the surfactant rich phase which can 
subsequently be determined by different spectrometric 
techniques such as flame atomic absorption spectrometry 
(FAAS) and UV/Visible spectrophotometry. The advantages 
and limitations of this technique have been summarized in 
recent reviews.14,15  
In this work, cloud point pre-concentration method was 
developed and optimized for the extraction and 
determination of Pd(II) in the aqueous samples. Pd(II)  
reacts with 2-hydroxyimino-3-(2-hydrazonopyridyl)butane 
(HHB) giving  colored chelate followed by extraction into p-
octylpolyethyleneglycolphenylether (Triton X-100) as a 
non-ionic surfactant. After optimization the main factors 
affecting the cloud point extraction, the proposed procedure 
has been applied for the pre-concentration of palladium in 
water and food samples prior to its determination either by 
FAAS or using visual colorimetric technique.  
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Experimental 
Instrumentation 
Experiments were carried out using a Varian model 
analyst AA240FS atomic absorption spectrometer equipped 
with deuterium back ground correction. Air-acetylene 
burner was used for Pd(II) measurement in both surfactant-
rich and poor phases. Palladium hollow cathode lamp was 
used as radiation source. The instrumental parameters, 
wavelength (244.8 nm), slit width (0.20 nm) and lamp 
current (5 mA), for determination of Pd(II) were adjusted 
according to the manufacturer's recommendations.  
The nebulizer flow rate and the burner height were 
adjusted in order to obtain the maximum absorbance signal 
by aspirating a solution containing the analyte in methanol 
containing 0.1 mol L−1 HNO3. A Unicam UV/Vis. 
spectrometer controlled by a Hewllet-Packard computer and 
equipped with 1 cm path length quartz cell was used for 
absorption measurement. Cole palmer pH/mV meter (model 
59003-05) was used for pH adjustment. A GFL Model D-
30938 thermostatic bath, maintained at the desired 
temperature, was used for cloud point temperature 
experiments. A Hettich, EBA 21 model centrifuge was used 
to accelerate the phase separation 
Chemicals and Reagents  
All reagents used were of analytical reagent grade and 
were used without further purification. PdCl2, 2-
hydrazinopyridine and 2,3-butandione monoxime  were 
purchased from Sigma Chemicals Co (St. Louis, MO). 
Triton X-100 was obtained from Merck chemicals 
(Germany).   
Standard stock solution of palladium (II) chloride 
(0.01mol L−1) was prepared in 100 mL of water acidified 
with 3.0 mL of concentrated hydrochloric acid. The 
resulting solution was standardized gravimetrically using the 
dimethylglyoxime method.25 Working solutions were 
obtained by suitable dilution of the stock solution with 
deionized-distilled water.  
A 1.0×10-3 mol L-1 stock HHB solution was prepared by 
dissolving the requisite amount in aqueous ethanolic 
solution and made up to the mark with 100 mL of doubly 
distilled water . 
Synthesis of 2-hydroxyimino-3-(2-hydrazonopyridyl)-butane 
(HHB) 
HHB was synthesized by mixing equimolar amounts of 2-
hydrazinopyridine with 0.5 mole 2,3-butanedione monoxime 
in ethanolic solvent and maintaining the reaction mixture at 
reflux temperature for 1hr. The products obtained were 
filtered off, recrystallized from ethanol and finally dried in 
vacuum desiccators over anhydrous CaCl2.26  
Characteristics of HHB are as follows: (C9H12N4O): Yield 
92 %. Color: pale yellow. Elemental analysis Calc.(%): C 
56.2; H 6.2; N 29.1. Found: C 56.3; H 6.2; N 28.8.  
CPE Procedure 
Typically cloud point extraction experiments were 
performed as follows: The pH of an aliquot of 60 mL of 
standard or sample solution containing Pd(II), was adjusted 
to pH 6 by introducing 4 mL of phosphate buffer solution. 
To this solution, 1 mL of  NaCl solution (0.5 mol L−1), and 2 
mL of 10 % (v/v) Triton X-100 solution were mixed and 
transferred into a graduated centrifuge tube. This mixture 
was heated at 70 °C for 20 min in a thermostatic bath. 
Separation of the two phases was achieved by centrifugation 
for 10 min at 3500 rpm. The mixture was cooled in an ice 
bath to increase the viscosity of the surfactant-rich phase, 
and the supernatant aqueous phase was carefully removed 
with a pipette. The remaining micellar phase (400 µL) was 
treated with 600 µL 0.1 mol L-1 HNO3 in ethanol in order to 
reduce its viscosity and facilitate sample handling. The final 
solution was introduced to the flame by conventional 
aspiration. Alternatively, 0.5 mL of methanol was added to 
the surfactant-rich phase and a 100 µL of the solution was 
transferred into a quartz cell containing the blank to measure 
the absorbance of the solution at 548 nm.  
Analytical applications 
The extraction efficiency was studied using spiked natural 
water samples for the recovery of palladium. The natural 
water samples were filtered through a 0.45 µm pore size 
membrane filter to remove suspended particulate matter, 
spiked with known amounts of Pd2+ ions standards (5, 10, 20 
ng mL−1) and stored at 4 °C in the dark. To 60 mL of water 
sample, the cloud point extraction experiments were 
performed as described above. 
For Pd determination in food samples, mallow, peas and 
meat samples were purchased from local markets in Egypt. 
First, Mallow and peas samples were cleaned with tap water 
and double distilled water. Then, these samples were dried 
at 110 °C. Each of the dried varieties of samples and meat 
sample were ground to reduce particle size and then 
thoroughly mixed to ensure homogeneity samples 
individually. Masses of 50 mg of Mallow, peas and meat 
were transferred into separate 250 mL beakers and 5 mL of 
0.5 mol L−1 nitric acid was added to moisten the samples 
thoroughly. This was followed by adding 10 mL of 
concentrated nitric acid and heating on a hot plate (130 °C) 
for 3 h. After cooling to room temperature, 5 mL of 
concentrated perchloric acid was added dropwise. The 
beaker was heated gently until completion of sample 
decomposition resulting in a clear solution. This was left to 
cool down and then was transferred into a 100 mL 
volumetric flask by rinsing the interior of the beaker with 
small portions of 0.1 mol L−1 nitric acid and the solution was 
filled to the mark with the same acid.27 
Results and discussions 
Separation of metal ions by CPE has several advantages 
such as high pre-concentration factor, ease of coupling to 
analytical instruments, simplicity and fast operation. Herein, 
2-hydroxyimino-3-(2-hydrazonopyridyl)butane(HHB) forms 
a stable complex with palladium ions (Fig. 1), which is 
extractable into surfactant-rich phase of Triton X-100.  
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Figure 1. Schematic representation for the preparation of HHB 
ligand and the structure of the complex formed 
 
The ligand (HHB) forms a stable 1:1 complex with 
palladium (II) as previously reported 28.  In order to establish 
the optimum conditions for the formation and extraction of 
the complex, the performance features such as pH; 
concentrations of ligand and surfactant, temperature, and 
incubation time were evaluated and presented in Table 1. 
Table 1.  Optimum conditions for the CPE of palladium ion. 
Optimum conditions for the CPE of 
palladium ion 
Value 
Concentration of chelating agent  3.0x10-5 mol L-1 
Concentration of surfactant  0.3 %(w/v) 
pH range  5-7 
Equilibrium temperature (oC) 70 
Equilibrium time (min)  20 
Centrifugation rate (rpm)  3500 
Centrifugation time (min)  10 
Diluent  0.1 mol L-1 HNO3 in 
methanol 
HHB shows maximum absorbance at 296 nm in the pH 2-
8 range, and its Pd(II) complex in the extracted surfactant-
rich phase has λmax at 548 nm (Fig. 2).  
 
 
 
 
 
 
 
 
 
Figure 2. Absorption spectra of (a) 3×10-5 mol L−1 HHB, (b) 
Pd(II)–HHB complex at pH 6.0 in the presence of: 5.00 ng mL−1 of 
palladium(II), 3×10-4 mol L−1 HHB, 0.3%Triton X-100 
Effect of pH 
The pH of the solution plays a unique role on metal-
chelate formation and subsequent extraction. The effect of 
pH on the complex formation reactions was investigated in 
the range 2–10 as shown in Fig. 3.  The recovery is nearly 
constant in the pH range of 5–7, indicating that the optimum 
pH value for the quantitative extraction of palladium (II) 
complexes lies in this range. Due to these results, pH 6.0 
was chosen for subsequent measurements. At pH <5, bad 
recovery was noticed due to unstable formation of Pd(HHB) 
complex. At pH >7, the recovery decreases due to the 
formation of some hydroxo complexes of Pd. 
 
 
 
 
 
 
 
 
Figure  3. Influences of pH on the recovery of analyte ion. 
Conditions: 30 µg L-1 Pd2+;Titon X-100 0.3%(w/v); HHB 0.3x10-4 
mol L-1. 
Influence of ligand concentration 
The effect of amount of 2-hydroxyimino-3-(2-
hydrazonopyridyl)butane (HHB) on the recovery of analyte 
ion was examined. Concentration of (HHB) was varied in 
the range of   0.2x 10-5–5.0x10-5 mol L–1. Inspection of data 
presented in Fig. 4 indicated that the recovery of Pd(II) 
increases by increasing HHB concentration up to a 
concentration of 3×10–5 mol L–1 and thereafter reaches a 
plateau.  
 
 
 
 
 
 
 
 
Figure 4. Influence of HHB concentration on the recovery 
performance of analyte ion. Conditions: 30 µg L-1 Pd2+;0.3% (w/v) 
Triton X-100; pH 6.0 
N N
H
NH2 +
H3C CH3
O N OH
N
H
N
N
H3C
CH3
N
O-
H2OPd
Cl
N
H
N
N
H3C
CH3
N
OHHHB
[Pd(HHB)Cl]. H2O
2-hydrazinopyridine 2,3-butadione monoxime PdC
l2
R
ef l ux, 1 h
200 300 400 500 600
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
(B)
(A)
296 nm
469 nm
544 nm
Ab
s.
Wavelength, nm
 HBB
 Pd/HBB complex
1 2 3 4 5 6 7 8 9 10
20
40
60
80
100
 
 
Re
co
ve
ry
, %
pH
0.0 0.1 0.2 0.3 0.4 0.5
40
50
60
70
80
90
100
 
 
R
ec
ov
er
y,
 %
Ligand concentration (10-4mol L-1) 
Cloid-point extraction and determination  of Pd in water and food samples      Section A-Research paper 
Eur. Chem. Bull., 2015, 4(2), 60-66   DOI: 10.17628/ecb.2015.4.60-66 63
Thus, a concentration of 3.0×10–5 mol L–1 of (HHB) was 
chosen for further experiments. When the experiments were 
performed without HHB at pH 6; the recoveries of the 
analyte ions were not quantitative. The use of more excess 
of HHB may adversely affect the system performance 
especially in AAS detection. This could be attributed to the 
rise in background signal in the presence of ligand, which 
presumably is trapped in micelles. However this behavior is 
not noticed in visual measurements which could be 
attributed to the great shift of the λmax of Pd(II) –HHB 
extracts from that of  HHB reagent. 
Effect of Triton X-100 concentration 
The amount of Triton X-100 not only affected the 
extraction efficiency, but also the volume of surfactant-rich 
phase. A successful cloud point extraction should maximize 
the extraction efficiency by minimizing the phase volume 
ratio (Vorg/Vaqueous), thus improving its concentration factor 
21.The effect of Triton X-100 concentration was studied in 
the range of 0.08–0.8 % (w/v). The extraction efficiency of 
analyte increased as the concentration of Triton X-100 
increased from 0.08 to 0.3 % (w/v). With the increase of 
triton X-100 concentration above 0.32 %, the siginal 
decrease because of the increment in the overall analyte 
volumes and the viscosity of the surfactant phase. So, a 
concentration of 0.3 % (w/v) was chosen as the optimum 
Triton X-100 concentration in order to achieve the highest 
possible extraction efficiency as shown in Fig. 5. 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of TritonX-100 concentration on the CPE 
performance. Conditions: 30 µg L-1 Pd2+; 0.3x10-4 mol L-1 HHB; 
pH 6.0 
Effect of ionic strength 
The influence of ionic strength on the performance of CPE 
was investigated. For this purpose, various experiments 
were performed by adding different amount of NaCl, 
keeping other experimental conditions constant. The results 
showed that addition of NaCl in the interval of (0.1–0.6 mol 
L−1) has no significant effect on the sensitivity and cloud 
point extraction efficiency. For further studies, the ionic 
strength was kept constant at 0.5 mol L−1 with sodium 
chloride. 
Effects of the equilibrium temperature and incubation time 
Equilibrium temperature and the incubation time were 
also optimized. The effect of equilibrium temperature was 
investigated in the range of t = 20–80°C. Results obtained 
indicated that the absorbance of the analyte reaches 
maximum in the 50–70°C range. The decrease in absorbance 
at temperature higher than 70 °C is probably due to the 
decomposition of the complex which reduces the extraction 
efficiency. So, an equilibrium temperature of 70 °C was 
selected as optimum temperature for further studies. The 
dependence of analytical signal upon incubation time was 
also investigated in the range of 5–30 min. It was observed 
that an incubation time of 10 min is adequate for 
quantitative extraction. 
Effect of viscosity on the analytical signal 
The surfactant rich phase obtain after cloud point 
extraction is rather viscous, ethanol containing 0.1 mol L-1  
nitric acid was added to the surfactant rich phase after 
separation of phase in order to facilitate its introduction into 
the nebulizer of the spectrometer. An optimum volume of 
600 µL methanole solution of 0.1 mol L-1 HNO3 was added 
to the remaining micellar phase (400µL) which shows the 
maximum analytical signal. This added volume of methanol 
was chosen in order to ensure a sufficient volume of sample 
for aspiration.  
Effect of diverse ions 
In view of the high selectivity provided by flame atomic 
absorption spectrometry, the only interference studied were 
those related to the pre-concentration step. The effect of 
foreign ions on the determination of Pd(II) by the proposed 
method was also investigated by measuring the absorbance 
of the solutions containing 20 ng mL−1 of palladium ion in 
the presence of various amounts of other ions. In order to 
evaluate the performance of this procedure, the highest 
tolerability of various common interfering ions were studied. 
Interferences may occur mainly due to competition of other 
existing ionic species in the test solution that may form 
complexes with the HHB. Results obtained indicated that, in 
spite of the high tendency of HHB to form complexes with 
different transition metal ions, fortunately, most of these 
complexes are not extracted in the rich phase and thus 
remains in the supernatant aqueous phase. Therefore, all of 
these interferences were completely controlled by adding 
excess HHB (1.0x10-4 mol L-1 especially in visual 
spectrometric measurements). The tolerable limits of various 
foreign ions were studied in solution containing 20 ng mL−1 
of Pd(II), by keeping the relative error between ± 5 %. It 
was found that most of the investigated species did not 
interfere even when present in 1000-fold excess over Pd(II). 
Data presented in Table 2 indicated that palladium 
recoveries were almost quantitative in the presence of the 
studied interfering species. 
Calibration, precision and detection limits 
The calibration graph was obtained by pre-concentration 
of 60 mL of sample in the presence of 0.3 % Triton X-100 
under the optimum instrumental condition.  
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Table 2. Effect of foreign ions on the preconcentartion and 
determination of Pd2+ 
Interferent Concentration (mg L-1) Recovery (%) 
K+ 20x103 101.3 
Na+ 20x103 103.1 
Ca2+ 100 99.6 
Mg2+ 50 101.4 
Fe2+ 1 101.9 
Zn2+ 1 102.7 
Cu2+ 2 98.6 
Ni2+ 2 102.8 
Al3+ 2 99.8 
Pb2+ 4 79.5 
Hg2+ 4 103.5 
Cd2+ 6 100.6 
Ba2+ 8 98.5 
Mn2+ 8 99.7 
 
Table 3 shows the calibration parameters, the standard 
deviations obtained for 10 samples subjected to the 
complete procedure and the detection limit. The enrichment 
factor was calculated as the ratio slope of the calibration 
curve obtained from the pre-concentrated samples to that 
obtained without pre-concentration. The precision of the 
method was established by repeated assays (n = 10) using 10 
ng mL-1 solutions of analyte ions. The limit of detection was 
sufficiently low as compared that obtained by FAAS 
without pre-concentration limits around 2 mg L-1.  
Table 3. Analytical characteristic of CPE method using FAAS 
technique 
Parameter Analytical feature 
Enrichment factor 80 
Limit of detection (ng mL-1) 0.08 
Regression equation  Y=1.5955x+0.0095 
Correlation coefficient (r2)  0.9991 
Linear range(ng mL-1) 0.5-15 
%R.S.D 2.2 
For visual detection, Table 4 summarizes the analytical 
characteristics of the optimized method, including 
regression equation, linear range, limit of detection, pre-
concentration and improvement factors. The limit of 
detection and limit of quantification are defined as LOD = 
3Sb/m and LOQ = 10Sb/m where Sb and m are standard 
deviation of the blank and slope of the calibration curve, 
respectively. By the use of the foregoing formula 0.035 and 
0.116 ng mL−1 were obtained for LOD and LOQ, 
respectively. Because the amount of palladium (II) in 10 mL 
of sample solution is measured after pre-concentration by 
cloud point extraction in a final volume of 0.7 mL (0.2 mL 
surfactant-rich phase and 0.5 mL methanol), the maximum 
pre-concentration factor of the solution is 20. The 
improvement factor defined as the ratio of the slope of the 
calibration graph for CPE method to that of the calibration 
graph in micellar media without pre-concentration was 100. 
The relative standard deviation (RSD) was 3.3 % and 2.9 % 
for concentrations of palladium of 2.0 and 5.0 ng mL−1, 
respectively (Table 4). 
Table 4. Analytical features of the proposed method for pre-
concentration of palladium (II) using visual spectrophotometric 
technique 
Parameter Analytical feature 
Linear range (a)             0.4−18.0 ( ng mL−1) 
Regression equation (a)       0.014C ng mL−1 + 0.090 (n 
= 8) 
Correlation coefficient (r2) (a) 0.995 
Linear range (b)                     50−2000 ( ng m L−1) 
Regression equation (b)         0.00011C ng mL−1+0.080 (n 
= 10) 
Correlation coefficient (r2) (b)  0.998 
Improvement factor        100 
Maximum pre-concentration 
factor    
20 
Repeatability     RSD 3.5 % (for 2.0 ng 
mL−1, n = 6) 
Repeatability RSD, 2.7 % (for 5.0 ng 
mL−1, n = 6) 
Limit of detection    0.0350 (3Sb, ng mL−1) 
(n = 7) 
Limit of qualification      0.110 (10Sb, ng mL−1)  
(n = 7) 
(a) After pre-concentration.(b) Before pre-concentration. 
Table 5. Determination of analyte ion in tape water, river water 
and food samples using proposed methodology (n=4) 
Sample Added  
(µg g-1) 
Found  
(µg g-1) 
Recovery, % 
Tap water 70  72 97.1 
 100 98 98 
River water 70  71.5 102.1 
 100 102 102 
Meat 70  69.7 99.6 
 100 97.5 97.5 
Malow 70  71.5 102.1 
 100 103.5 103.5 
Peas 70  68.8 98.3 
 100 102.7 102.7 
Determination of palladium in real samples 
The developed method was applied to the determination 
of palladium in tap water, river water (El-Mansourah, 
Egypt) and food samples (meat, mallow and peas). The 
results were given in Table 5. These samples were subjected 
to preconcentration and metal ions determination using the 
proposed procedure. The percentage recovery (R) was 
calculated by using the equation:  
 
 
 
where Cm is a value of metal in a spiked sample, C0 is a 
value of metal in a sample and m is the amount of metal 
spiked.29 The obtained recoveries were reasonable for trace 
palladium analysis in food matrices, in a range of 94–106 %. 
m 0100
C C
R
m
−=
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Table 6. Comparison of the present method with reported methods for the preconcentration and CPE of palladium 
Reagent Surfactant Technique Detection 
limit 
Ref. 
2-Hydroxyimino-3-(2-hydrazonopyridyl)butane (HHB) 
[CHCl3 solvent extraction] 
 
Solvent 
extraction 
spectrophotometry 5.0 µg mL−1 12 
Bis((1H-benzo[d]imidazol-2yl)ethyl)sulfane TritonX-114 FAAS 1.6 ng mL−1 21 
 
2-Hydroxyimino-3-(2-hydrazonopyridyl)butane (HHB) 
[flotation] 
 
Oleic acid 
(HOL) 
 
Spectrophotometry 
 
80 µg mL−1 
 
30 
 
ICP 
 
0.3 µg mL−1 
 
1,8-Diamino-4,5-dihydroxyanthraquinone  
 
TritonX-114 
FAAS 0.3 ng mL-1 
31 
 
(2-((1H-Benzo[d]imidazole-2-yl)methoxy)phenoxy)-
methyl)-1H-benzo[d]imidazole (BIMPI) 
 
TritonX-114 
 
FAAS 
 
25 ng mL−1 
32 
 
1-(2-Pyridylazo)-2-naphthol 
 
TritonX-114 
 
ETASS 
 
0.01 ng mL−1 
33 
 
4-(2-Benzothiazolylazo)-2,2-biphenyldiol 
 
TritonX-114 
 
spectrophotometry 
 
0.6 ng mL−1 
34 
 
1-Phenyl-3-methyl-4-benzoyl-5-pyrazolone  
 
PONPE 7.5 
 
GFAAS 
1.8 µg mL−1 35 
 
2-Hydroxyimino-3-(2-hydrazonopyridyl)butane (HHB) 
 
TritonX-100 
TritonX-100 
 
FAAS 
spectrophotometry 
 
0.08 ng mL−1 
0.033 ng mL−1 
 
Present 
work 
Conclusions 
We described the use of new micellar system as an 
alternative method for pre-concentration of palladium in 
water and food samples before analysis using CPE-FAAS or 
by using visual detection. This study offers a simple, rapid, 
inexpensive, and nonpolluting technique for the 
preconcentration and determination of trace metals. This 
approach offered several advantages over reported 
method,12,21,30-35 as shown in Table 6. The proposed reagent 
is versatile, as it has been early applied for pre-concentration 
of Pd(II) either by using solvent extraction or by floatation 
techniques.12,30 Foreign ions did not interfere in the proposed 
method, which is making the method selective and were 
successfully applied for the determination of palladium in 
water and food samples. 
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CONFORMATIONAL EXCHANGE OF 1,8-DIBENZOYL-2,7-
DIMETHOXYNAPHTHALENE ANALOGUES IN SOLUTION 
Akiko Okamoto,[a]* Shinji Ohisa,[a] Sayaka Yoshiwaka,[a] and                        
Noriyuki Yonezawa[a] 
 
Keywords: peri-Aroylated naphthalene, Solution structure, Cooperative bond rotation, interconversion behaviour, 1H NMR study. 
Dynamic feature of 1,8-dibenzoyl-2,7-dimethoxynaphthalene in solution is revealed through systematic comparison with the analogues
bearing p-carboxy group or p-amino one.  (Carbonyl)C–C(naphthalene) bond rotation of aroyl group in amino group-bearing analogue is 
slower than that of aroyl group in no substituent-bearing (i.e., benzoyl group or carboxy group) analogues.  NMR study of unsymmetrically
substituted 1,8-dibenzoylnaphthalene analogues shows that (carbonyl)C–C(naphthalene) bond rotation of one benzoyl group is retarded by 
the other aroyl group bearing p-amino group.  These results strongly indicate that the bond rotation behaviour of two aroyl groups in the
1,8-diaroylnaphthalene analogue does not occur independently with each other but cooperatively. 
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Introduction 
1,2-Disubstituted polyaromatic compounds (e.g., 
naphthalene, phenanthrene, and anthracene) have been 
recognized as important building blocks because of their 
great number of chemical properties, including 
stereoselectivity in organic reactions, molecular recognitions, 
axial chilarity, and so on.1-5  These unique chemical 
properties are originated from configurationally stable 
isomers and the transformation.  Therefore, conformational 
studies of this type of the polyaromatic frameworks in 
crystal and in solution have been actively performed.6-8  We 
have found that peri (1,8)-selective diaroylation of 
naphthalene ring core readily proceeds by employing 
suitable acidic mediator.9,10  The naphthalene ring bearing 
two identical α-substituted benzoyl groups in peri-positions 
is expected to involve two types of conformers, because the 
peri-substituted benzoyl groups can adopt either an anti-
disposition (with the two benzoyl groups oriented in an 
opposite direction) or a syn-disposition (with the two 
benzoyl groups oriented in same direction).  In crystalline 
form, almost all peri-aroylnaphthalene derivatives reported 
by us have two common structural features, viz., two 
benzoyl groups are attached almost perpendicularly to the 
naphthalene ring and oriented in an opposite direction (anti-
conformer).11-13  Several examples have proved the 
existence of peri-aroylnaphthalene compounds in which the 
two aroyl groups are oriented in same direction (syn-
conformer).14,15  To clarify the structure determining factors 
of the anti-conformer and syn-one, we have investigated the 
spatial organizations and the molecular accumulation 
structures of the syn-conformer and the designed syn-
candidates in their crystals. Comparison of syn-conformer 
with the syn-candidate analogues has revealed that selection 
of anti- or syn-conformer in crystal state is mainly 
determined by the balance between strong molecular 
interaction and molecular packing density.16 In solution, 
both conformers are unlikely to be configurationally stable 
and would rapidly interconvert at ambient temperature. In 
fact, by using variable temperature NMR, we have reported 
that the two aroyl groups in 1,8-dibenzoylated naphthalene 
compounds rotate freely.17 Recently, we have found that 
bridged peri-aroylnaphthalene can be easily prepared by a 
reaction of 1,8-bis(4-fluorobenzoyl)naphthalene derivatives 
and catechol without high dilution conditions.18 The 
susceptibility of the intramolecularly connection indicates 
that peri-aroylnaphthalene analogues partially take syn-
conformation in solution.  However, the detailed bond 
rotation behaviour of the two aroyl groups in peri-
aroylnaphthalene derivatives and the conformational 
exchange has not been revealed yet.    
Herein, we will discuss the rotation behaviour of the 
neighbouring two aroyl groups in 1,8-diaroylnaphthalene 
analogues in solution and estimate the interconversion 
behaviour including plausible intermediates through 
systematic comparison of 1H NMR spectra of symmetrically 
substituted 1,8-diaroylnaphthalene analogues and the 
unsymmetrically substituted ones. 
Experimental 
All reagents were of commercial quality and were used as 
received. Solvents were dried and purified using standard 
techniques.19 2,7-dimethoxynaphthalene (1) was prepared 
according to literature method.20 
Measurements 
1H NMR spectra were recorded on a JEOL JNM-AL300 
spectrometer (300 MHz) and a JEOL ECX400 spectrometer 
(400 MHz).  Chemical shifts are expressed in ppm relative 
to internal standard of TMS (δ 0.00).  13C NMR spectra 
were recorded on a JEOL JNM-AL300 spectrometer (75 
MHz).  Chemical shifts are expressed in ppm relative to 
CDCl3 (δ 77.0).  IR spectra were recorded on a JASCO 
FT/IR-4100 spectrometer.  Elemental analyses were 
performed on a SUMIKA CHEMICAL ANALYSIS 
SERVICE Sumigraph NHC-22F analyzer. High-resolution 
FAB mass spectra were recorded on a JEOL MStation 
(MS700) ion trap mass spectrometer in positive ion mode. 
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Synthesis of 1,8-dibenzoyl-2,7-dimethoxynaphthalene (2) 
The title compound was synthesized by a direct 
condensation of 2,7-dimethoxynaphthalene (1) with benzoic 
acid, mediated by P2O5–MsOH. To a mixture of 2,7-
dimethoxynaphthalene (0.200 mmol, 37.6 mg) and benzoic 
acid (0.440 mmol, 174 mg), P2O5–MsOH (0.88 mL) was 
added by portions at room temperature. After the reaction 
mixture was stirred at 60 ˚C for 3 h, it was poured into iced 
water (20 mL) and the mixture was extracted with CHCl3 
(15 mL × 3).  The combined extract was washed 
successively with 2 M aqueous NaOH and brine.  The 
organic layer thus obtained was dried over anhydrous 
sodium sulfate.  The solvent was removed under reduced 
pressure to give a powdery product.  Isolation of the title 
compound was carried out by column chromatography 
[hexane : AcOEt = 2 : 1] (1,8-diaroylnaphthalene 63 %; 3-
monoaroylnaphthalene 19 %; 1-monoaroylnaphthalene 3 %).  
Colorless single crystals suitable for X-ray diffraction were 
obtained by recrystallization from ethanol as colorless 
needles, m.p.: 530 K. IR (KBr): 1665, 1626 cm-1. 1H NMR δ 
(300 MHz, DMSO-d6): 3.61 (6H, s), 7.35 (4H, t, J = 7.4 Hz), 
7.41 (2H, d, J = 9.0 Hz), 7.47 (4H, d, J = 7.8 Hz), 7.50 (2H, 
t, J = 6.9 Hz), 8.16 (2H, d, J = 9.0 Hz) ppm. 1H NMR δ (400 
MHz, CDCl3): 3.68 (6H, s), 7.21 (2H, d, J = 9.2 Hz), 7.34 
(4H, dd, J = 7.6, 7.6 Hz), 7.49 (2H, t, J = 7.4 Hz), 7.70 (4H, 
d, J = 7.4 Hz), 7.95 (2H, d, J = 9.2 Hz) ppm. 13C NMR δ (75 
MHz, CDCl3): 56.40, 111.24, 121.47, 125.55, 127.95, 
129.09, 129.84, 132.03, 132.64, 138.61, 156.28, 196.875 
ppm.  The recorded m.p. and spectral data are compatible 
with the literature values.21 
Synthesis of 1,8-bis(4-carboxymethylbenzoyl)-2,7-dimethoxy-
naphthalene (3) 
In a 10 mL-flask, substrate 1 (1.0 mmol, 188 mg), 
terephthaloyl chloride (4.0 mmol, 208 mg) and 
dichloromethane (2.5 mL) were placed.  The reaction 
mixture was heated with stirring up to 60 ˚C, and then TiCl4 
(4.4 mmol, 0.48 mL) was added.  After stirring at 60 ˚C for 
6 h, the reaction mixture was poured into methanol (30 mL), 
and stirred at room temperature overnight.  The reaction 
mixture was added to water (20 mL), and extracted with 
chloroform (20 mL × 3).  The combined extract was washed 
successively with water (20 mL × 3) and brine (20 mL × 3).  
The organic layer thus obtained was dried over anhydrous 
MgSO4.  The solvent was removed under reduced pressure 
to give a  cake.  Compound (3) was isolated by silica gel 
column chromatography (hexane: AcOEt = 5 : 4) as pale 
white yellow powder, Yield:  23%, m.p.: 467–468 K. IR 
(KBr): 1724, 1670, 1609, 1511, 1270 cm-1. 1H NMR δ (300 
MHz, CDCl3): 3.66 (6H, s), 3.93(6H, s), 7.20 (2H, d, J = 9.0 
Hz), 7.76 (4H, d, J = 8.4 Hz), 7.97 (2H, d, J = 9.0 Hz), 8.03 
(4H, d, J = 8.4 Hz) ppm. 13C NMR δ (75 MHz, CDCl3): 
52.33, 56.27, 111.13, 120.49, 125.52, 128.87, 129.43, 
133.35, 141.90, 156.66, 166.57, 196.90, 196.95 ppm. Calcd 
for C30H24O8: C, 70.31; H, 4.72; found C, 70.19; H, 4.74. 
Synthesis of 1,8-bis(4-carboxybenzoyl)-2,7-dimethoxynaphtha-
lene (4) 
In a 50 mL flask, the methyl ester (3) (0.23 mmol, 118 
mg), acetone (2.5 mL), and 2 M aqueous NaOH (2.5 mL) 
were placed.  After stirring at room temperature for 3 h, 
conc. HCl was added to the reaction mixture until the pH is 
2.  The precipitates were collected by filtration with suction 
and washed with water followed by drying in vacuo. Colour: 
yellow powdery solid, Yield: 99 %, m.p.: 612 K. IR (KBr): 
1698, 1673, 1268 cm-1. 1H NMR δ (300 MHz, DMSO-d6): 
3.62 (6H, s), 7.46 (2H, d, J = 9.0 Hz), 7.59 (4H, d, J = 8.1 
Hz), 7.91 (4H, d, J = 8.7 Hz), 8.20 (2H, d, J = 9.0 Hz) ppm. 
13C NMR δ (75 MHz, CDCl3): 56.910, 112.352, 119.972, 
125.470, 129.170, 129.466, 129.733, 133.434, 134.715, 
141.732, 156.876, 167.297, 196.687 ppm. Calcd. for 
C28H20O8: C, 69.42 %, H, 4.16%, found C, 69.32 %, H, 
4.01 %. 
Synthesis of 2,7-dimethoxy-1,8-bis(4-nitrobenzoyl)naphthalene 
(5)  
In a 10 mL flask, 4-nitrobenzoyl chloride (1.2 mmol, 222 
mg) and 1,2-dichloroethane (1.0 mL) were placed.  The 
reaction mixture was stirred at 70 ˚C, and TiCl4 (1.2 mmol, 
0.13 mL) was added.  After stirring for 0.5 h, substrate 1 
(0.2 mmol, 37.6 mg) was added to the reaction mixture and 
further stirred for 3 h.  Then the mixture was poured into 
iced water (30 mL) and extracted with chloroform (15 mL × 
3).  The combined extract was washed successively with 2 
M aqueous NaOH solution (15 mL × 3) and brine (15 mL × 
3).  The organic layer thus obtained was dried over 
anhydrous MgSO4.  The solvent was removed under reduced 
pressure to give a cake.  The crude product was purified by 
re-precipitation with chloroform/hexane.  The precipitate 
was collected with suction filtration and dissolved in 
acetone.  After decolorization by activated charcoal powder, 
acetone solution was evaporated (81% isolated yield).  The 
product was further washed with ethanol–ethyl acetate 
solution and dried in vacuo. Yield: 25 %, m.p.: 567–574 K. 
IR (KBr): 1657, 1604, 1519 cm-1. 1H NMR δ (300 MHz, 
CDCl3): 3.69 (6H, s), 7.24 (2H, d, J = 12.0 Hz), 7.90 (2H, d, 
J = 11.6 Hz), 8.04 (2H, d, J = 11.6 Hz), 8.27 (2H, d, J = 
11.6 Hz) ppm. 13C NMR δ (125 MHz, CDCl3): 56.35, 
111.11, 119.58, 123.63, 125.61, 129.86, 130.54, 133.48, 
143.47, 150.22, 157.14, 196.84 ppm; HRMS (FAB; m-
NBA) m/z: [M + H]+, Calc. for C26H19N2O8, 487.1141;  
found, 487.1197. 
Reduction of 2,7-dimethoxy-1,8-bis(4-nitrobenzoyl)naphtha-
lene (5) 
In a 10 mL flask, (5) (0.2 mmol, 97.3 mg), stannous 
chloride dihydrate (2.0 mmol, 431 mg), and ethanol (1.6 
mL) were placed.  The reaction mixture was stirred at 70 ˚C 
for 2 h.  After the reaction is over, the mixture was poured 
into 2 M aqueous HCl (15 mL) and stirred at room 
temperature for 15 min.  The solution mixture was washed 
with chloroform (15 mL ×3) and poured into 4 M aqueous 
NaOH solution (40 mL).  The precipitate was collected with 
suction filtration, and dried under reduced pressure.  The 
collected precipitate was dissolved in acetone, filtered and 
solvent was removed to get the product, 1,8-bis(4-
aminobenzoyl)-2,7-dimethoxynaphthalene (6).13 The 
product was further purified for X-ray crystallography by 
recrystallization from methanol as yellow needles. Yield: 
93 %, m.p. = 580.5–583 K (decomp.). IR (KBr): 3455, 3374, 
1660, 1625 cm-1. 1H NMR δ (300 MHz, DMSO-d6): 3.62 
(6H, s), 5.89 (4H, s), 6.40 [4H, d (broad), J = 8.4 Hz], 7.15 
[4H, d(br), J = 7.5 Hz], 7.35 (2H, d, J = 9.0 Hz), 8.02 (2H, d, 
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J = 9.0 Hz) ppm. 13C NMR δ (75 MHz, DMSO-d6); 56.37, 
111.59. 112.22, 122.11, 125.06. 127.41, 128.86, 131.15, 
131.29, 153.09, 155.06, 192.49 ppm. HRMS (FAB; m-
NBA) m/z: [M+H]+: Calc. for C26H23O4N2, 427.1658; found, 
427.1633. 
Synthesis of methyl 4-(2,7-dimethoxy-1-naphthoyl)benzoate (7) 
Terephthaloyl chloride (0.60 mmol, 122 mg) and 
dichloromethane (1.0 mL), and TiCl4 (0.66 mmol, 0.072 
mL) stirred in a 10 mL flask to give a clear yellow solution.  
Then substrate 1 (0.4 mmol, 75.2 mg) was added to the 
reaction solution and stirred at room temperature for 3 h.  
After the reaction is over, the mixture was poured into 
methanol (30 mL) and stirred for 1 h.  The mixture was 
added to water (20 mL) and extracted with chloroform (20 
mL × 3).  The combined extract was washed successively 
with water (20 mL × 3), 2 M NaOH aqueous (20 mL × 3) 
and brine (20 mL × 3).  The organic layer thus obtained was 
dried over anhydrous MgSO4.22 The solvent was removed 
under reduced pressure to give cake.  Compound (7) was 
isolated by silica gel column chromatography (hexane: 
AcOEt = 4 : 1; 66% isolated yield; pale yellow powder).  
The product was further purified for X-ray crystallography 
by recrystallization from methanol. Colour: pale yellow, 
yield: 66 %, m.p. = 428–430 K. IR (KBr): 1674, 1625, 1511 
cm-1. 1H NMR δ (300 MHz, CDCl3): 3.73 (3H, s), 3.76 (3H, 
s), 3.94 (3H, s), 6.83 (1H, s), 7.01 (1H, d, J = 9.0 Hz), 7.14 
(1H, d, J = 9.0 Hz), 7.71 (1H, d, J = 9.0 Hz), 7.87–7.90 (3H, 
m), 8.07 (2H, d, J = 8.1 Hz) ppm. 13C NMR δ (75 MHz, 
CDCl3): 52.4, 55.2, 56.2, 101.9, 110.1, 117.2, 121.0, 124.4, 
129.2, 129.7, 129.8, 131.6, 133.0, 133.9, 141.6, 155.4, 159.1, 
166.4, 197.5 ppm. Calc. For C21H18O5: C, 71.99; H, 5.18; 
found C, 72.05; H, 5.25.  
Synthesis of unsymmetric 1,8-diaroylated analogue (8) 
Benzoyl chloride (0.60 mmol, 0.070 mL), methylene 
chloride (0.5 mL), and TiCl4 (0.9 mmol, 0.099 mL) were 
placed in a 10 mL flask and stirred to give a clear yellow 
solution. Compound (7) (0.15 mmol, 52 mg) was added to 
the this mixture.  After stirring at room temperature for 20 h, 
the mixture was poured into iced water (30 mL), and 
extracted with chloroform (15 mL × 3).  The combined 
extract was washed with water (20 mL × 3), 2 M NaOH aq. 
(20 mL × 3) and brine (20 mL × 3).  The organic layers thus 
obtained were dried over anhydrous MgSO4.  The solvent 
was removed under reduced pressure to give a cake.  1-
Benzoyl-8-(4-carboxymethylbenzoyl)-2,7-
dimethoxynaphthalene (8) was isolated by preparative TLC 
(PTLC; toluene: AcOEt = 15 : 1) as a yellow powdery solid, 
Yield: 46 %, m.p.: 450–451 K. IR (KBr): 1725, 1664, 1650, 
1608, 1510, 1458 (Ar, naphthalene), 1268 cm-1. 1H NMR δ 
(300 MHz, DMSO-d6): 3.65 (3H, s), 3.67 (3H, s), 3.92 (3H, s), 
7.19 (1H, d, J = 9.0 Hz), 7.21 (1H, d, 9.0 Hz), 7.35 (2H, t, J = 
8.4, 8.5 Hz), 7.50 (1H, t, J = 2.4 Hz), 7.71 (2H, d, J = 8.4 Hz), 
7.77 (2H, d, J = 8.4 Hz), 7.95 (1H, d, J = 9.3 Hz), 7.96 (1H, d, J 
= 9.3Hz), 8.02 (2H, d, J = 8.7 Hz) ppm. 13C NMR δ (75 MHz, 
CDCl3): 52.417, 56.413, 56.490, 111.157, 111.396, 120.842, 
121.282, 125.651, 128.156, 128.969, 129.227, 129.456, 
130.126, 132.363, 132.621, 132.946, 133.328, 138.673, 
142.086, 156.589 (overlap), 166.752, 196.620, 197.432 ppm. 
HRMS (FAB; m-NBA) m/z: [M+H]+: Calc. for C28H22O6, 
454.1416, found, 454.1425. 
Synthesis of unsymmetric 1,8-diaroylated analogue 9 
The unsymmetric methyl ester (8) (0.06 mmol, 27.2 mg), 
methanol (1.0 mL), and 2 M aqueous NaOH (1.0 mL) were 
refluxed in a 10 mL flask with a Dimorth condenser for 3 h. 
The reaction mixture was cooled to room temperature and 
then HCl was added till pH becomes 2.  The precipitate was 
collected by filtration with suction and washed with water, 
followed by drying in vacuo. The yield of 1-benzoyl-8-(4-
carboxybenzoyl)-2,7-dimethoxynaphthalene (9) was 98 %. 
Colour: pale yellow solid, m.p. = 510–511 K. IR (KBr): 
3448(COO–H), 1697 (C=OOH), 1664 (C=O), 1610, 1512 
(Ar, naphthalene), 1268 (O-Me) cm-1. 1H NMR δ (300 MHz, 
DMSO-d6): 3.61 (3H, s), 3.62 (3H, s), 7.33-7.378 (2H, m), 
7.44-7.49 (5H, m), 7.55 (2H, d, J = 8.1 Hz), 7.90 (2H, d, J = 
8.1 Hz), 8.18 (1H, d, J = 9.0 Hz), 8.18 (1H, d, J = 9.3 Hz) 
ppm. 13C NMR δ (75 MHz, DMSO-d6): 56.868, 56.887, 
112.257, 112.324, 120.145, 120.460, 125.448, 128.701, 
129.130 (overlap), 129.397, 129.712, 133.079, 133.270, 
133.356, 134.615, 138.678, 141.787, 156.639, 156.705, 
167.369, 196.270, 196.938 ppm. HRMS (FAB; m-NBA) 
m/z: [M+H]+:calcd for C27H21O6, 441.1338 ; found, 
441.1384. 
Synthesis of 1-(4-nitrobenzoyl)-2,7-dimethoxynaphthalene (10) 
4-Nitrobenzoyl chloride (6.6 mmol, 1.21 g), 
dichloromethane (15 mL), and AlCl3 (7.26 mmol, 968 mg) 
were placed in a 10 mL flask and stirred at 0 ˚C.  Substrate 1 
(6.0 mmol, 1.13 g) was added to the mixture and further 
stirred at 0˚C.23 After stirring for 24 h, the mixture was 
poured into iced water (40 mL) and extracted with 
chloroform (20 mL × 3).  The combined extract was washed 
successively with 2 M aqueous NaOH solution (30 mL × 3) 
and brine (20 mL × 3).  The organic layer thus obtained was 
dried over anhydrous MgSO4.  The solvent was removed 
under reduced pressure to give the cake.  Compound (10) 
was isolated by preparative crystallization 
(chloroform/hexane) as yellow cubic crystals. Yield: 45 %, 
m.p.: 440 K. IR (KBr): 1357, 1594, 1267 cm-1. 1H NMR δ 
(300 MHz, CDCl3): 3.76 (3H, s), 3.76 (3H, s), 6.87 (1H, d, J 
= 2.3 Hz), 7.05 (1H, dd, J = 9.0, 2.3 Hz), 7.16 (1H, d, J = 
9.01 Hz), 7.75 (1H, d, J = 8.71 Hz), 7.93 (1H, d, J = 9.01 
Hz), 7.98 (2H, d, J = 9.01 Hz), 8.27 (2H, d, J = 8.71 Hz) 
ppm. 13C NMR δ (75 MHz, CDCl3): 21.790, 22.730, 68.346, 
76.447, 82.545, 83.897, 90.317, 91.026, 95.666, 96.490, 
96.704, 98.822, 99.605, 109.643, 122.302, 125.961, 162.866 
ppm. Calc. For C19H15O5N, C, 67.65; H, 4.48; N, 4.15; 
Found C, 67.52 ; H, 4.51 ; N, 4.06.  
Synthesis of unsymmetric 1,8-diaroylated analogue 11  
Benzoyl chloride (1.4 mmol, 0.16 mL), methylene 
chloride (2.5 mL), and TiCl4 (1.1 mmol, 1.21 mL) were 
placed in a 10 mL flask and heated with stirring to 30 ˚C.  
Compound (10) (1.00 mmol, 337 mg) was added to the 
reaction mixture.  After stirring at 30 ˚C for 5 h, the mixture 
was poured into iced water (30 mL), and extracted with 
chloroform (15 mL × 3).  The combined extract was 
successively washed successively with water (20 mL × 3), 2 
M aqueous NaOH (20 mL × 3) and brine (20 mL × 3).  The 
organic layer thus obtained was dried over anhydrous 
MgSO4.  The solvent was removed under reduced pressure 
to give the cake. 1-Benzoyl-8-(4-nitrobenzoyl)-2,7-
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dimethoxynaphthalene (11) was isolated by preparative 
crystallization (chloroform/hexane) as a yellow powdery 
solid. Yield: 44 %, m.p.: 509–510 K. IR (KBr): 1663(C=O), 
1608, 1513, 1454 (Ar, naphthalene), 1346 (C–NO2), 1268 
(O–Me) cm-1. 1H NMR δ (300 MHz, DMSO-d6): 3.67 (3H, 
s), 3.69 (3H, s), 7.21 (1H, d, J = 9.0 Hz), 7.24 (1H, d, J = 9.3 
Hz), 7.87 (2H, d, J = 8.7 Hz), 7.984 (2H, d, J = 9.0 Hz), 8.00 
(2H, d, J = 9.3 Hz), 7.70 (2H, dd, J = 1.5, 7.65 Hz), 7.53 
(1H, t, J = 1.5, 7.2 Hz), 7.37 (2H, t, J = 7.2, 7.4 Hz) ppm. 
13C NMR δ (75 MHz, CDCl3); 56.413, 56.470, 110.966, 
111.501, 120.010, 120.995, 123.500, 125.613, 128.242, 
129.217, 129.925, 130.202, 132.592, 133.089, 133.128, 
138.682, 143.405, 150.021, 156.714, 156.800, 195.702, 
197.901 ppm. HRMS (FAB; m-NBA) m/z: [M+H]+: Calc. 
for C26H20NO6, 442.1291, found, 442.1311.  
Reduction of Compound 11 
Compound (11) (0.4 mmol, 176 mg), stannous chloride 
dihydrate (2.0 mmol, 431 mg), and ethanol (2.0 mL) were 
placed in a 10 mL flask with a Dimorth condenser.  The 
reaction mixture was stirred at 70˚C for 2.5 h.  After the 
completion of reaction, the mixture was poured into iced 
water (20 mL), and 2 M aqueous NaOH (20 mL) was added.  
The basic solution was extracted with chloroform (10 mL 
×3).  The combined extract was successively washed with 
water (20 mL × 3), 2 M aqueous NaOH (20 mL × 3) and 
brine (20 mL × 3), and dried over anhydrous Na2SO4.  The 
solvent was removed under reduced pressure to give the 
cake (58%).  1-(4-Aminobenzoyl)-8-benzoyl-2,7-dimeth-
oxynaphthalene (12) was isolated by silica gel column 
chromatography (Toluene : AcOEt = 2 : 1) as a pale yellow 
powder. Yield:  48%, m.p.: 537 K. IR (KBr): 3467 (N–H), 
3378 (N–H), 1663, 1646 (C=O), 1597, 1510, 1450 (Ar, 
naphthalene), 1271 (O-Me) cm-1. 1H NMR δ (300 MHz, 
DMSO-d6): 3.59 (3H, s), 3.65 (3H, s), 5.92 (2H, broad), 
6.34 (2H, broad), 7.12 (2H, broad), 7.31 (2H, m), 7.39 (2H, 
d, J = 9.0 Hz), 7.40-7.50 (3H, m), 8.07 (1H, d, J = 9.0 Hz), 
8.09 (1H, d, J = 9.0 Hz) ppm. 13C NMR δ (75 MHz, DMSO-
d6): 56.786, 56.882, 112.027, 112.266, 112.677, 121.234, 
122.133, 125.422, 127.257, 128.366, 128.586, 128.959, 
129.294, 131.225, 131.933, 132.506, 132.707, 153.922, 
155.777, 156.083, 193.197, 195.406 ppm. HRMS (FAB; m-
NBA) m/z: [M+H]+: Calc. for C26H22NO4, 412.1549 ; found, 
412.1595. 
Synthesis of unsymmetric 1,8-diaroylated analogue 13 
Terephthaloyl chloride (1.0 mmol, 203 mg) and 
dichloromethane (0.7 mL), and TiCl4 (1.1 mmol, 0.21 mL) 
were placed in a 10 mL flask and stirred with heating at 
30˚C.  Compound 10 (0.2 mmol, 67.4 mg) was added to the 
reaction mixture and stirred at 30˚C for another 24 h.  After 
the reaction is over, the mixture was poured into methanol 
(30 mL) and water (20 mL) was added.  The reaction 
mixture was extracted with chloroform (15 mL × 3).  The 
combined extract was washed successively with water (20 
mL × 3) and brine (20 mL × 3), and dried over anhydrous 
MgSO4.  The solvent was removed under reduced pressure 
to give the cake.  The product, 1-(4-carboxymethyl)-8-(4-
nitrobenzoyl)-2,7-dimethoxynaphthalene (13) was isolated 
by silica gel column chromatography (hexane: AcOEt = 5 : 
4) as a yellow powdery solid. Yield: 61 %, m.p.: 468–469 K. 
IR (KBr): 1722, 1679, 1608, 1513, 1345 cm-1. 1H NMR δ 
(300 MHz, CDCl3): 3.668 (3H, s), 3.673 (3H, s), 3.932 (3H, 
s), 7.21-7.25 (2H, m), 7.78 (2H, d, J = 8.1 Hz), 7.88 (2H, d, 
J = 8.4 Hz), 7.99-8.03 (2H, m), 8.05 (2H, d, J = 7.8 Hz), 
8.23 (2H, d, J = 9.0 Hz) ppm. 13C NMR δ (75 MHz, CDCl3): 
52.33, 56.23, 110.88, 111.22, 119.70, 120.27, 123.39, 
125.49, 128.82, 129.42, 129.75, 130.25, 132.87, 133.55, 
141.92, 143.26, 149.97, 156.78, 156.89, 196.04, 197.43, 
221.54 ppm. HRMS (FAB; m-NBA) m/z: [M+H]+: Calc. for 
C28H22NO8, 500.1345, found 500.1361.  
Reduction of Compound 13 
Compound (13) (0.165 mmol, 82.5 mg), stannous chloride 
dihydrate (0.825 mmol, 186 mg), and ethanol (2.0 mL) were 
placed in a 50 mL flask with a Dimorth condenser.  The 
reaction mixture was stirred at 70˚C for 2 h.  After the 
completion of the reaction, the mixture was poured into iced 
water (20 mL) and 2 M aqueous NaOH (20 mL) was added.  
The basic reaction solution was extracted with chloroform 
(10 mL × 3).  The combined extract was washed 
successively with 2 M aqueous NaOH (20 mL × 3) and 
brine (20 mL × 3).  The organic layer was dried over 
anhydrous Na2SO4.  The solvent was removed under 
reduced pressure to give the cake (58%).  1-(4-
Aminobenzoyl)-8-(4-carboxymethyl)-2,7-
dimethoxynaphthalene (14) was isolated by silica gel 
column chromatography (Toluene : AcOEt = 2: 1) as a pale 
yellow powder.  Yield: 69 %, m.p.: 507-508 K. IR (KBr): 
3463 (N–H), 3370 (N-H), 2935 (O–C), 2849 (Ar–OMe), 
1720 (MeOC=O), 1664 (C=O), 1610, 1511,  (Ar, 
naphthalene), 1277 (O-Me) cm-1. 1H NMR δ (300 MHz, 
DMSO-d6): 3.59 (3H, s), 3.66 (3H, s), 3.84 (3H, s), 5.98 (2H, 
s), 6.32 (2H, broad), 7.18 (2H, broad), 7.41 (2H, J = 9.0 Hz), 
7.55 (2H, broad), 7.90 (2H, d, J = 6.9 Hz), 8.08–8.14 (2H, 
m) ppm. 13C NMR δ (75 MHz, CDCl3); 52.398, 56.432, 
56.604, 111.033, 111.540, 113.681, 121.072, 122.037, 
125.642, 128.950, 129.361, 129.523, 129.982, 131.799, 
132.057, 132.420, 132.994, 142.086, 151.312, 156.131, 
156.360, 166.877, 195.004, 195.951 ppm. HRMS (FAB; m-
NBA) m/z: [M+H]+: Calc. for C28H24NO6, 470.1604 found, 
470.1610. 
Synthesis of unsymmetric 1,8-diaroylated analogue 15 
The unsymmetric methyl ester (14) (0.12 mmol, 54.6 mg), 
2 M aqueous NaOH (1.0 mL), and methanol (1.0 mL) are 
placed in a 10 mL flask with a Dimorth condenser and 
heated with stirring up to 80 ˚C for 1 h.  The reaction 
mixture was then cooled and conc. HCl was added to render 
the neutral (pH 7).  The reaction mixture was extracted with 
chloroform (10 mL x 3).  The combined organic layer thus 
obtained was dried over anhydrous Na2SO4.  The solvent 
was removed under reduced pressure to give the cake.  1-(4-
Aminobenzoyl)-8-(4-carboxy)-2,7-dimethoxynaphthalene 
(15) was isolated by preparative crystallization 
(Chloroform/methanol) as a yellow powdery solid. Yield: 
75 %, m.p.: 545-547 K. IR (KBr): 3364 (O–H), 1653 (C=O), 
1653, 1590, 1511 (Ar, naphthalene), 1262 (O-Me)cm-1. 1H 
NMR δ (300 MHz, DMSO-d6): 3.59 (3H, s), 3.66 (3H, s), 
5.98 (2H, s), 6.35 (2H, broad), 7.13 (2H, broad), 7.40 (2H, d, 
J = 9.0 Hz), 7.54 (2H, broad), 7.89 (2H, d, J = 6.6 Hz), 8.07-
8.13 (2H, m) ppm. 13C NMR δ (75 MHz, DMSO-d6): 56.786, 
56.834, 111.979, 112.295, 112.773, 120.622, 121.789, 
125.383, 128.930, 129.303, 129.495, 130.432, 131.751, 
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132.869, 141.694, 154.094, 155.872, 156.245, 167.756,  
195.167, 197.069 ppm. HRMS (FAB; m-NBA) m/z: 
[M+H]+: Calc. for C27H22NO6, 456.1447, found 456.1455. 
Results and Discussion 
1,8-Dibenzoyl-2,7-dimethoxynaphthalene (2) was 
synthesized by a direct condensation of 2,7-
dimethoxynaphthalene (1) with benzoic acid mediated by 
phosphorus pentoxide–methanesulfonic acid (P2O5–MsOH) 
(Scheme 1, see Experimental section). 24 Both the carboxy 
group-bearing analogue (4) and amino group-bearing one 
(6) were prepared via electrophilic aromatic aroylation at 
peri-positions of the naphthalene ring, followed by 
transformation reaction of the substituents in the aroyl 
groups (Schemes 2 and 3).  Analogue (3) was isolated by 
quenching with methanol after diaroylation of substrate (1) 
with terephthaloyl chloride. 
 
Scheme 1. Synthesis of 1,8-dibenzoyl-2,7-dimethoxynaphthalene 
(2) via P2O5–MsOH-mediated direct condensation. 
 
Scheme 2. Synthesis of 1,8-dibenzoylnaphthalene analogue (4). 
 
Scheme 3. Synthesis of 1,8-dibenzoylnaphthalene analogue (6). 
The dynamic behaviour of the conformational exchange of 
analogues 2, 4 and 6 in solution was analyzed by NMR 
measurement performed in DMSO-d6 solution.  Figure 1 
shows the aromatic proton region of the 1H NMR spectrum 
of 1,8-dibenzoylnaphthalene compound (2).  Two signals at 
δ 8.16 ppm and 7.44 ppm are assigned to the protons at 
4(5)- and 3(6)-positions of the naphthalene ring, 
respectively.  The signal at δ 7.35 ppm (triplet) is assigned 
to the aromatic protons at m-positions of the benzoyl groups.  
The signals from δ 7.54 ppm to 7.42 ppm are assigned as the 
aromatic protons at p- and o-positions of the benzoyl groups.  
Figure 2 exhibits the 1H NMR spectrum of 1,8-diaroylated 
naphthalene compound bearing carboxy groups (4).  The 
signals at δ 8.20 ppm and 7.46 ppm are assigned to the 
protons at the 4(5)- and 3(6)-positions of the naphthalene 
ring, respectively.  The signals at δ 7.91 ppm and 7.59 ppm 
are due to the protons at o- and m-positions of the benzene 
ring bearing the carboxy groups.  Figure 3a displays the 1H 
NMR spectrum of the amino group-bearing analogue (6).  
Two signals at δ 8.02 ppm and 7.35 ppm, and the signal at δ 
5.89 ppm are assigned to the protons at 4(5)- and 3(6)-
positions of the naphthalene ring, and the protons of the 
amino groups.  The broad signals at δ 7.15 ppm and 6.40 
ppm are assigned to the aromatic protons at m- and o-
positions of the benzene ring bearing the amino group.  The 
two broad signals of the aroyl groups become sharp at 150 
˚C as shown in Figure 3b.   
 
Figure 1. 1H NMR spectrum of 1,8-dibenzoyl-2,7-
dimethoxynaphthalene (2) in DMSO-d6 (5.5–8.5 ppm). 
 
 
Figure 2. 1H NMR spectrum of 1,8-dibenzoylnaphthalene 
analogue bearing p-carboxy group 4 in DMSO-d6 (5.5–8.5 ppm). 
 
Figure 3. 1H NMR spectra of 1,8-dibenzoylnaphthalene analogue 
bearing p-amino group (6) in DMSO-d6 (5.5–8.5 ppm), (a) at room 
temperature, (b) at 150 ˚C.  
The changes of the signal shape for the protons at o- and m-
positions of the aroyl group in the amino group-bearing 
analogue (6) at room temperature and 150 ˚C suggest that 
C–C bond rotation between the carbonyl group and the 
naphthalene ring in the amino group-bearing analogue (6) is 
relatively slower than that in other 1,8-diaroylnaphthalene 
analogues 2 and 4 at room temperature.  At 150 ˚C, the bond 
rotation is faster than room temperature, hence a 
magnetically equivalent environment is made on the 
benzene ring.  As the result, the protons of the benzene rings 
are expressed as sharp signals. 
Unsymmetrically substituted 1,8-diaroylnaphthalene 
analogues in which one aroyl group has no substituent (i.e., 
benzoyl group) and the other aroyl group has a carboxyl 
group (9) or an amino one (12), or each aroyl group has a 
carboxy group and an amino one (15) were designed and 
successively synthesized by essentially the same procedure 
as described in Schemes 1, 2, and 3 (Schemes 4, 5, and 6; 
see Experimental section). 
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Scheme 4. Synthesis of unsymmetrically substituted 1,8-
dibenzoylnaphthalene analogue bearing carboxy group 9. 
 
Scheme 5. Synthesis of unsymmetrically substituted 1,8-
dibenzoylnaphthalene analogue bearing amino group 12. 
 
 
Scheme 6. Synthesis of unsymmetrically substituted 1,8-
dibenzoylnaphthalene analogue 15. 
1H NMR spectra of unsymmetrically substituted 1,8-
diaroylnaphthalene analogues (9) and (12) are exhibited in 
Figures 4 and 5.  In the case of unsymmetrically substituted 
analogue bearing carboxy group (9), the chemical shifts of 
the signals of the protons in two kinds of the aroyl groups 
are almost same with those of the corresponding 
symmetrically substituted analogues (2) and (4), i.e., δ 7.45 
ppm (protons at o- and p-position for the benzoyl group), 
7.35 ppm (protons at m-positions of the benzoyl group), 
7.90 ppm (protons at o-positions to the carboxy group), and 
7.55 ppm (protons at m-positions to the carboxy group).  In 
a similar manner, the chemical shifts of the signals of the 
benzene rings in unsymmetrically substituted analogue 
bearing amino group (12) seem to the sum of the 
symmetrically substituted analogues (2) and (6).  However, 
the shape of the signals assigned to the non-substituted aroyl 
group (from δ 7.39 to 7.52 ppm and from δ 7.22 to 7.38 
ppm) are broadened in contrast to the sharp signals of the 
corresponding protons of the symmetric analogue (2) and 
the unsymmetric analogue (9).  Similar behaviour is 
observed in unsymmetrically substituted 1,8-
diaroylnaphthalene analogue bearing amino group and 
carboxy group (15) (Figure 6).  Therefore, all of signals of 
the benzene rings are broadened if one aroyl group in the 
1,8-diaroylated compound has an amino group. 
NMR studies of unsymmetrically substituted 1,8-
diaroylnaphthalene analogues, which have no substituent, a 
carboxy group, or an amino group in the aroyl groups, show 
that the (carbonyl)C–C(naphthalene) bond rotation 
behaviour of the aroyl groups in unsymmetrically 
substituted analogue coincides with that of  the either of the 
symmetrically substituted analogue.  (Carbonyl)C–
C(naphthalene) bond rotation behaviour of one aroyl group 
follows that of the other aroyl group.   In other words, the 
bond rotation of the neighbouring two aroyl groups in the 
1,8-diaroylnaphthalene analogue does not occur 
independently with each other but cooperatively. 
 
Figure 4. 1H NMR spectra of unsymmetrically substituted 1,8-
dibenzoylnaphthalene analogue bearing carboxy group 9 in 
DMSO-d6 (5.5–8.5 ppm): C6H5 (●), p-COOH-C6H4 (■)  
 
 
Figure 5. 1H NMR spectra of unsymmetrically substituted 1,8-
dibenzoylnaphthalene analogue bearing amino group 12 in DMSO-
d6 (5.5–8.5 ppm): C6H5 (●), p-NH2-C6H4 (▲) 
 
 
Figure 6. 1H NMR spectra of unsymmetrically substituted 1,8-
dibenzoylnaphthalene analogue bearing carboxy group and amino 
one 13 in DMSO-d6 (5.5–8.5 ppm): p-COOH-C6H4 (■), p-NH2-
C6H4 (▲) 
Plausible interconversion behaviour of 1,8-
diaroylnaphthalene analogue is exhibited in Figure 7.  If 
neighbouring two aroyl groups rotate independently, 
interconversion between anti-oriented conformers I and I’ 
should proceed through unfavourable intermediate IV at 
least partially.  Thus the neighbouring two aroyl groups 
rotate cooperatively with avoiding the intermediate IV.  The 
interconversion process via cooperative (carbonyl)C–
C(naphthalene) bond rotation of two aroyl groups 
presumably include syn-conformer III.   
Recently, our group has reported intermolecularly 
connection reactions of aroyl groups in peri-
aroylnaphthalene without high dilution conditions.18   
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According to X-ray crystal study of the bridged product, 
the two aroyl groups are oriented in a same direction.  These 
results strongly indicate that two aroyl groups take syn 
fashion along with anti fashion in solution.  However, syn-
conformer would be unobservable independently on a time 
scale of 1H NMR measurements at room temperature. 
Conclusively, the aroyl groups of 1,8-bis(4-
aminobenzoyl)-2,7-dimethoxynaphthalene rotate slower 
than other symmetric 1,8-diaroylnaphthalene analogues in 
solution.  About the unsymmetrically substituted analogues, 
the bond rotation behaviour of the neighbouring two aroyl 
groups in 1,8-diaroyl-2,7-dimethoxynaphthalene, which one 
aroyl group rotates in conjunction with the other aroyl group, 
is demonstrated.  These results strongly indicate that 
interconversion behaviour of 1,8-diaroyl-2,7-
dimethoxynaphthalene analogue occurs through cooperative 
(carbonyl)C–C(naphthalene)  bond rotation of the two aroyl 
groups at peri-positions of the naphthalene ring. 
 
 
Figure 7. Plausible interconversion of 1,8-dibenzoylated 
naphthalene analogue with intermediates. 
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SYNTHESIS AND CHARACTERIZATION OF SOME METAL 
COMPLEXES WITH BIS[O,O-2,3;O,O-5,6-(N,N-DICARBOXYLIC 
METHYLIDENE)-N-2-METHYLENEPYRIDYL]-L-ASCORBIC 
ACID  
Fawzi Yahya Waddai,[a]*  Falih Hassan Musa[a] and  Huda Ahmed Fidhel[a] 
Keywords: Synthesis, bis[O,O-2,3;O,O-5,6-(N,N-dicarboxylicmethylidene)-N-2-methylene pyridyl]-L-ascorbic acid, metal complexes; 
analysis. 
The reaction of bis[O,O-2,3;O,O-5,6-(chloro(carboxylic)methylidene)]-L-ascorbic acid with the 2-picolylamine gave new product bis[O,O-
2,3;O,O-5,6-(N,N-dicarboxylicmethylidene)-N-2-methylenepyridyl]-L-ascorbic acid (LP), which was isolated and characterized by 1H,13C-
NMR, elemental analysis (CHN), mass spectroscopy, UV-visible and Fourier Transform infrared (FTIR) methods. The complexes of LP
with metal ions, M2+ (Cu, Co, Ni, Cd, Hg) and Cr3+ were synthesized and characterized by FTIR, UV-Visible, molar conductance, atomic
absorption, magnetic susceptibility, elemental analysis (CHN) methods. The analysis showed that the ligand coordinates with metal ions
through the monodentate carboxylato and amino group resulting in six-coordinated metal ion complexes. The TLC for LP and complexes 
showed one spot for each, indicating the purity of these compounds.  
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Introduction 
Taking into account of the activity of four hydroxyl 
groups (pKa1 = 4-12) and their steric environments in L-
ascorbic acid, studies of its alkylation, allylation, photo 
oxygenation, etc. under different experiment conditions 
have been carried out.1 The reaction of L-ascorbic acid with 
chloro-, dichloro- and trichloroacetic acids in the presence 
of potassium hydroxide with different molar ratio gave (X-
carboxylicmethylidene)-L-ascorbic acid derivatives(X= Cl1-
4 ), these derivatives are easy to prepare and are significant 
in organic synthesis as they are more soluble in organic 
solvents.  
Some metal ions complexes of these ligands have already 
been prepared and characterized.2-5  
In view of this we used bis[O,O-2,3;O,O-5,6-(chloro 
(carboxylic)methylidene)]-L-ascorbic acid as starting material, and 
reacted it with 2-picolylamine to give new a derivative of L-
ascorbic acid, LP, and reacted it with some  metal ions to 
give complexes. The properties and characterization of these 
new metal complexes are also presented.  
Experimental  
Materials and Methods  
All chemicals were purchased from BDH, and used 
without further purifications. FTIR spectra were recorded in 
KBr on a Shimadzu- spectrophotometer in the range of 
4000-400 cm-1. Electronic spectra in distilled water were 
recorded using a Shimadzu UV-visible spectrophotometer in 
the range of 200-1100 nm with quartz cell of (1 cm) path 
length. Melting points where measured with an electro 
thermal Stuart apparatus, model SMP30. Electrical 
conductivity measurements of the complexes were recorded 
at (25 oC) for 10-3 mol L-1 solution of the samples in 
dimethylsulfoxide (DMSO) using WTW inolap cond 720 
digital conductivity meter. Mass spectra in agilent mass 
spectrometer 5975 quadrupole analyser, was performed at 
Tarbiat Modares University, Tehran, Iran. 1H NMR and 13C 
NMR spectra were recorded on a Bruker DRX (500-MHz) 
spectrometer in DMSO and Bruner DRX (500-MHz) at 
Sharif Sainte University, Tehran, Iran. Chemical shifts are in 
ppm relative to internal Me4Si. Elemental microanalyses of 
the ligand and complexes were carried out by using Euro 
Vectro-3000A.  
Metal content of the complexes were measured using 
atomic absorption technique by Shimadzu (AA620) atomic 
absorption Spectrophotometer, while Hg metal is 
determined using Biotech Eng. Management Co. Ltd. (UK). 
Magnetic susceptibility values were obtained at room 
temperature using the Gouy method, Johnson Mattey, model 
M5B-MKs Magnetic Susceptibility Balance   Mode (MSB-
MKI). Thin layer chromatography (TLC) was performed on 
aluminium plates coated with silica gel Fluke, and detection 
was performed using iodine. 
Synthesis of ligand (LP) 
Bis[O,O-2,3;O,O-5,6-(chloro(carboxylic)methylidene)]-L-
ascorbic acid (0.375 g, 1 mmole) was dissolved in a mixture 
of 15 mL ethanol+5mLwater. Then 2-picolylamine (0.103 
mL, 0.001 mole) was added drop wise to the solution and 
refluxed for 2 h, A dark brown solution was formed, this 
solution was left to stand at room temperature for a few days 
when a dark brown mass crystallized out. The resultant mass 
was recrystallized from ethanol when a dark brown less stiff 
crystalline material was formed, melting point was found to 
be 121 °C, yield was 81.62 %. 
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Table 1. Physical properties and analytical data for the synthesized ligand (LP) and its complexes 
 
Table 2. shows the RF for ligand (LP) and its complexes 
Synthesis of Metal Complexes  
To a solution of LP (0.392 g, 1 mmol) in (20 mL ethanol) 
a solution of 1 mmol of metal chloride (0.170 g CuCl2.2H2O, 
0.237 g NiCl2.6H2O, 0.238 g CoCl2.6H2O, 0.183 g 
CdCl2.H2O, 0.271 g HgCl2.2H2O or 0.266 g CrCl3.6H2O) in 
20 mL ethanol was added.  The solutions were stirred for 1 
hr and were left to evaporate slowly to precipitate the 
complexes. The complexes were recrystallized from ethanol. 
The isolated complexes are coloured solids, stable in air and 
insoluble in common organic solvents but completely 
soluble in water, ethanol, methanol, DMSO and DMF. Some 
physical properties of LP and its complexes are shown in 
Table 1.  
Thin layer chromatography (TLC)  
The solution of LP and its complexes in ethanol as solvent, 
appeared as one spot each, confirming that all these 
compounds are pure and have only one isomer. Table 2 
shows the Rf for complexes and the ligand (LP).  
Results and discussion 
LP was synthesized in a good yield by the reaction of 
bis[O,O-2,3;O,O-5,6-(chloro(carboxylic)methylidene)]-L-ascorbic 
acid with 2-picolylamine in the ratio (1:1) in ethanol as a 
solvent  to give a new derivative of L-ascorbic acid, LP, 
(Scheme 1).  
FT-IR spectral analysis  
The IR spectrum of bis[O,O-2,3;O,O-5,6-(chloro 
(carboxylic) methylidene)]-L-ascorbic acid as starting 
material is compared with the spectrum of the ligand, LP. 
The results are summarized in Table 3.  
 
 
 
 
 
Scheme 1. The reaction of bis[O,O-2,3;O,O-5,6-
(chloro(carboxylic)methylidene)]-L-ascorbic acid with 2-
picolylamine.  
Bis[O,O-2,3;O,O-5,6-(chloro(carboxylic)methylidene)]-L-
ascorbic acid exhibits a band at 833 cm-1 due to υ(C-Cl) 
position, this disappeared in the spectrum of the ligand, LP, 
with the appearance aromatic C-H stretching. Two bands 
assigned to aromatic absorption are of medium intensity at 
3080 and 3016 cm-1. The presence a broad band is seen at 
3383 cm-1 and is related to carboxylic-OH band.6 1683 cm-1 
is due to υ(C=O) in carboxylic acid. The lactone (C-1=O) 
stretching vibration appeared at 1737 cm-1. The band centred 
at 1597, 1683 cm-1 are due to υ(C=C), (C=O) 
respectively.3,6,7 The band at 1477 cm-1 is attributed to the 
conjugated C=C and C=N bonds in pyridine ring. The band 
at 1190 cm-1 is assigned to the N-C bond.8  
In all the complexes, bands at 1519 and 1355 cm-1  in the 
Cr-complex, at 1573 and 1363 cm-1  in the Cu-complex, at 
1562, 1350 cm-1 in the Co-complex, at 1568 and 1384 cm-1  
in the Ni-complex, at 1572 and 1390 cm-1 in the Cd-
complex, and at 1593 and 1394 cm-1 in the Hg-complex are 
due to the asymmetric and the symmetric stretching 
frequencies of the carboxylic group. The value of ∆υCOOH= 
164, 210, 212, 184, 182, 199 cm-1, respectively indicated 
that the carboxylic group coordinate to metal ion as a 
monodentate ligand.9,10 The pyridine-N in all complexes are 
shifted to lower frequencies and is attributed to coordination 
of pyridine-N group with the metal ion.10 The absorption 
band in the range of 886-802 cm-1 is assigned to the 
coordinated water in all complexes.11,12  Conclusive evidence 
of the bonding is also shown by observation that new bands 
in the spectra of all metal complexes appeared in the low 
frequency region at 499-439 cm-1 and 465-412 cm-1 
characteristic to M-N and M-O stretching vibration.9,10  One 
carboxylic group is present in the spectra of all complexes 
confirming that one COOH is uncomplexed, whose 
stretching frequency is lower as compared to that of LP, this 
is related to the degree of hydrogen bonding.10                   
Found(Calc.)(%) Empirical formula Color Mp
°C 
Yield
% C H                    N M(II), Cr+3 
Ligand  C16H12O10N2 Dark Brown   121 81.62 48.41  (48.98) 2.97  (3.08)     6.96  (7.14)  
[Cr(C16H12O10N2)Cl2(H2O)2]Cl.7H2O  Dark walnut 166 76.41 42.89  (43.25) 2.61  (2.72)     6.06  (6.30) 7.53    (7.68) 
[Cu(C16H12O10N2)Cl(H2O)3]Cl.2H2O  Charcoal 190 78.2 41.98  (42.15) 2.51  (2.65)     6.02  (6.14) 11.44 (11.29) 
[Co(C16H12O10N2)Cl(H2O)3]Cl.2H2O  Reddish-Brown 139 73.68 42.18  (42.59) 2.48  (2.68)     6.10  (6.20) 10.64 (10.42) 
[Ni(C16H12O10N2)Cl(H2O)3]Cl.4H2O  Pale Green 147 75.17 42.20  (42.61) 2.56  (2.68)     6.23  (6.21)  9.70   (9.88) 
[Cd(C16H12O10N2)Cl(H2O)3]Cl.3H2O  Light orangr 163 69.44 37.90  (38.07) 2.28  (2.39)     5.40  (5.55) 17.61  (17.85) 
[Hg(C16H12O10N2)Cl(H2O)3]Cl.4H2O  Dark olive 185 71.12 32.01  (32.41) 1.91  (2.04)     4.45  (4.72) 26.98  (27.26) 
Compound  Molecular weight     Rf  
Ligand (LP) 392.28 0.51 
LP-Cr 712.78 0.34 
LP-Cu 616.83 0.40 
LP-Co 612.21 0.37 
LP-Ni 647.97 0.29 
LP-Cd 683.69 0.22 
LP-Hg 789.87 0.16 
+ 2HCl
ref/2h
O O
O
O
HOOC
Cl
OO
COOH
Cl
O O
O
O
HOOC
OO
COOHN
CH2
N
+ C6H8N2
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NMR spectra for the ligand (LP)  
1H-NMR spectrum (Figure 1) of LP in DMSO-d6 
exhibited several signals, carboxylic-OH weak signal 
appeared at 9.75 ppm. Pyridine showed multiplet at 7.17-
8.41 ppm. Peaks at 3.98, 4.16 ppm are attributed to CH2-6, 
CH-5, while that at 5.56 is due to CH-4 lactone ring. 3.74 
ppm attributed to pyridine-CH2. 
 
 
 
 
 
 
 
    13C-NMR spectrum Figure 2 showed signal at 178 ppm  
 
 
 
 
Figure 1. 1H-NMR spectrum of the ligand (LP) 
13C-NMR spectrum (Figure 2) showed a peak at 178 ppm 
which is due to carboxylic acid, while the C=O carbon and 
pyridine C=N signals are appeared at 168 and 163 ppm. The 
two peaks at 127 and 136 ppm are attributed to C-2 and C-3 
carbons, respectively. This may be due to the conjugated 
double bond from C-1 to C-3 causing up field shift of C-3 
carbon signal. The signals at 73,72 and 63 ppm are assigned 
to C-4, C-5 and C-6 carbon atoms,  whereas the signals at 
123, 122 ppm are assigned to C-7, C-8 carbon atoms, the 
signals at 38, 161, 123, 138, 121 and 148 ppm are assigned 
to C-9, C-10, C-11, C-12, C-13 and C-14 carbon atoms of 2-
methylpyridine. 
 
 
 
 
 
 
Figure 2. 13C-NMR spectrum of the ligand (LP) 
Mass spectrum for the ligand (LP) 
The mass spectrum data for LP (Figure 3) showed a 
molecular ion peak at (m/z =395).13 The molecular ion peak 
corresponds to (C16H12O10N2+3H). Other fragments are 
summarised in Table 4 and Scheme 2. 
 
 
 
 
 
 
 
 
Figure 3. Mass spectrum of the ligand LP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. The fragmentation of the ligand (LP) 
UV-VIS Spectral studies 
The electronic absorption bands as well as the magnetic 
moment values are summarized in Table 5. The UV-Visible 
spectrum of LP showed one absorption at 270 nm (37037 
cm-1), which is due to π−π* transition.14  
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Table 3. Assignments of the IR spectral bands of starting material, LP and its complexes(cm-1) 
 
Table 4. Mass spectral data of ligand (LP) 
 
The electronic spectrum of Cr(III) complex in ethanol 
solution showed three bands in the visible region at 24509.8 
cm-1 (4A2g→4T1g(P)) (υ3), 17543.85 cm-1 (4A2g→4T1g(F)) 
(υ2)  and the last one is at 12537 cm-1 (4A2g→4T2g) (υ1). The 
ratio of υ2/υ1, (1.39) was applied on Tanaba-Sugano diagram 
for d3 octahedral complexes, B complex and β, 10Dq(υ1) were  
calculated theoretically.15 Spectrum of Co-complex in 
ethanol solution exhibited two bands appearing at 14992.5 
cm-1 and 17452 cm-1, which were assigned to the 4T1g→4A2g 
(υ2) and 4T1g→4T1g(p) (υ3) transitions respectively of 
octahedral geometry.16 From the ratio of υ3/υ2 (1.16) the 
value of Dq/B (0.98) was obtained. The value of B' (869.52) 
as well as the position of υ1(10Dq) (8375 cm-1) were 
calculated by using Tanaba-Sugano diagram for d7 
configuration of the octahedral configuration geometry.17  
The value of β (0.88) indicates some covalent character. The 
conductivity measurement indicates that the Co-complex is 
ionic.   Spectrum of Ni(II) complex showed three bands in 
the visible region at 24271.84 cm-1, 13449.89  cm-1  and 
10385 cm-1 which are assigned 3A2g→3T1g(P) (υ3), 
3A2g→3T1g(F) (υ2) and 3A2g→3T2g, (υ1) respectively. The 
ratio of υ2/υ1, (1.29) was applied on Tanaba-Sugano 
diagram for d8 octahedral complexes,18,19 Bcomplex and β, 
10Dq(υ1) were  calculated theoretically. The conductivity 
showed that the Ni(II)-complex was electrolyte. The 
spectrum of Cu(II) complex showed broad band at 12804 
cm-1 assigned to 2Eg→2T2g transition which refers to Jahn-
Teller distortion of octahedral geometry.20  The conductivity 
measurement of the complex indicates that the complex is 
an electrolyte. The spectra of Cd(II), Hg(II) complexes gave 
no bands in the visible region, only bands assigned to charge 
transfer transitions were observed at 31446.54 cm-1 and 
29154.5 cm-1 Hg(II) and Cd(II) complexes, compared to free 
ligand  which showed one band at 37037 cm-1 confirming 
the complex formation.21 The conductivity measurements of 
the two complexes indicate that the complexes are 
electrolytes. 
Magnetic studies 
The magnetic moment values at 294 K of the 
[MLCl.3H2O]Cl.XH2O [M = Cu(II), Co(II) and Ni(II)] and 
[CrLCl2.2H2O]Cl.XH2O are 1.85, 4.64, 3.16 and 3.73 B.M. 
(Table 5) respectively which are lower than the total spin-
only values indicating a high spin octahedral geometry 
around metal ion. The lowering of these magnetic moments 
indicates a dominant antiferromagnetic interaction in all 
complexes. This may due to the fact that the syn-syn 
carboxylate provide a small metal-metal distance and results 
in a good overlap of the magnetic orbitals, an 
antiferromagnetic coupling is always induced.22  
Conclusion  
The ligand, LP, coordinates with metal ions through the 
monodentate carboxylato and amino group resulting in six-
coordinated metal ion in an octahedral geometry (Figure 5). 
 
 
 
 
 
 
(a) 
 
     (b)     
Figure 5. The proposed molecular structure of complexes, M(II) = 
Cu, Co, Ni, Cd, Hg  (a) and Cr(III)   (b). 
νCOOH Empirical formula υOH, 
υCOOH   
υC−H 
aromatic 
υC=O υC=C 
υC=O υas υs 
Coordina- 
ted H2O 
υC-Cl υM-N 
 
υM-O 
 
Starting material C10H6O10Cl2 3392,br - 1726  1670,br 1600  1412 - 833,s - - 
Ligand C16H12O10N2 3383,br 3016,w 1737 1683,m 1595 1433 - - - - 
[Cr(C16H12O10N2)Cl2(H2O)2]Cl.7H2O  3332,br 3012,w 1702 1664,m 1519 1355 802,w - 480  443  
[Cu(C16H12O10N2)Cl(H2O)3]Cl.2H2O  3373,br 3076,w 1710 1627,m 1573 1363 875,w - 495  426  
[Co(C16H12O10N2)Cl(H2O)3]Cl.2H2O  3371,m 3113,w 1720 1655,m 1562 1350 879,w - 499  463  
[Ni(C16H12O10N2)Cl(H2O)3]Cl.4H2O  3365,br 3062,w 1716 1645,m 1568 1384 873,w - 488  465  
[Cd(C16H12O10N2)Cl(H2O)3]Cl.3H2O  3367,m 3025,w 1726 1600,m 1572 1390 856,w - 439  412  
[Hg(C16H12O10N2)Cl(H2O)3]Cl.4H2O  3383,br 3069,w 1751 1680,m 1593 1394 886,w - 487  464  
Relative abundance 
% 
Formula weight,  
g mol-1 
Fragments 
11.4 395 C16H15N2O10 +3H 
23.68 302 C10H8NO10 +H 
6.14 285 C10H7NO9 +H 
10.52 225 C9H7NO6 
87.71 198 C8H6O6 
16.66 182 C8H6O5 
100 107 C6H3O2 
99.12 80 C4O2 
93.85 93 C6H7N 
58.77 65 C5H5 
89.47 52 C4H4 
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Table 5. Magnetic moments and electronic spectral bands (cm-1) the complexes. 
 
Table 6. Molar ratio data for LP-complexes. 
V, ml LP-Cr( λ=408) LP-Co (λ=573)  LP-Ni (λ=412)  LP-Cu (λ=781)  LP-Cd (λ=318)  LP-Hg (λ=343)  
       
0.25  0.239  0.244  0.213  0.338  0.204  0.211  
0.5  0.463  0.390  0.335  0.514  0.351  0.390  
0.75  0.635  0.493  0.446  0.662  0.458  0.505  
1  0.790  0.607  0.530  0.835  0.566  0.662  
1.25  0.909  0.680  0.664  0.950  0.645  0.750  
1.5  0.970  0.745  0.729  1.010  0.718  0.826  
1.75  1.020  0.800  0.753  1.090  0.786  0.890  
2  1.064  0.892  0.840  1.117  0.845  0.993  
2.25  1.092  0.931  0.906  1.169  0.930  1.072  
2.5  1.106  0.973  0.921  1.178  1.040  1.124  
2.75  1.132  0.998  0.970  1.239  1.107  1.201  
3  1.201  1.100  0.995  1.320  1.197  1.300  
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PYRIDAZINE AND ITS RELATED COMPOUNDS: PART 40. 
SYNTHESIS AND EVALUATION OF ANTIMICROBIAL 
ACTIVITY OF SOME NEW PYRIMIDINE FUSED WITH 
THIENOPYRIDAZINE DERIVATIVES 
A. Deeb,[a]* F. El-Mariah[b] and H. Abd El-Mawgoud[b] 
 
Keywords: Pyridazine, thienopyridazine, pyrimidothienopyridazine, synthesis, antimicrobial activity. 
In the present study we  have investigated the behaviour of 5-amino-3,4-diphenylthieno[2,3-c]pyridazine-6-carbonitrile  towards the 
hydrazine hydrate which gives 5-amino-3,4-diphenylthieno[2,3-c]pyridazine-6-carboximidohydrazide which in turn was subjected to 
subsequent reactions with benzaldehyde, acetic anhydride, acetyl acetone, formic acid, maleic anhydride and phthalic anhydride. The new
synthesized compounds were confirmed by their IR spectra, mass spectrum, 1H-NMR, and elemental analyses, and were screened for 
antimicrobial activity. Several compounds showed moderate to low activity against the examined microorganisms. 
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Introduction  
Literature survey revealed that pyridazine derivatives have 
diverse biological importance.1,2 On the other hand, 
heterocyclic ring systems containing the thiophene ring 
fused to pyrimidine or pyridazine rings are interesting 
classes of compounds which are both chemically and 
biologically active, e.g., thienopyrimidines and 
thienopyridazines display significant chemical properties 
and exhibit a wide range of biological properties.3-8 In view 
of these results and as an extension of our recent work  
concerned with the synthesis of heterocycles of interesting 
biological activity,9 we decided to synthesis some new 
pyrimidothienopyridazine derivatives starting from   the 
readily obtainable 5-amino-3,4-diphenylthieno[2,3-
c]pyridazine-6-carbonytrile (1)10 as  a highly versatile and 
useful building block for the synthesis of a wide variety of 
pyrimido[4’,5’:4,5]thieno[2,3-c]pyridazine derivatives and to 
test their antimicrobial activity. 
Experimental 
Melting points were determined in open glass capillaries 
and are uncorrected. Elemental analyses (CHN) were carried 
out using a Perkin-Elmer 240 C Microanalyzer at the 
Microanalytical Laboratory, Cairo University. The IR 
spectra of compounds were recorded on a Perkin-Elmer 
spectrophotometer model 1430 as KBr pellets and 
frequencies are reported in cm-1. The 1H-NMR spectra were 
recorded on a Perkin-Elmer R12B spectrometer 200 MHz 
and chemical shifts δ are in ppm relative to internal TMS, 
and mass spectra were recorded on a mass spectrometer HP 
model MS 5988 El 70 ev. Reactions were routinely followed 
by thin layer chromatography (TLC) on silica gel F254 
aluminum sheets (Merck). The spots were detected by UV 
irradiation at 254–365 nm. Compounds (1) and the 
corresponding carboximidohydrazide (2) were synthesized 
according to reported procedures.10 
5-Amino-Ǹ-benzylidene-3,4-diphenylthieno[2,3-c]pyridazine-6-
carboximidohydrazide (3) 
To a solution of compound (2) (0.5 g, 1.39 mmol) in 
absolute ethanol (10 ml), benzaldehyde (0.15 g, 1.39 mmol) 
was added. The reaction mixture was refluxed for 10 h. The 
solvent was evaporated under reduced pressure, and the 
residue was washed with petroleum ether 40 - 60° C. the 
solid product was filtered off, dried, and recrystallized from 
ethanol to give (3).    Yield: 0.31 g (49.82 %), m.p. 179 – 
180 °C. IR: broad bands around 3378, 3168 (–NH2, =NH, –
NH), 1675 (C=N); MS (m/z %): 448 (M+, 0.45 %), 178 
(100 %). 1H-NMR (DMSO-d6): 8.76 (s, H, NH), 8.43 (s, 1H, 
N=CH), 7.94-7.31 (m, 15H, 3Ph), 5.69 (s, 1H, =NH), 4.56 (s, 
2H, 5-NH2). Anal Calcd. For C26H20N6S: C, 69.62; H, 4.49; 
N, 18.74, Found C, 69.98; H, 4.57; N, 18.98 %. 
7-Benzylideneamino-8-imino-6-methyl-3,4-
diphenylpyrimido[4’ ̀,5’ ̀:4,5]thieno[2,3- c]pyridazine (4) 
A solution of compound (3) (0.5 g, 1.12 mmol) in acetic 
anhydride (10 ml) was refluxed for 5 h. The solvent was 
evaporated under reduced pressure, and the solid product 
was recrystallized from acetic acid to give (4).     Yield: 0.27 
g (51.24 %), m.p. 184 – 185 °C. IR: 3422, 3168 (=NH), 
2925(–CH3), 1669 (C=N). MS (m/z %): 472 (M+, 0.60 %), 
327 (100). Anal Calcd. For C28H20N6S: C 71.16, H 4.27, N 
17.79, Found C, 71.49; H, 4.18; N, 17.51 %. 
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7-Amino-8-imino-3,4-diphenylpyrimido[4’̀,5’ ̀:4,5]thieno[2,3-c]-
pyridazine (5) 
Method A 
A mixture of compound (2) (0.5 g, 1.39 mmol) and DMF 
(10 ml) was refluxed for 12 h. The reaction mixture was 
cooled to room temperature, and poured into ice water. The 
solid product was filtered off, washed with water, dried, and 
recrystallized from ethanol to give (5).    Yield: 0.4 g 
(77.84 %), m.p. 230 – 231 °C. IR: 3300, 3157 (–NH2, =NH), 
1669 (C=N). MS (m/z %): 370 (M+, 54.69 %), 77 (100 %). 
Anal: Calcd. For C20H14N6S: C, 64.85; H, 3.81; N, 22.69; 
Found: C, 64.55; H, 3.73; N, 22.95 %. 
Method B 
A solution of compound (3) (0.5 g, 1.12 mmol) in DMF 
(10 ml) was refluxed for 8 h. The reaction mixture was 
cooled to room temperature, and then poured into ice water. 
The solid product was filtered off, washed with water, dried, 
and recrystallized from ethanol to give (5). It was identical 
with that prepared by method A (m.p and mixed m.p). 
Yield: 0.24 g (58.13 %). 
7-Diacetylamino-8-imino-6-methyl-3,4-diphenylpyrimido-
[4’ ̀,5’ ̀:4,5]thieno[2,3- c]pyridazine (6) 
A solution of compound (2) (0.5 g, 1.39 mmol) in acetic 
anhydride (10 ml) was refluxed for 5 h. The solvent was 
evaporated under reduced pressure, and the solid product 
was recrystallized from acetic acid to give (6).    Yield: 0.42 
g (64.62 %). m.p. 180-182 °C. IR: 3422 (=NH), 2969, 2926 
(–CH3), 1722 (C=O), 1670 (C=N). MS (m/z %): 469 (M+ +1, 
2.56 %), 77 (100 %). 1H-NMR (DMSO-d6): 7.90-7.34 (m, 
10H, 2Ph), 5.62 (s, 1H, =NH), 2.45 (s, 6H, 2-COCH3), 2.15 
(s, 3H,CH3). Anal: Calcd. For C25H20N6O2S: C, 64.08; H, 
4.31; N, 17.94; Found: C, 64.43; H, 4.38; N, 18.23 %. 
7-Acetylamino-8-imino-6-methyl-3,4-diphenylpyrimido-
[4̀’,5’ ̀:4,5]thieno[2,3-c]pyridazine (7) 
Compound (6) (0.5 g, 1.07 mmol) was added to a solution 
of sodium hydroxide (1 g) in ethanol (10 mL). The reaction 
mixture was refluxed for 2 h. After cooling, it was poured 
into ice water, and neutralized with conc. HCl. The solid 
product was filtered off, washed with water, dried and 
recrystallised from ethanol to give (7). Yield: 0.3 g, 
(65.9 %), m.p. 220-222 °C. IR (cm-1): 3422, 3157 (=NH, -
NH amide), 2923 (-CH3), 1652 (C=O amide), 1595 (C=N). 
MS (m/z %): 425 (M+-1, 10.8), 383 (59.9), 178 (96.2), 77 
(100 %); Anal: Calcd., for C23H18N6OS (426.48): C, 64.77; 
H, 4.25; N, 19.71; Found: C, 64.40; H, 4.30; N, 19.90 %. 
5-Amino-6-[(3,5-dimethyl-1H-pyrazol-1-yl)(imino)methyl]-3,4-
diphenylthieno[2,3-c]pyridazine (10) 
To a solution of compound (2) (0.5 g, 1.39 mmol) in 
absolute ethanol (10 mL), acetylacetone (0.14 g, 1.39 mmol) 
was added. The reaction mixture was refluxed for 24 h. The 
solvent was evaporated under reduced pressure and the 
residue was washed with pet. ether 40-60 oC. The solid 
product was collected and recrystallized from ethanol. 
Yield: 0.52 g (88.3 %), mp 170-171oC; IR: 3318, 3178 (-
NH2, =NH), 2975, 2925 ( 2 Me group), 1674 (C=N). MS 
(m/z %): 422 (M+-2, 6.8), 406 (4.0), 347 (7.0). 1H-NMR 
(DMSO-d6) δ ppm: 7.81-7.28 (m, 10H, 2Ph), 6.13 (s, 2H, 
NH2), 5.69 (s, 1H, -CH pyrazole), 5.36 (s, 1H, =NH), 2.20 (s, 
3H, CH3-5), 2.15 (s, 3H, CH3-3). Anal Calcd., for 
C23H20N6S (424.51): C, 67,90; H, 4.75; N, 19.80. Found: C, 
67.50; H, 4.60; N, 19.50 %.  
7-Formylamino-8-imino-3,4-diphenylpyrimido[4’̀,5’ ̀:4,5]thie-
no[2,3-c]pyridazine (11) 
Method A 
A mixture of compound (2) (0.5 g, 1.39 mmol) and formic 
acid (10 mL) was heated under reflux for 3 h. The cooled 
reaction mixture was poured into water (50 mL), the solid 
product was filtered, washed with water, dried and 
recrystallized from ethanol. Yield: 0.35 g (63.33 %), m.p. 
190-191o C. IR (cm-1): 3311, 3183 (=NH, -NH), 1670 (C=O), 
1650 (C=N). MS (m/z %): 389 (M+, 2.12), 396 (25.4), 307 
(100). 1H-NMR (DMSO-d6) δ ppm: 8.17 (s, 1H, H-6), 8.06 
(s, 1H, -CHO), 7.83-7.33 (m, 10H, 2Ph), 6.13 (s, 1H, -
NHCO), 5.38 (s, 1H, =NH). Anal: Calcd., for C21H14N6OS 
(398.43): C, 63.30; H, 3.54; N, 21.09. Found: C, 63.60; H, 
3.60; N, 21.3 %. 
Method B 
A mixture of compound (5) (0.5 g, 1.35 mmol) and formic 
acid (10 mL) was refluxed for 2 h. The cooled reaction 
mixture was poured into water (50 mL). The solid product 
was filtered off, washed with water, dried and recrystallized 
from ethanol to give (11). It was identical with that obtained 
by method A (m.p. and mixed m.p.). Yield: 0.38 g 
(70.66 %). 
6-Imino-10,11-diphenylpyridazino[4’’,3’’,4’ ̀,5’ ̀]- 
thieno[3’,2’ ̀:4,5]-pyrimido[1,2-b]pyridazin- 3(4H)-one (12) 
To a solution of compound (2) (0.5 g, 1.39 mmol) in DMF 
(10 mL), malic anhydride (1.36 g, 1.39 mmol) was added 
and the reaction mixture was refluxed for 5 h. The cooled 
reaction mixture was poured into water (50 mL). The solid 
product was filtered off, washed with water, dried and 
recrystallized from ethanol. Yield: 0.39 g (66.53 %), m.p. 
193-195o C. IR (cm-1): 3420, 3162 (=NH, -NH), 1692 (C=O 
amide), 1595 (C=N). MS (m/z %): 422 (M+, 3.83), 421 
(10.31), 149 (100). 1H-NMR (DMSO-d6) δ ppm: 8.41 (s, 1H, 
NH amide), 7.80-6.60 (m, 12H, Ar-H), 5.05 (s, 1H, =NH). 
Anal: Calcd., for C23H14N6OS (422.45): C, 65.39; H, 3.34; N, 
19.89. Found: C, 65.70; H, 3.40; N, 20.15 %. 
8-Imino-12,13-diphenylpyridazino[4’’,3’’:4’,5’ ̀] thieno-
[3’,2’:4,5]pyrimido[2,1-a]phthalazin-5(6H)-one (13) 
To a solution of compound (2) (0.5 g, 1.39 mmol) in DMF 
(10 mL), phthalic anhydride (0.21 g, 1.39 mmol) was added 
and the reaction mixture was refluxed for 5 h. The cooled 
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reaction mixture was poured into water (50 mL). The solid 
product was filtered off, washed with water, dried and 
recrystallized from ethanol. Yield: 0.49 g (74.75 %), m.p. 
209-210o C. IR (cm-1): 3400, 3155 (=NH), 1742 (C=O 
amide), 1674 (C=N). MS (m/z %): 472 (M+, 64.59), 473 
(100), 444 (2.03). 1H-NMR (DMSO-d6) δ ppm: 8.15 (s, 1H, 
NH amide), 8.10-7.33 (m, 14H, Ar-H), 5.39 (s, 1H,=NH). 
Anal: Calcd., for C27H16N6OS (472.51): C, 68.63; H, 3.41; N, 
17.79. Found: C, 68.91; H, 3.47; N, 17.60 %. 
3-Chloro-6-imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’]thieno 
[3’,2’:4,5]pyrimido[1,2-b]pyridazine (14) 
A mixture of compound (12) (0.5 g, 1.18 mmol) and 
phosphoryl chloride (10 mL) was refluxed for 3 h. The 
cooled reaction mixture was poured into iced water (50 mL), 
the solid product was filtered, washed with water, dried and 
recrystallized from ethanol. Yield: 0.38 g (76.28 %), m.p. 
184-186 oC. IR (cm-1): 3422 (=NH), 1599 (C=N). MS 
(m/z %): 441 (M+, 0.26), 443 (M+ +2, 0.22), 414 (0.22), 149 
(100). Anal: Calcd., for C23H13ClN6S (440.90): C, 62.65; H, 
2.97; N, 19.06. Found: C, 62.80; H, 3.00; N, 19.22 %. 
6-Imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’]thieno-
[3’,2’:4,5]pyrimido[1,2-b]tetrazolo[5,1-f]pyridazine (15) 
To a solution of compound (14) (0.5 g, 1.13 mmol) in 
ethanol (10 mL), sodium azide (0.22 g, 3.39 mmol) was 
added and the reaction mixture was heated under reflux for 
7 h. The solvent was evaporated under reduced pressure and 
the residue was treated with water. The solid product was 
filtered off, washed with water, dried and recrystallized 
from ethanol. Yield: 0.40 g (78.82 %), m.p. 270-272 oC. IR 
(cm-1): 3394, (=NH), 1627 (C=N), 1559 (N=N). MS 
(m/z %): 447 (M+, 3.21), 423 (2.01), 178 (100). Anal: Calcd., 
for C23H13N9S (447.46): C, 61.73; H, 2.93; N, 28.17. Found: 
C, 62.00; H, 3.00; N, 28.30 %. 
3-Ethoxy-6-imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’]thieno 
[3’,2’:4,5]pyrimido[1,2-b]pyridazine (16) 
To a solution of sodium ethoxide (0.1 g Na in absolute 10 
mL ethanol), compound (14) (0.5 g, 1.13 mmol) was added 
and the reaction mixture was refluxed for 3 h. The solvent 
was evaporated under reduced pressure and the residue was 
treated with water/HCl. The solid product was filtered off, 
washed with water, dried and recrystallized from ethanol. 
Yield: 0.35 g (68.51 %), m.p. > 300 oC. IR (cm-1): 3384, 
(=NH), 2922, 2853, 1444 (-OEt), 1622 (C=N). MS (m/z %): 
449 (M+-1, 1.02), 420 (1.15), 63 (100). Anal: Calcd., for 
C25H18N6OS (450.50): C, 66.65; H, 4.03; N, 18.66. Found: 
C, 66.90; H, 4.10; N, 18.90 %.  
6-Imino-N-(4-methoxyphenyl)-10,11-diphenylpyridazino-
[4’’,3’’:4’,5’]thieno[3’,2’:4,5]pyrimido[1,2-b]pyridazin-3-amine 
(17) 
To a solution of compound (14) (0.5 g, 1.13 mmol) in 
ethanol / THF (10 mL, 1:4), p-anisidine (0.14 g 1.13 mmol) 
was added, the reaction mixture was refluxed for 3 h. The 
solvent was evaporated under reduced pressure and the 
residue was treated with water. The solid product was 
filtered off, washed with water, dried and recrystallized 
from ethanol. Yield: 0.46 g (76.88 %), m.p. 148-149 o C. IR 
(cm-1): broad band 3371, (=NH, -NH), 1612 (C=N), 2843, 
1443 (-OMe). MS (m/z %): 527 (M+, 0.26), 496 (0.31), 63 
(100). Anal Calcd., for C30H21N7OS (527.58): C, 68.29; H, 
4.01; N, 18.58. Found: C, 68.60; H, 4.10; N, 18.30 %. 
4-[(6-Imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’] thieno-
[3’,2’:4,5]pyrimido[1,2- b]pyridazin-3-yl)amino]-N-phenyl-
benzenesulphonamide (18) 
A mixture of compound (14) (0.5 g, 1.18 mmol) and 4-
amino-N-phenylbenzenesulphonamide (0.28 g, 1.13 mmol) 
in ethanol / THF (10 mL 1:4) was refluxed for 3 h. The 
solvent was evaporated under reduced pressure, the residue 
was triturated with ethanol and the solid product was filtered 
off, washed with water, dried and recrystallized from 
ethanol. Yield: 0.44 g (59.44 %), m.p. 174-176 oC. IR (cm-
1): 3420, 3349, 3295 (=NH, -NH groups), 1636 (C=N), 1317 
(SO2, asym.), 1150 (SO2, sym.). MS (m/z %): 652 (M+, 0.03), 
576 (0.01), 474 (0.05), 247 (50.00). Anal: Calcd., for 
C35H24N8O2S2 (652.72): C, 64.40; H, 3.71; N, 17.17. Found: 
C, 64.71; H, 3.80; N, 16.90 %. 
5-Chloro-8-imino-12,13-diphenylpyridazino[4’’,3’’:4’,5’]thi-
eno[3’,2’:4,5]pyrimido[2,1-a]phthalazine (19) 
A mixture of compound (13) (0.5 g, 1.06 mmol) and 
phosphoryl chloride (10 mL) was refluxed for 5 h. The 
cooled reaction mixture was poured into ice water (50 mL), 
the solid product was filtered, washed with water, dried and 
recrystallized from ethanol. Yield: 0.39 g (75.10 %), m.p. 
216-217 oC. IR (cm-1): 3419 (=NH), 1627 (C=N). MS 
(m/z %): 491 (M+, 4.82), 493 (M+ +2, 2.58), 455 (1.49), 289 
(100). Anal: Calcd., for C27H15ClN6S (490.96): C, 66.05; H, 
3.08; N, 17.12. Found: C, 66.30; H, 3.10; N, 17.30 %. 
6-Imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’]thieno 
[3’,2’:4,5]pyrimido[2,1-a]tetrazolo[1,5-c] phthalazine (20) 
To a solution of compound (19) (0.5 g, 1.02 mmol) in 
ethanol (10 mL), sodium azide (0.20 g 3.06 mmol) was 
added, the reaction mixture was refluxed for 7 h. The 
solvent was evaporated under reduced pressure and the 
residue was treated with water. The solid product was 
filtered off, washed with water, dried and recrystallized 
from ethanol. Yield: 0.40 g (78.88 %), m.p. 221-222 oC. IR 
(cm-1): 3421, (=NH), 1622 (C=N), 1576 (N=N). MS 
(m/z %): 497 (M+, 0.61), 469 (0.75), 57 (100). Anal: Calcd., 
for C27H12N9S (497.52): C, 65.18; H, 3.04; N, 25.34. Found: 
C, 65.50; H, 3.10; N, 25.09 %. 
5-Ethoxy-8-imino-12,13-diphenylpyridazino[4’’,3’’:4’,5’]thieno 
[3’,2’:4,5]pyrimido[2,1-a]phthalazine (21) 
To a solution of sodium ethoxide (0.1 g Na in absolute 
ethanol 10 mL) compound (19) (0.5 g, 1.01 mmol) was 
added and the reaction mixture was refluxed for 3 h. The 
solvent was evaporated under reduced pressure and the 
residue was treated with water / HCl. The solid product was 
filtered off, washed with water, dried and recrystallized 
from ethanol. Yield: 0.30 g (58.79 %), m.p. 253-254 oC. IR 
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(cm-1): 3389, (=NH), 2919, 2850, 1443 (-OEt), 1600 (C=N). 
MS (m/z %): 500 (M+, 0.78), 471 (0.35), 57 (100). Anal: 
Calcd., for C29H20N6OS (500.56): C, 69.58; H, 4.03; N, 
16.79. Found: C, 69.93; H, 4.12; N, 16.51 %. 
8-imino-N-(4-methoxyphenyl)-12,13-diphenylpyridazino- 
[4’’,3’’:4’,5’]thieno-[3’,2’:4,5]pyrimido[2,1-a]phthalazin-5-
amine (22) 
To a solution of compound (19) (0.5 g, 1.02 mmol) in 
ethanol / THF (10 mL, 1:4), p-anisidine (0.13 g 1.02 mmol) 
was added, the reaction mixture was heated under reflux for 
3 h. The solvent was evaporated under reduced pressure and 
the residue was treated with water. The solid product was 
filtered off, washed with water, dried and recrystallized 
from ethanol. Yield: 0.41 g (69.63 %), m.p. 166-167 oC. IR 
(cm-1): broad band 3421, (=NH, -NH), 1617 (C=N), 2917, 
1443 (-OMe). MS (m/z %): 577 (M+, 0.04), 562 (0.04), 108 
(100); 1H-NMR (DMSO-d6) δ ppm: 7.90-6.85 (m, 18H, Ar-
H), 5.52 (s, 1H,=NH), 3,90 (s, 1H, -NH), 3.71 (s, 3H, -
OCH3).  Anal: Calcd., for C34H23N7OS (577.63): C, 70.69; H, 
4.01; N, 16.97. Found: C, 70.99; H, 4.09; N, 16.70 %. 
4-[(8-Imino-12,13-diphenylpyridazino[4’’,3’’:4’,5’]thieno-
[3’,2’:4,5]pyrimido[2,1-a]phthalazin-5-yl)amino]-N-phenyl-
benzenesulphonamide (23) 
A mixture of compound (19) (0.5 g, 1.01 mmol) and 4-
amino-N-phenylbenzenesulphonamide (0.25 g, 1.02 mmol) 
in ethanol / THF (10 mL 1:4) was refluxed for 3 h. The 
solvent was evaporated under reduced pressure, the residue 
was triturated with ethanol and the solid product was filtered 
off, washed with water, dried and recrystallized from 
ethanol. Yield: 0.38 g (53 %), mp.. 204-206o C. IR (cm-1): 
3378, 3250 (=NH, -NH groups), 1627 (C=N). 1304 (SO2, 
asym.), 1151 (SO2, sym.). MS (m/z %):702 (M+, 24.68), 651 
(22.08), 610 (14.72), 216 (100). Anal: Calcd., for 
C39H26N8O2S2 (702.78): C, 66.65; H, 3.73; N, 15.94. Found: 
C, 66.90; H, 3.80; N, 15.70 %. 
Results and Discussion 
The carboximidohydrazide derivative (2) was the starting 
material for syntheses carried out. This compound was 
prepared by refluxing 5-Amino-3,4-diphenylthieno[2,3-
c]pyridazine-6-carbonitrile (1) with hydrazine hydrate in 
ethanol for 2 h according to the method reported by us 
previously.10 
 
 
 
Scheme 1 
The condensation of 5-amino-3,4-diphenylthieno[2,3-
c]pyridazine-6-carboximidohydrazide  (2)  with 
benzaldehyde was carried out in 1:1 molar ratio with 
elimination of one molecule of water producing Ǹ-
benzylidene-6-carboximidohydrazide derivative (3), which 
can be cyclized on boiling with acetic anhydride to give 7-
benzylideneamino-8-imino-6-methyl-3,4-diphenylpyrimido- 
[4 ̀,5 ̀:4,5]thieno[2,3-c]pyridazine (4) in good yield. On 
heating compound (2) in DMF at refluxing temperature for 
12 h, a single product 5 in 77.8% yield was obtained. The 
isolated product was proven to be 7-amino-8-imino-3,4-
diphenylpyrimido[4 ̀,5 ̀:4,5] thieno[2,3-c]pyridazine. On the 
other hand, compound (3) on refluxing with DMF 
underwent formylation and cyclisation, followed by 
hydrolysis with elimination of a benzaldehyde molecule to 
furnish (5) 
 
 
 
 
 
 
Reagents: a, PhCHO, ethanol, reflux; b, acetic anhydride reflux; c, 
DMF, reflux; d, acetic anhydride, reflux. 
Scheme 2 
Refluxing compound (2) with acetic anhydride for 5 h 
produced the corresponding monoacetyl derivative, which 
underwent smooth cyclization to the corresponding fused 
primidothienopyridazine followed by diacetylation of the 
amino group to give (6) which was proven to be 7-
diacetylamino-8-imino-6-methyl-3,4-diphenylpyrimido 
[4 ̀,5 ̀:4,5]thieno[2,3-c] pyridazine.  Solvolysis of compound 
(6) in boiling 2N ethanolic sodium hydroxide followed by 
cooling and neutralizing with hydrochloric acid leads to 
formation of crystals, which was identified by the analytical 
and spectral data as 7-acetylamino-8-imino-6-methyl-3,4-
diphenylpyrimido [4 ̀,5 ̀:4,5]thieno[2,3-c]pyridazine (7) as 
proved by the analytical and spectral data. Neither the 
expected 7-amino-8-imino derivative (8) nor the tetracyclic 
triazolopyrimido thienopyridazine derivative (9) is formed. 
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When an ethanolic solution of (2) is treated with 
acetylacetone at refluxing temperature, it easily afforded the 
corresponding pyrazolyl derivative (10). The structure of 
prazolyl derivative (10) was proved from its analytical and 
spectral data to be 5-amino-6-[(3,5-dimethyl-1H-pyrazol-1-
yl)(imino)-methyl]-3,4-diphenylthieno[2,3-c]pyridazine. 
The expected 7-formylamino derivative (11) was obtained 
in moderate yield by refluxing (2) with formic acid. The 
structure of compound 11 was elucidated by elemental 
analysis and spectral data. The structure of (11) was 
confirmed by comparison with an authentic sample also 
(m.p, mixed m.p and super imposable IR) prepared by 
formylation of compound (5) with formic acid at reflux 
temperature (Scheme 4). 
 
 
 
 
 
 
Scheme 4  
Heating a mixture of carboximidohydrazide (2) and 
maleic anhydride and/or phthalic anhydride in DMF at 
reflux temperature afforded a single product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5 
The isolated product was proven to be 6-imino-10,11-
diphenyl-pyridazino[4’’,3’’:4’,5’]thieno-
[3’,2’:4,5]pyrimido[1,2-b]-pyridazine-3(4H)-one (12) or 
pentacyclic compound (13). The structure of compound (12) 
was assigned by its spectral and elemental data. 
Mechanistically, the formation of the tetracyclic compound 
(12) involves the initial formation of a maleimide derivative, 
which undergoes intramolecular nucleophilic attack of the 
thiophene amino group on the maleimide carbonyl group 
with elimination of one molecule of water. Similarly, 
formation of compound (13) takes place through the initial 
formation of a cyclic isoindol derivative, which undergoes 
immediate intramolecular nucleophilic attack of the 
thiophene amino group on the isoindol carbonyl group with 
elimination of one molecule of water (Scheme 5). The 
structure of 8-imino-12,13-diphenyl-
pyridazino[4’’,3’’:4’,5’]thieno-[3’,2’:4,5]pyrimido[2,1-a]-
phthalazin-5(6H)-one (13) was proved by its spectral and 
elemental data. 
Compounds (12) and (13) on reaction with phosphoryl 
chloride at reflux temperature gave the corresponding 3-
chloro derivatives (14) and (19) (Scheme 6). The infrared 
spectrum of compound (14) showed absorption band at 1599 
(C=N) cm-1 and there is no band in the carbonyl region. 
Since the reactivity of the chlorine atom was expected, the 
chloro compound (14) was subjected to nucleophilic 
substitution reactions to obtain the newer derivatives of the 
ring systems, it was reacted with sodium azide in ethanol at 
reflux temperature giving 6-imino-10,11-diphenyl-
pyridazino[4’’,3’’:4’,5’]thieno-[3’,2’:4,5]pyrimido[1,2-b]-
tetrazolo[5,1-f]pyridazines (15) and (20), wherein 3-azido 
derivative was formed in the first step of this reaction , then 
intramolecular cyclization to the tetrazolo derivative 
occurred immediately. 
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The predomination formation of the tetrazolo derivatives 
(15) and (20) were supported by the infrared spectral data , 
which exhibited no absorption bands around 2200 cm-1 due 
to azido group, and there is absorption bands at 1627(C=N) 
and 1559(N=N). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6 
 
 
 
 
 
 
 
Scheme 7  
 
In continuation of the substitution of the 3-chloro group in 
(14) and (19), we found that refluxing (14) and (19) with 
sodium ethoxide in absolute ethanol afforded a good yield of 
3-ethoxy 6-imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’]-
thieno-[3’,2’:4,5]pyrimido[1,2-b]pyridazine (16) and (21). 
Heating the 3-chloro derivatives, (14) and (19), with 
equimolar amount of p-anisidine in EtOH/THF (1:4) at 
reflux temperature gives the expected product (17) and (22), 
which were proven to be 6-imino-N-(4-methoxyphenyl)-
10,11-diphenylpyridazino[4’’,3’’:4’,5’]thieno-[3’,2’:4,5]py-
rimido[1,2-b]pyridazin-3-amine (17) and 8-amino-N-(4-
methoxyphenyl)-12,13-diphenylpyridazino[4’’,3’’:4’,5’]thi-
eno-[3’,2’:4,5]pyrimido[2,1-a]phthalazin-5-amine (22). 
Reaction of  equimolar amounts of  the 3-chloro derivativs, 
(14) and (19), with 4-amino-N-benzenesulphonamide in 
EtOH/THF (1:4) at reflux temperature afforded a single 
product each. The isolated products are shown to be 4-[6-
imino-10,11-diphenylpyridazino[4’’,3’’:4’,5’]thieno-
[3’,2’:4,5]pyrimido-[1,2-b]pyridazin-3-yl)amino]-N-phenyl-
benzenesulphonami-de (18) and 4-[8-imino-12,13-
diphenylpyridazino[4’’,3’’:4’,5’]thieno-[3’,2’:4,5]pyrimido-
[2,1-a]phthalazin-5-yl)amino]-N-phenylbenzenesulphon-
amide (23) (Scheme 7). 
The newly synthesized compounds were characterized by 
the IR, NMR, and mass spectrum as well as the elemental 
analysis listed in experimental section. The spectral analyses 
were in accordance with the assigned structures. 
Screening for antimicrobial activities 
Applying the agar plate diffusion technique,11 the newly 
synthesized compounds were screened in vitro for 
antimicrobial activity against Gram positive bacteria 
(Staphylococcus aureus and Bacillus subtilis), Gram 
negative bacteria (Escherichia coli and Pseudomonas 
aeruginosa), yeast (Candida albicans), and a fungus 
(Aspergillus niger). In this method, a standard 5 mm 
sterilized filter paper disk impregnated with the compound 
(0.3 mg / 0.1 ml of DMF) was placed on an agar plate 
seeded with the tested organism. The plates were incubated 
for 24 h at 37 °C for bacteria and 28 °C for fungi. The 
inhibition zones of bacteria and fungi growth around the 
discs were determined. The screening results are given in 
Table 1. 
The results indicated that seven synthesized compounds 
(3), (10), (12), (14), (18) and (23) showed moderate 
antimicrobial activity against the examined Gram positive 
bacteria Staphylococcus aureus. In addition, compound (12) 
showed very high antifungal activity against the examined 
yeast, Candida albicans and a fungus, Aspergillus niger.  
In summary, results of antimicrobial activity revealed that 
the synthesised compounds showed moderate and / or very 
high antimicrobial activity against bacteria and fungi, 
respectively. It could be concluded from these results that 
the biologically active synthesised compounds are nearly as 
active as the standard antibacteria Ciprofloxacin against the 
both tested Gram positive bacteria (Staphylococcus aureus 
and Bacillus subtilis) and Gram negative bacteria 
(Escherichia coli and Pseudomonas aeruginosa). On the 
other hand, the biologically active synthesised compounds 
are active as the standard fungicide Nystin against the both 
tested fungi Candida albicans and Aspergillus niger.  
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Table 1   Anti-microbial activity of synthesized compounds. 
Compd. Staphylococcus Aurus Bacillus 
Subtitles 
E.coli Pseudomonas 
aeruginosa 
Candida 
albicans 
Aspergillums 
Niger 
3 +++ ++ - ++ ++ ++ 
4 ++ ++ - ++ ++ +++ 
6 ++ ++ - ++ ++ ++ 
10 +++ ++ - + ++ ++ 
11 ++ ++ + - ++ ++ 
12 +++ ++ - - ++++ ++++ 
13 ++ ++ ++ + ++ + 
14 +++ + - - ++ ++ 
15 ++ ++ - ++ ++ ++ 
17 ++ ++ - ++ ++ - 
18 +++ ++ - ++ ++ ++ 
19 ++ + - + +++ ++ 
20 ++ + - + ++ + 
22 ++ + - ++ ++ ++ 
23 +++ ++ - - ++ +++ 
DMF -  - - - - 
Nystin - - - - ++++ ++++ 
Ciprofloxacin ++++ ++++ ++++ ++++ - - 
The concentration of all synthesised compounds and the two references was 0.30 mg 0.10 mL-1 of dimethylformamide. Zone of inhibition: 
+ = < 15 mm; ++ = 15-24 mm; +++ = 25-34 mm; ++++ = 35-44 mm; - = no inhibition. 
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ORGANICALLY MODIFIED CLAY FOR ADSORPTION OF 
PETROLEUM HYDROCARBON 
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Keywords: organoclay, adsorption, petroleum, hydrocarbon. 
Organically modified clay mineral was prepared by exchanging hexadecyltrimethylammonium bromide (HDTMA) onto kaolinite clay 
mineral. The prepared organoclay was characterized using FTIR, XRD and TGA for assigning the surface groups, layer spacing and
thermal stability. The adsorption efficiency of the produced organoclay towards hydrocarbons that likely to be present in oily wastewaters 
and oil spills (gasoline and kerosene) was studied. Different process parameters as contact time, adsorbent dose and HDTMA concentration
were studied. The obtained results clarified that the adsorption capacity of the prepared organoclay was potentially enhanced than that of
unmodified clay. The batch adsorption capacity was found to be more than 5 g g-1 and 7 g g-1 with respect to kerosene and gasoline, 
respectively after 24 h of contact. 
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Introduction 
Environmental authorities all over the world have been 
involved in development of processes and roles to avoid and 
prevent the release of pollutants into water and environment. 
A series of pollutants are produced from oil and 
petrochemical industries, which are reported to have high 
polluting potentials. These pollutants are characterized as 
being stable towards light and heat and are also biologically 
undegradable.1 The presence of these pollutants also 
decreases the contact area between water surface and 
atmospheric air, which prevent oxygen transfer. 
Consequently researchers are involved in development of 
new materials, new procedures and techniques for removal 
of pollutants and hazardous materials form waste streams 
before releasing in the environment. Petroleum 
hydrocarbons also cause huge changes in environment and 
physicochemical properties of water. Many procedures were 
studied and developed for removal of these types of 
pollutants. One of the most important employed process 
used to remove these pollutants is the adsorption process, 
which has accepted great importance due its low cost and 
available natural materials and biomass materials.2,3 A wide 
range of materials have been modified and studied as 
adsorbent material for oil and petrochemical pollutants as 
biomass and natural materials.4-12 These materials are highly 
hydrophobic with high porosity, have adsorption 
characteristics towards oils, and have high tendency to 
adsorb organic contaminants. Natural materials could be 
used for oils decontamination either as it is or modified. 
Clay constitutes were studied as an adsorbent material is one 
of the techniques recently applied for the treatment of 
hydrocarbon contaminated water effluents. Clay minerals 
are natural materials, abundant with low cost and have large 
surface area, as it has high mass transfer rates.13 The clay 
materials have hydrophilic nature, so they are ineffective 
adsorbent for aromatic compounds present in contaminated 
sites as petrochemical sites. The adsorption of hydrocarbon 
onto clay materials is hindered through the competition of 
water molecules in relation to non-polar compounds to the 
surface of the adsorbent material. The adsorption of organic 
compounds onto clay mineral surface can be improved by 
exchanging the inorganic cations presents on the clay 
surface and within the interlayer space by surfactant cations, 
such as: hexadecyletrimethylammonium (HDTMA), tetra-
methylammonium (TMA), tetraethylammonium (TEA), 
tetrabutylammonium (TBA), and tribenzylmethyl-
ammonium (TBMA).  
The physico-chemical modifications of clay minerals have 
been studied for the preparation of improved adsorbents. 
Different procedures have been studied for clay 
modification e.g., adsorption of surfactant and adsorption 
and intercalation of organic polymers. The modification of 
clay materials creates a porous material, which is more 
effective in adsorption of organic compounds.14 The 
properties of the modified clay minerals render it as 
promising materials in adsorption technologies and other 
applications. The suggested mechanism for reaction of clay 
with organic surfactants is based on the displacement of 
interlayer water molecules in smectites and vermiculites 
with the organic surfactant molecule. The organic molecules 
can form complexes with the interlayer cations also. 
Different chemical interactions like hydrogen bonding, ion-
dipole interaction, co-ordination bonds, acid-base reactions, 
charge transfer and van der Waals forces, control the 
adsorption of neutral organic molecules onto the clay. 
Another reaction type is grafting reactions, in which 
covalent bonds are formed between reactive surface groups 
and organic species. It has been established that the 2:1 clay 
minerals could undergo grafting reactions, due to the 
presence of silanol and aluminol groups on surface which 
react with organic molecules.  
The preparation of organoclays is generally based on 
cation exchange reactions,15-17 involving the exchange of 
quaternary alkylammonium cations with interlayer cations 
of the clay mineral in aqueous solution. Several types of 
organoclay have been prepared under different reaction 
conditions.18-24 
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The present work deals with studying the adsorption 
behavior of hydrocarbons (kerosin and gasoline) using 
organically modified kaolinite produced by cation exchange 
of interlayer cations with quaternary ammonium salt, 
hexadecyltrimethylammonium bromide (HDTMA). The 
adsorption process was optimized in terms of time of contact, 
surfactant concentration and adsorbent dose.  
Experimental 
Materials 
Kaolinite clay, provided by (Sigma-Aldrich), was used for 
preparation of organoclay. The kaolinite sample was sieved 
to the sieve No 200 (0.074 mm). HDTMA, purchased from 
Aldrich Chemical Company Inc. was used as surfactant. 
Preparation of organokaolinite 
The organokaolinite was prepared a cation exchange 
reaction, adapted from a reported procedure.25 The 
procedure involves firstly the dispersion of the clay in 
distilled water with agitation (4 % w/w) for 30 min, then it 
was allowed to settle for 24 h. HDTMA was added to the 
suspension, then the mixture was stirred for further 20 min 
and left to settle for 24-h. The organoclay was filtered out, 
dried at (60 ± 5) oC till constant weight and sieved at 230 
(0.063 mm) sieve.  The process was repeated using different 
initial concentrations of HDTMA. The concentrations of 
HDTMA were reported as a ratio of kaolinite cation 
exchange capacity (CEC) at a given conditions. HDTMA 
solutions of different concentrations were prepared, and then 
2 g of kaolinite clay was added as the previously mentioned 
procedure. The concentration of unreacted HDTMA was 
determined through complexation with methyl orange in 
acidic conditions, followed by chloroform extraction, water–
chloroform phase separation and then spectrophotometric 
determinationt at 401 nm.26 
Characterization 
The XRD patterns of the samples were recorded on a 
XPert Philips X-ray diffractometer. All patterns were 
obtained using Cu/Kα1 radiation with a graphite 
monochromator at 0.02° min−1 scanning rate at King Khalid 
University. Analyses were performed upon the original and 
modified clay. Thermogravimetric analysis (TGA) 
experiments were conducted using Shimadzu TGA-50H 
thermal analyzers at King Khalid University. All 
experiments were performed using a single loose top 
loading platinum sample pan under nitrogen at a flow rate of 
30 mL min−1 and a 10 °C min−1 heating rate for the 
temperature range 25–800 °C. Fourier transform infrared 
(FT-IR) spectra of kaolinite, HDTMA and modified 
kaolinite using were recorded by KBr method on a 
NICOLET 6700 FTIR thermo scientific. 
Sorption Experiment 
The sorption capacity of petroleum hydrocarbons 
(gasoline and kerosene) was studied using a standard 
method,27,28 which used for determining the efficiency of the 
sorbent for removing oily liquids form surface water. The 
hydrocarbon (400 mL) was taken to a beaker and then 0.5 g 
of the organoclay clay was put into a 200 mesh stainless 
steel basket. The organoclay basket was placed into the 
beaker of hydrocarbon consequently the modified clay 
particles were completely immersed in the hydrocarbon. 
After the appropriate contact time the organoclay sorbent 
was withdrawn in a vertical way and left to drop out of 
liquid for about 30 min into a pre-weighed vessel. The 
adsorbent loaded with hydrocarbon was directly transferred 
to a pre-weighed vessel and weighed. The experiment was 
performed three times and the mean value was considered. 
The amount of hydrocarbon adsorbed onto the organoclay 
was calculated as follows: 
 
 
 
where 
ϕ - amount adsorbed (g hydrocarbon g-1 sorbent)  
Wc is the initial weight of dry clay,  
Ws is the weight of the loaded adsorbent at end of 
experiment.  
The effect of different parameters on the adsorbed 
amount of hydrocarbon onto organoclay was studied.  
Results and Discussion 
Characterization of adsorbent organoclay 
X-ray diffraction analysis  
The presence and the arrangement of the organic 
compound within the clay interlayer are assigned using 
XRD analysis for the clay before and after treatment.29 The 
results in Figure 1 show the XRD diffraction patterns of 
kaolinite clay before and after treatment. The produced layer 
spacing expansion due to the intercalation of organic 
surfactant (HDTMA), into the clay interlayer, was 
confirmed by the shift of peak position (change in the 2 
theta values consequently change in the layer spacing. The 
slight decrease in 2 theta value of peak position corresponds 
to an increase in the basal spacing of the organo-clay, could 
be assigned to the intercalation of the organic surfactant into 
the interlayer spacing of kaolinite depending on the ion 
exchange capacity CEC.30,31 
FTIR studies 
The FTIR spectra of kaolinite clay before and after 
treatment were represented in Figure 2. The results in this 
figure show infrared spectra of kaolinite, HDTMA and 
kaolinite-HDTMA within the range of 400-4000 cm-1 for 
comparison. 
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Figure 1. XRD of kaolinite clay mineral (a), and organokaolinite 
(b). 
The peak observed at 1000-1100 cm-1 was assigned for the 
stretching vibration of Si-O-Si and Si-O-Al, while the peak 
at 3400-3650 cm-1 corresponds to the stretching absorption 
of Si-OH.32  
Figure 2.  FT-IR spectra of kaolinite, HDTMA and orgo-
kaolinite. 
The results in the FTIR spectrum of the untreated clay 
clarify the presence of the characteristic peaks of the clay 
with no presence of characteristic peaks of organic 
surfactant.  
While in the FTIR spectrum of the modified clay, the 
characteristic peaks of clay were clearly observed, and the 
peaks characteristic for the organic surfactant. This finding 
indicates the presence of the surfactant with clay. The peaks 
at 2950, 2850 and 1450 cm-1 could be assigned for the 
stretching vibration of CH2 and CH3. This observation 
confirms the intercalation of the organic surfactant into the 
interlayer spacing of clay.19 
Thermal analysis 
TGA was performed upon the modified kaolinite. The 
weight loss against temperature was represented in Figure 3, 
while the degradation of samples was studied by TGA. 
Sample of 7 - 10 mg was heated from 25 to 800 °C at a rate 
of 10 °C min-1. The weight loss percentage (%) was used to 
determine the degradation temperature of the organic 
content in the modified clay. It is well known that the 
ammonium surfactants have low thermal stability, while it 
suffers degradation and leading to variety of undesirable 
effects in the final compound. The TGA of the organoclay 
shows four degradation steps are observed. Firstly from the 
ambient to 70 °C a weight loss is assigned for water 
desorption, secondly from 150 to 300 °C, the observed 
weight loss is due to releases of hydration water of 
interlayer cations. The third mass loss observed at 450 oC is 
assigned for the degradation of surfactant. The fourth step of 
mass loss was observed at 500-700 oC, which could be 
attributed to the dehydroxylation of the clay hydroxyl 
groups. These findings reflect the thermal stability of 
organokaolinite. 
 
 
 
 
 
 
 
Figure 3. Thermogravimetric analysis of organokaolinite. 
Adsorption results  
Effect of contact time 
The amount of hydrocarbon adsorbed onto the modified 
clay was studied at different contact time periods ranging 
from 5min to 48 h. The results (Figure 4) show that the 
adsorption process of kerosene and gasoline hydrocarbons 
on organkaolinite reached equilibrium fastly in the first hour 
with adsorbed amount reached 5 and 6 g g-1 of kerosene and 
gasoline, respectively. The results clarify that, increasing the 
contact time up to 48 h give slight increase in the amount 
adsorbed of hydrocarbon onto the modified clay and reached 
5.5 and 6.5 g g-1 of kerosene and gasoline, respectively after 
48 h. 
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Figure 4. Effect of contact time on the adsorbed amount of 
hydrocarbon onto organokaolinite. 
Effect of adsorbent amount 
The adsorption of kerosene and gasoline onto the 
modified clay was studied using different amounts of 
organoclay while keeping all other parameters constant. The 
results given in Figure 5 show that the adsorbed amount of 
hydrocarbon increases sharply with increasing amounts of 
adsorbent up to 0.5 g, however, further increase in adsorbent 
amount from 0.5-2 g leads only to slight increase in the 
amount adsorbed of hydrocarbon per gram of organoclay 
adsorbent. 
 
 
 
 
 
 
 
 
Figure 5. Effect of weight of adsorbent on the adsorbed amount of 
hydrocarbon onto organokaolinite. 
 
The initial sharp increase in adsorption could be explained 
as the increase the available adsorption sites on the surface 
relative to the hydrocarbon concentration on increasing the 
amount organoclay. The less effect of increase in the 
amount of organoclay, in the higher range, could be due to 
particles aggregation with increasing adsorbent dose. 
Possible interactions between particles of adsorbent could be 
also responsible for these phenomena, as the adsorption 
occurs within the interlayer surfaces of the organoclay 
which involve intra and inter-particle diffusion 
mechanisms.33,34 Increasing the adsorbent dose increases, 
the possibility of floc formation with greater size, 
consequently the intra particle diffusion resistance increases 
leading to the ineffective increase or slight decrease in 
adsorbed amount of hydrocarbon per gram of adsorbent.35 
Effect of surfactant concentration on the adsorption of 
hydrocarbon 
The adsorption of hydrocarbon was studied onto modified 
clay with different concentrations of surfactant. The results 
in Figure 6 show that the amount of hydrocarbon adsorbed 
increase with increasing the amount of surfactant adsorbed 
onto the modified clay. The results also reflect that the 
maximum hydrocarbon removal was achieved at 
concentration of surfactant corresponding to 100% of the 
CEC of kaolinite clay. This finding proves firstly the 
presence of strong chain interactions and multilayer 
formation as well. Also the change in the exchanged 
concentration of the surfactant has a pronouced effect on the 
adsorbed amount of hydrocarbon onto the modified clay. An 
increase in the concentration of surfactant more than that of 
the CEC of the clay have very slight effect upon the 
adsorbed amount of hydrocarbon upon the organoclay. This 
finding could be due to the formation of second layer of 
adsorbed surfactant, which is weakly bonded to the surface 
compared to the first layer bonded through strong chain 
interactions, keeping the surfactant within the first layer.36 
 
 
 
 
 
 
 
 
Figure 6. Effect of surfactant concentration as a percentage of the 
clay CEC on the adsorbed amount of hydrocarbon onto 
organokaolinite. 
Conclusion 
Based on the obtained results it could be concluded that: 
Organoclay adsorbent based on exchanging surfactant 
within the clay surface could be prepared for potential 
adsorption of hydrocarbons with high efficiency and high 
sorption capacity. The prepared organoclay adsorbent shows 
high adsorption efficiency for hydrocarbon relative to its 
weight.  
The adsorption efficiency of the prepared organoclay is 
highly dependent on hydrocarbon type, surfactant 
concentration on the clay surface, amount of adsorbent and 
time.  
The adsorption of hydrocarbon onto the organoclay is a 
fast process rendering the organoclay economically 
applicable material for removal of organic pollutants from 
waste waters. 
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A REVISION OF THE GUTMANN DONOR NUMBERS OF A 
SERIES OF PHOSPHORAMIDES INCLUDING TEPA 
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The donor numbers (DN) of a series of 20 phosphoramides with general structure (R2N)(X2N)(Y2N)P=O (with R,X and Y alkyl radicals, 
nitrogen-heterocycles or hydrogen atoms)  were revised on the basis of a series of rather simple considerations. It is shown that all the
phosphoramides considered even after the revision are characterized by high DN. In a scale of 163 different type of solvent molecules, the 
phosphoramides are all collocated with their DN above 35 kcal mol-1 till 50 kcal mol-1. The extremely high DN value reported previously 
for (tris(1-aziridinyl)phosphine oxide (TEPA), is now revised to 50 kcal mol-1. The highest DN values in the phosphoramides considered in 
this investigation were those of TEPA, (NHEt)3P=O and (pyrrolidino)3P=O. 
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Introduction 
Different methodologies and scales are available to 
measure the polarity of solvents, their ability to act as 
electron pair donors, electron pair acceptors and their 
interaction with solutes and electrolytes. One of the most 
comprehensive reviews on this topic can be found in the 
book of Reichardt and references reported therein.1 
One of the earlier way to measure the Lewis base 
behaviour of a solvent was proposed by Gutmann and led to 
the development of the Gutmann’s Donor Number (DN) or 
donicity of a solvent.2-6 The measurement of the DN 
involves the use of a relatively strong electron pair acceptor 
(Lewis acid), antimony pentachloride (SbCl5), and its 
formation of a 1:1 adduct with the solvent under study in an 
inert medium (1,2-dichloroethane). The enthalpy of this 
exothermal reaction (1) is corrected with the mixing 
enthalpy of the solvent under study S: dissolved in an inert 
medium 1,2-dichloroethane (DCE). 
S: + SbCl5 Æ  [SÆSbCl5] + ∆Hadduct   (1) 
S: + DCE Æ S(DCE) + ∆Hmix       (2) 
so that 
DN = - ∆Hdonor  = ∆Hadduct – ∆Hmix                    (3) 
The donor number is expressed in kcal mol-1 although it 
can be used in a normalized dimensionless scale the DNN 
which is obtained by dividing the following relationship.1 
DNN = DN/38.8                                       (4) 
Since the DN value is expressed in kcal mol-1 and 38.8 
kcal mol-1 is the DN value of hexamethyl phosphoric acid 
triamide (HMPT), a solvent with high donicity, then the 
DNN is a dimensionless number. 
The stronger is the bond in the 1:1 adduct formed between 
SbCl5 and the solvent, the higher is the reaction enthalpy 
and hence higher is the donor number.     
The DN scale is very useful for chemists and although 
many other scales have been developed, it remains an 
important reference as shown by very recent publications.7-9 
A similar solvent scale known as “Gal and Maria scale” was 
developed using another stronger Lewis acid: boron 
trifluoride, measuring again the enthalpy of reaction in the 
formation of the 1:1 adduct –∆HD-BF3 and expressed in kJ 
mol-1.1,7 Of course, there is a pretty nice correlation between 
the DN scale and the Gal and Maria Scale of values.1,7 
Our interest is currently focused on the DN properties of 
the phosphoramides and the sulphur analogous 
thiophosphoramides, whose general structures are as follows.  
(R2N)(X2N)(Y2N)P=O 
and                   
(R2N)(X2N)(Y2N)P=S 
where R, X, Y can be any kind of alkyl radical, nitrogen 
heterocyclic or hydrogen atom. These molecules have a 
series of interesting and sometimes unique applications and 
properties. The most known phosphoramide is hexamethyl 
phosphoric acid triamide, [(CH3)3N]3P=O (abbreviated 
HMPT and sometimes also HMPA) which has found a wide 
application as solvent in organic chemistry some time ago 
and whose use is now limited after the discovery of its 
carcinogenetic nature in animals.10,11  
Other well known phosphoramides are METEPA  [tris(2-
methylaziridinyl)phosphine oxide] and TEPA which are 
used as crosslinking agents in dyeing, crease proofing and  
flame proofing of textiles, as crosslinkers and stabilizers in 
polymer chemistry and as an insect chemosterilants.12 
METEPA is also a well known antineoplastic agent which, 
together with its thio analogue THIOTEPA, is adopted in 
cancer chemiotherapy.12 Phosphoramides are also interesting 
because their ability to act as inhibitors of enzymatic 
reactions.13,14 In all the above applications the unique 
donicity properties of phosphoramides are put in place. 
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The DN number of a series of phosphoramides, including 
TEPA were measured some time ago15 and reported recently 
in a review without any substantial critical discussion and 
revision.7 The purpose of the present work is to discuss and 
revise the DN values of phosphoramides measured in ref. 15 
Results and Discussion   
Among the solvents whose DN number has been 
measured according to the Gutmann method (eqn. 1-3), a 
series of phosphoramides are reported as compounds with 
high and very high DN values.7,15 Particularly impressive is 
the fact that the compound with the strongest donicity in 
absolute appears to be TEPA with a DN= 91.5 kcal mol-1.7,15  
The widely accepted and used DN value of HMPT is 38.8 
kcal mol-1, 1,16 while in a paper dedicated to phosphoramides 
by Bollinger et al., the DN value of HMPT was reported  as 
50.3 kcal mol-1.15 As commented by Reichardt,1 this 
important difference in the DN value for a molecule selected 
for the DN scale normalization shows that “serious problems 
arise in measuring [calorimetrically] the Lewis basicity of 
this electron pair donor solvent towards SbCl5”. As a 
consequence of these differences in the measured DN values 
of HMPT, usually the phosphoramides DN values are 
omitted in general reviews of solvents1 or are reported 
without any further comment.7   
To arrive at useful DN values of phosphoramides and to 
make a suitable comparison with the DN values of other 
solvents, we propose a simple and operative approach. Since 
Bollinger et al15 have reported the DN values of the 
phosphoramides taking that of HMPT as 50.3 kcal mol-1 
against the commonly accepted value of 38.8 kcal mol-1, we 
propose here to normalize the DN values of all the 
phosphoramides by a correction factor, A = 38.8/50.3 = 
0.7714.  
In this way, not only the HMPT value is brought at 38.8 
kcal mol-1, but also all the other phosphoramides values are 
corrected with the same factor and can be harmonized with 
the DN values of other solvents. This correction does not 
necessarily implies that the DN values of phosphoramides in 
the paper of Bollinger et al. are affected by a systematic 
error, but it is reasonable to apply to all of them  the 
correction factor which is de facto applied to the key 
phosphoramide, HMPT. 
Furthermore, the DN value of (Me2N)2(pyrrolidino)P=O 
(MPPA) was measured as 51.1 kcal mol-1 by Bollinger et 
al,15 while other authors have found it be 38.0 kcal mol-1.16 
Once again a correction factor B of 0.7436 should be 
applied to bring the DN value from 51.1 to 38.0 kcal mol-1. 
It is curious to note here how close each other are the 
correction factors A and B.  Another example of this 
situation is offered by the case of (pyrrolidino)3P=O (TPPT 
or TPPA) whose DN value was found to be 54.8 kcal mol-1 
by Bollinger et al,15 while it was found later as 47.2 kcal 
mol-1 by other authors,16 requiring a correction factor C of 
0.8613 to go from the higher DN value to the lower value. 
In Table 1 we applied the three correction factors A, B 
and C as determined above to the DN values of 
phosphoramides measured by Bollinger et al.15 With this 
operation, the DN of phosphoramides appear more 
homogeneous each other and may be more comparable to 
the DN value of other solvents.   
A key consideration regards the basicity of each amine 
attached to the P=O group. The pKb values of some of the 
bases are given below.17  
Aziridine  = 5.96, azetidine  = 2.71, pyrrolidine = 2.73, 
piperidine = 2.80, (CH3)NH2 = 3.37, (CH3)2NH = 3.22, 
(CH3)3N  = 4.20, EtNH2 = 3.27, Et2NH = 2.89, Et3N  = 3.36 
 
It should be noted here that stronger bases have low pKb 
and are able bind strongly a proton (H+) than a weaker base 
which instead has a high pKb value. In other words, stronger 
bases are excellent lone pairs donors binding the H+ ion. 
Once the amine is attached to the P=O group in the 
phosphoramide molecule, strong bases act as electron 
attractors and reduce the lone pair charge on the P=O 
oxygen, thus reducing the DN. On the other hand weaker 
bases would attract the electron less,  causing less decrease 
in the charge concentration of the oxygen lone pair in the 
P=O group, thus enhancing the DN. From the pKb data 
presented here, all the amine groups including the 
heterocycles, with the exception of aziridine, are strong 
bases. Consequently, we should not expect any large 
difference in the DN value by passing from azetidine to 
pyrrolidine or to piperidine. Looking at the DN values in 
Table 1, especially those multiplied by the correction factor 
A (fourth column from the right), one can see that the DN 
values are all similar, as expected and range between 40 and 
48 kcal mol-1. Furthermore, partial substitution or complete 
substitution of heterocyclic amines as phosphoramide 
substitutents with aliphatic amines has a minor impact since 
all values remain around 40 kcal mol-1 in line with the DN 
value of HMPT of 38.8 kcal mol-1. 
 
Table 1 also shows that the introduction of a pyrrolidine 
moiety in phosphoramide as replacement of a 
dimethylamino unit causes very limited changes in the DN 
value.16 
 
(NMe2)3P=O  Æ    (NMe2)2(pyrrolidino)P=O   Æ     (5) 
[DN= 38.8]  [DN= 38.0] 
 
(NMe2)(pyrrolidino)2P=O   Æ   (pyrrolidino)3P=O      (6) 
[DN= 45.4]      [DN= 47.2]   
 
The trend is confirmed also by the data of Bollinger et al15 
not only in the case of the pyrrolidine but also in the case of 
the other nitrogen heterocycles considered, i.e. azetidine and 
piperidine. 
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Table 1. DN values of phosphoramides with and without using correction factors  
 
 
 
The unique exception to the above trend is represented by 
the substitution by aziridine in phosphoramides: 
 
(NMe2)3P=O  Æ   (NMe2)2(aziridino)P=O   Æ 
[DN= 38.8]  [DN= 48.6] 
 
(NMe2)(aziridino)2P=O   Æ   (aziridino)3P=O            (7) 
[DN= 49.1]  [DN= 70.6 ?] 
 
The enhancement of the DN is expected since aziridine is 
the weaker base of all amines considered here and is much 
weaker also than dimethylamine. Thus, the passage from 
38.8 kcal mol-1 to 48.6 kcal mol-1 for the aziridine 
monosubstitution is fully justified as well as the minimal 
jump in the DN from the monosubstituted to the 
disubstituted phosphoramide. What it is not expected at all 
is the enormous post-correction DN value of 70.6 kcal mol-1 
(91.5 kcal mol-1 before correction) for the tris(aziridinyl)-
phosphine oxide or TEPA. The maximum DN we may 
expect from TEPA should be around 50 kcal mol-1. The 
excess of enthalpy must be due to a side and undesired 
reaction. In fact, it is well known that aziridine ring is very 
prone to opening to give a linear ethyleneimine oligomer.17   
Considering that the reaction between TEPA and SbCl5 was 
conducted in diluted conditions in an inert solvent (DCE), at 
relatively low temperature (25°C), it is reasonable to assume 
that on average only one aziridine ring per molecule has 
undergone the ring-opening reaction. When a three-terms 
ring is opened, the strain energy is released as enthalpy.18 
The strain energy of the aziridine ring is analogous to that of 
a cyclopropane ring.19,20 Group increment thermochemical 
calculations although not highly refined, are reliable and 
were used also in recent research works.21-23 For the ring 
opening of a three-terms ring Van Krevelen group increment 
approach suggests a release of a strain enthalpy of 23.9 kcal 
mol-1.18 
This enthalpy is the amount of heat that was released by 
the opening of an aziridine ring during the 1:1 adduct 
formation between TEPA and SbCl5. Therefore, this 
enthalpy excess should be subtracted from the corrected DN 
value of TEPA reported in Table 1 (fourth column from 
right): 
 
70.6-23.9 = 46.7 kcal mol-1 ≈ 50 kcal mol-1     (9) 
 
Phosphoramide Original 
DN Values 
ref. 15 
DN values 
from ref. 
16 
Correction 
factor A = 
0.7714 
Correction 
factor B = 
0.7436 
Correction 
factor C = 
0.8613 
Recommen-
ded values 
  DN DN DN corr A DN corr B DN corr C   
       
(EtO)3P=O 24.0   24.0     24.0 
(NMe2)(EtO)2P=O 29.5   29.5     29.5 
(NMe2)2(EtO)P=O 47.2   36.4 35.1 40.7 36.4 
              
(NMe2)3P=O (HMPA or HMPT) 50.3 38.8 38.8 37.4 43.3 38.8 
(NEt2)3P=O 47.4   36.6 35.2 40.8 36.6 
              
(NMe)2(MeN-CH2-CH2-NMe)P=O 54.6   42.1 40.6 47.0 42.1 
(NMe2)2(NEt2)2P=O 49.0   37.8 36.4 42.2 37.8 
              
(NMe2)2(NHEt)P=O 53.4   41.2 39.7 46.0 41.2 
(NMe2)(NHEt)2P=O 52.6   40.6 39.1 45.3 40.6 
(NHEt)3P=O 61.3   47.3 45.6 52.8 47.3 
              
(piperidino)3P=O 53.0   40.9 39.4 45.6 40.9 
              
(NEt2)(pyrrolidino)2P=O 55.2   42.6 41.0 47.5 42.6 
(NEt2)2(pyrrolidino)P=O 52.1   40.2 38.7 44.9 40.2 
              
(NMe2)2(pyrrolidino)P=O (MPPA) 51.1 38.0 39.4 38.0 44.0 38.0 
(NMe2)(pyrrolidino)2P=O (DPPA) 49.4 45.4 38.1 36.7 42.5 45.4 
(pyrrolidino)3P=O (TPPA or TPPT) 54.8 47.2 42.3 40.7 47.2 47.2 
              
(NMe2)2(azetidino)P=O 53.3   41.1 39.6 45.9 41.1 
(NMe2)(azetidino)2P=O 54.8   42.3 40.7 47.2 42.3 
(azetidino)3P=O 55.7   43.0 41.4 48.0 43.0 
              
(NMe2)2(aziridino)P=O 63.0   48.6 46.8 54.3 48.6 
(NMe2)(aziridino)2P=O 63.6   49.1 47.3 54.8 49.1 
(aziridino)3P=O        (TEPA) 91.5   70.6 68.0 78.8 50.0 
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yielding a corrected DN value for TEPA of 46.7 kcal mol-1 
which can be rounded to 50 kcal mol-1. 
Table 2. Gutmann's solvent donor number (DN) in kcal mol-1 
Solvent or Donor Name Gutman's 
DN DN 
References 
and notes 
 
   
1,2-dichloroethane 0 1,7 
hexane 0 1,7 
heptane 0 1,7 
tetrachloromethane 0 1,7 
benzene 0.1 1,7 
toluene 0.1 1,7 
thionyl chloride 0.4 1,7 
dichloromethane 1 1,7 
m-dichlorobenzene 2 1,7 
carbon disulphide 2 1,7 
benzoyl chloride 2.3 1,7 
nitromethane 2.7 1,7 
fluorobenzene 3 1,7 
o-dichlorobenzene 3 1,7 
bromobenzene 3 1,7 
chlorobenzene 3.3 1,7 
chloroform 4 1,7 
iodobenzene 4 1,7 
nitrobenzene 4.4 1,7 
nitroethane 5 1,7 
m-xylene 5 1,7 
p-xylene 5 1,7 
styrene 5 1,7 
2-chloroethanol 5 1,7 
furan 6 1,7 
ethylbenzene 6 1,7 
cumene 6 1,7 
phenetole 8 1,7 
anisole 9 1,7 
monochloroacetonitrile 9.6 1,7 
mesitylene 10 1,7 
acetic anhydride 10.5 1,7 
phenol 11 1,7 
biacetyl 11 1,7 
methyl propanoate 11 1,7 
phosphorus oxychloride 11.7 1,7 
benzonitrile 11.9 1,7 
ethyl chloroacetate 13 1,7 
acetonitrile 14.1 1,7 
dioxane 14.8 1,7 
sulfolane 14.8 1,7 
3-pentanone 15 1,7 
ethyl benzoate 15 1,7 
acetophenone 15 1,7 
butyl acetate 15 1,7 
4-methyl-2-oxo-1,3-
dioxolane 
15.1 1,7 
benzyl cyanide 15.1 1,7 
propylene carbonate 15.1 1,7 
i-butanenitrile 15.4 1,7 
di(2-chloroethyl)ether 16 1,7 
propyl acetate 16 1,7 
benzaldehyde 16 1,7 
methyl isobutyl ketone 16 1,7 
diethyl carbonate 16 1,7 
propanenitrile 16.1 1,7 
methyl acetate 16.3 1,7 
ethylene carbonate 16.4 1,7 
butanenitrile 16.6 1,7 
contg. Table 2.  
 
  
   
2-propanone (acetone) 17 1,7 
t-butyl-methyl ketone 17 1,7 
ethyl propanoate 17.1 1,7 
methyl i-propyl ketone 17.1 1,7 
ethyl acetate 17.1 1,7 
dimethyl carbonate 17.2 1,7 
2 butanone 17.4 1,7 
water 18 1,7 
cyclopentanone 18 1,7 
cyclohexanone 18 1,7 
2-methyltetrahydrofuran 18 1,7 
4-butyrrolactone 18 1,7 
di-n-propyl ether 18 1,7 
di-i-propyl ether 19 1,7 
di-n-propyl ether 19 1,7 
formic acid 19 1,7 
methanol 19 1,7 
glycerol 19 1,7 
dibenzyl ether 19 1,7 
diethyl ether 19.2 1,7 
ethanol 19.2 1,7 
butanol 19.5 1,7 
propanol 19.8 1,7 
tetrahydrofuran 20 1,7 
acetic acid 20 1,7 
1,2-ethandiol 20 1,7 
1,2-dimethoxyethane 20 1,7 
tetrahydrofuran 20 1,7 
2-propanol 21.1 1,7 
1,3-dioxolane 21.2 1,7 
2-methyl-2-propanol 21.9 1,7 
tetrahydropyran 22 1,7 
2-phenylethanol 23 1,7 
benzyl alcohol 23 1,7 
trimethyl phosphate 23 1,7 
tributyl phosphate 23.7 1,7 
1,8-cineole 24 1,7 
formamide 24 1,7 
n-pentanol 25 1,7 
triethyl phosphate 26 1,7 
N,N-dimethylformamide 26.6 1,7 
N-methylformamide 27 1,7 
N,N-dimethylaniline 27 1,7 
N-methylpyrrolidone 
(NMP) 
27.3 1,7 
N,N-dimethylacetamide 27.8 1,7 
1,3 
dimethylimidazolidin-2-
one (DMEU) 
 1,7 
n-butanol 29.0 1,7 
(NMe2)(EtO)2P=O 29.5 This work 
revised 
from 15 
N,N,N',N'-
tetramethylurea 
29.6 1,7 
dimethyl sulfoxide 29.8 1,7 
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methanol 30 1,7 
n-propanol 30 1,7 
n-hexanol 30 1,7 
N,N-diethylformamide 30.9 1,7 
o-chloroaniline 31 1,7 
contg. Table 2.  
 
  
   
n-decanol 31 1,7 
dibutyl sulfoxide 31 1,7 
quinoline 32 1,7 
ethanol 32 1,7 
isopentanol 32 1,7 
n-octanol 32 1,7 
N,N-diethylacetamide 32.2 1,7 
3,4,5,6-tetrahydro-1,3-
dimethylpyrimidin-
2(1H)-one (DMPU) 
33 ? 1,7 
N-methylaniline 33 1,7 
pyridine 33.1 1,7 
4-methylpyridine 34 1,7 
pyridine oxide 34.4 1,7 
aniline 35 1,7 
isopropanol 36 1,7 
p-methypyridine N-oxide 36.3 1,7 
(NMe2)2(EtO)P=O 36.4 This work 
revised 
from 15 
(NEt2)3P=O 36.6 This work 
revised 
from 15 
isobutanol 37 1,7 
(NMe2)2(NEt2)2P=O 37.8 This work 
revised 
from 15 
n-butanol 38 1,7 
(NMe2)2(pyrrolidino)P=O  
(MPPA) 
38.0 This work 
revised 
from 15 
HMPA or HMPT 38.8 1,7 
3-methylpyridine 39 1,7 
dimethylsulphide 40 1,7 
(NEt2)2(pyrrolidino)P=O 40.2 This work 
revised 
from 15 
(NMe2)(NHEt)2P=O 40.6 This work 
revised 
from 15 
(piperidino)3P=O 40.9 This work 
revised 
from 15 
diethylsulphide 41 1,7 
(NMe2)2(azetidino)P=O 41.1 This work 
revised 
from 15 
(NMe2)2(NHEt)P=O 41.2 This work 
revised 
from 15 
n-butylamine 42 1,7 
(NMe)2(MeN-CH2-CH2-
NMe)P=O 
42.1 This work 
revised 
from 15 
(NMe2)(azetidino)2P=O 42.3 This work 
revised 
from 15 
(NEt2)(pyrrolidino)2P=O 42.6 This work 
revised 
from 15 
 
contg. Table 2.  
 
  
   
(azetidino)3P=O 43 This work 
revised 
from 15 
t-pentanol 44 1,7 
hydrazine 44 1,7 
(NMe2)(pyrrolidino)2P=O  
(DPPA) 
45.4 This work 
revised 
from 15 
(pyrrolidino)3P=O    
(TPPA or TPPT) 
47.2 This work 
revised 
from 15 
(NHEt)3P=O 47.3 This work 
revised 
from 15 
(NMe2)2(aziridino)P=O 48.6 This work 
revised 
from 15 
(NMe2)(aziridino)2P=O 49.1 This work 
revised 
from 15 
diethylamine 50 1,7 
tri-n-butylamine 50 1,7 
(aziridino)3P=O   (TEPA) 50 This work 
revised 
from 15 
piperidine 51 1,7 
Trioctylamine N-oxide 52.3 1,7 
ammonia 59 1,7 
triethylamine 61 1,7 
 
 
Thus, eq. 8 can be written as follows:  
 
(NMe2)3P=O  Æ   (NMe2)2(aziridino)P=O   Æ 
[DN= 38.8]  [DN= 48.6] 
 
(NMe2)(aziridino)2P=O   Æ   (aziridino)3P=O            (10) 
[DN= 49.1]  [DN≈ 50]                        
 
and now makes sense. 
Conclusions 
The available Gutmann Donor Number (DN) values for a 
series of phosphoramides were corrected by a correction 
factor 38.8/50.3, the ratio between the accepted DN value of 
HMPT and that found by Bollinger et al.15 The selection of 
the correction factor is also supported by the comparison of 
the DN values of HMPT, MPPA and TPPT or TPPA 
measured by Bollinger et al.15 and the experimental DN 
values measured by other authors.16  
Only for TEPA it was necessary to consider a further 
correction of the DN value, since the value of  91.5 kcal 
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mol-1 originally reported by Bollinger et al.15, is affected by 
the systematic error and by a ring-opening reaction of about 
one aziridine ring per TEPA molecule. These considerations 
have led to the conclusions that TEPA has a high DN ≈ 50 
kcal mol-1 but not the extraordinary high and unexplainable 
of 91.5 kcal mol-1. 
In Table 2 are reported the DN values of 162 different 
solvent molecules including all the revised values of 
phosphoramides. From this table it is possible to observe 
that all the phosphoramides considered are characterized by 
the highest DN values among all the solvents considered, 
but their values are not at all extraordinarily high as it was 
thought in the past. TEPA has a DN value similar to certain 
amines like diethylamine, tributylamine and piperidine. 
It is also interesting the following regularity which is 
linked to the number of terms in the heterocyclic rings: 
(aziridino)3P=O             DN = 50 kcal mol-1 
(azetidino)3P=O             DN = 43 kcal mol-1 
(pyrrolidino)3P=O          DN = 47.2 kcal mol-1 
(piperidino)3P=O          DN = 40.9 kcal mol-1 
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POLYVINYL ALCOHOL - MELAMINE FORMALDEHYDE 
FILMS AND COATINGS WITH SILVER NANO PARTICLES AS 
WOUND DRESSINGS IN DIABETIC FOOT DISEASE 
Rita Kakkar[a]*, Kalpana Madgula[a]*,  Y. V. Saritha Nehru[a], Jayesh Kakkar[b] 
 
Keywords: wound dressings, nanosilver, antimicrobial, diabetic ulcers, polyvinyl alcohol-melamine formaldehyde resin. 
Globally there is a large population of people suffering with diabetes. A large percentage of these patients develop foot ulcers at some point
that heal very slowly and can worsen very rapidly.  The use of silver nanoparticles in silver release dressings and in management of infected
wounds is important, as several pathogenic bacteria have developed resistance against various antibiotics.  Such dressings vary in
technological nature of their silver content and release. Use of silver dressings in recent times has a considerable challenge of lacking cost
effectiveness. In-vitro susceptibility of microorganisms causing foot ulcers to a silver nanocomposite of Polyvinyl alcohol (PVA) and 
Melamine formaldehyde (MFR) resin both as films and coatings is being reported. AgNP solution was prepared by colloidal route and
characterised. MFR was prepared and reacted with PVA and AgNP solution to obtain PVA-MFR composite and PVA-MFR-Ag composite.
The antimicrobial composites were casted into films, also soaked into polyvinyl foam, and coated on Whatman paper. Antimicrobial
efficacy of such prepared dressing materials was tested. They are stable and do not lose their antimicrobial activity with time. Tissues from 
the wounds of five diabetic patients with deep foot infections were collected to isolate and identify the microorganism responsible for
causing foot ulcers in the diabetic patients. Their sensitivity towards various antibiotics was studied. Staphylococcus aureus, Proteus 
vulgaris, Pseudomonas aeruginosa and Enterobacter cloacae species isolated from wound samples, though were found resistant to many
antibiotics are sensitive to PVA-MFR-Ag films. These silver composites can be cost effective for the reason that efficacy of nanosilver is 
superimposed on antimicrobial activity of cheaper PVA-MFR composite. Thus, AgNP immobilised on antimicrobial PVA-MFR, could 
probably be a promising wound dressing in diabetic foot disease management. 
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INTRODUCTION 
Diabetic foot ulcers occur in about 25% of diabetics. 
India currently has a diagnosed diabetic population of 
about 60 million and another 60 million are considered to 
be pre-diabetics/ undiagnosed diabetics. Diabetic foot 
infections account for about 40% of hospital admissions 
worldwide due to diabetes. These infections are 
frequently polymicrobial and include organisms like 
Staphylococcus Aureus both methicillin susceptible and 
methicillin resistant, Pseudomonas, Proteus, Escherichia 
Coli, Klebsiella etc. Due to various reasons including 
misuse, many of these organisms are today resistant to 
conventional antibiotics and antimicrobial dressings.1,2 
With the manifestation of more and more antibiotic 
resistant bacterial strains, another major healthcare related 
problem is bacterial infection from medical devices.3,4,5 
Application of silver nanoparticles on the surface of 
medical devices is in use, to help decrease such 
complications. Silver has been used since time 
immemorial in the treatment of infected wounds. The use 
of nanoparticles of silver in the treatment of infected 
wounds is documented and has been studied.6,7,8  
Currently the nanocrystalline silver is bound to a cloth 
base commercially and used for dressings, examples 
being Biatain AG9 (produced by Coloplast), Atrauman 
AG10 (produced by Hartmann) and various others. These 
commercial applications in the Indian and third world 
scenario are prohibitively expensive. PVA-MFR 
composite and PVA-MFR-Ag nanocomposite are found 
to be antimicrobial.11  Hence, the  nanosilver immobilised 
on PVA -MFR was studied in vitro for antimicrobial 
activity in isolates from foot infections.  
EXPERIMENTAL 
Materials and Methods 
Silver nitrate (AgNO3) from SD Fine Chemicals, starch 
from Merck, Mumbai and trisodium citrate dihydrate (AR 
grade), from Finar Chemicals, Ahmadabad were used. 
Poly(vinylalcohol) (PVA) M.W. 85,000 - 1, 24,000 (LR 
grade), formaldehyde (37 % w/v, LR) were purchased 
from S.D. Fine Chemicals Limited, Mumbai. Melamine 
powder (AR grade) was purchased from Gujarat Natural 
Fertilizers Limited (GNFC). All the solutions were made 
using double distilled water. TEM samples were prepared 
by placement of the sample mixture drops directly on 
Formvar polymer-coated grids with a micropipette. The 
morphology, size and shape distribution of the 
nanoparticles were recorded with a TECNAI FE12 TEM 
(Eindhoven, The Netherlands) instrument operating at 
120 kV. UV–Vis spectra were recorded on Systronics 
model 2201. FT-IR absorption spectra were carried out 
using the Fourier transform-infrared spectrometer (FTIR-
Bruker Optics, Germany Model: TENSOR27). FT-IR 
spectra of the samples were obtained in the spectral range 
of 4000 – 400 cm-1.      
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The antimicrobial activity of the samples was 
performed by Kirby-Bauer disc diffusion method11 to 
check whether the samples are active or not. The Nutrient 
agar (Himedia) was prepared, sterilized, poured into petri 
dish and allowed to solidify. The bacterial culture was 
spread with the help of ‘L’ shaped glass rod. Then 
samples were added into wells and the petri dishes were 
incubated for 24 h at 37 oC.  The antibacterial activity of 
the AgNP solution, PVA-MFR hereafter called composite, 
PVA-MFR-Ag, hereafter called Ag-composite were  
studied using the bacterial cultures of Klebsiella 
pneumonia (K. pneumonia), Pseudomonas aeruginosa (P. 
aeruginosa), Escherichia coli (E. coli), Staphylococcus 
aureus (S. aureus), Bacillus subtilis (B. subtilis ) and 
Proteus vulgaris (P. vulgaris ). 
A piece of tissue from the depth of the infected 
wound was excised and passed through a tissue 
homogenizer to blend the tissue, so as to expose the 
organism present in the tissue. The homogenized tissue 
was then plated into various culture media for growth of 
bacteria and fungi. From the homogenized tissue, gram 
stains for bacteria and KOH stains for fungi were also 
done. The plates were checked for bacterial colony 
growth after 48 hours and for fungal growth after 7 days. 
Based on colony characteristics and culture media, gram 
staining was done to identify the organism as well as 
various identification reactions were run for the same. 
The colonies were then subjected to antibiotic 
susceptibility using disk diffusion technique to identify 
the susceptibility of the organisms to various antibiotics 
and antimicrobials. 
Preparation of Melamine Formaldehyde Resin (MFR)  
These are primarily oligomers and are formed in a two 
stage process by Melamine – Formaldehyde reaction with 
a 1: (2–12) molar ratio of melamine to formaldehyde. The 
first stage reaction is carried out at 70- 80 °C and pH 9-
10; and the second stage involves subsequent 
polycondensation of the products in an acid medium.  In 
our study the reaction has been carried to the first stage 
only. Melamine-formaldehyde used in the study was 
prepared by method12 where formaldehyde and melamine 
are reacted under base catalyst and it’s polymeric 
molecular weight increased by addition process. 57 g of 
(37 %) formaldehyde was taken in a double necked RB 
flask and brought to pH 9.5 - 10 by the addition of few 
drops of 2 N NaOH solution. The RB flask was kept on a 
magnetic stirrer and 50 g of melamine powder slowly 
added under stirring followed by 15 ml of distilled water. 
The reaction mixture was heated with continuous stirring 
till the temperature increased to about 60 °C and then 
very gradually allowed the temperature to rise to about 
95 °C.  Reflux and stirring at this temperature was 
continued till a clear liquid was obtained.  
Further heating was carried while checking the water 
tolerance of the reaction mixture after every 10 minutes, 
until the water tolerance at 30 °C dropped to 1:4. The 
mixture was allowed to cool to room temperature. Final 
properties of the resin were fixed by parameters like 
viscosity, water tolerance and gel time.13 Viscosity at 32 
°C is 30 - 40 s; water tolerance at 30 °C is 1: 2 to 1:4, and 
gel time at 150 °C is 210 - 230 s. Under these conditions 
the reaction mixture is partially cured and is a clear 
viscous liquid with the shelf life of 4-5 days at room 
temperature and about a month when stored in 
refrigerator. The prepared resin mixture however can be 
diluted with methanol if necessary for storage at room 
temperature.  
Preparation and characterisation of silver nanoparticles 
AgNP solution was prepared from AgNO3 and trisodium 
citrate, by the colloidal route which involves not only 
reduction of Ag+ ion but also stabilisation of AgNPs by a 
lyophilic colloid. 50 ml of 0.008 M AgNO3 was stirred 
for 15 minutes under reflux condition with a magnetic 
stirrer (Spinot Model MC-02), followed by addition of a 
solution of 200 mg starch powder dissolved in 100 ml of 
double distilled water and then 50ml of 0.08 M sodium 
citrate solution was added, under continuous stirring and 
heating for 2 h at 95 oC. The silver content of this solution 
is 2x10-6 mol ml-1. The procedure was repeated three 
times, replacing starch with polyvinyl alcohol (PVA), 
polyethylene glycol (PEG), and Gum acacia.  
Preparation of PVA-MFR-Ag nanocomposite as films and 
coatings 
Preparation of these films and coatings has been  
carried out as  by the procedure discussed in detail  in our 
earlier work.11  A (10 wt %) solution of PVA in 20 ml of 
AgNP solution, was prepared by stirring and heating over 
a water bath at 90 °C till all the PVA was dissolved. To 
this solution 2 ml of prepared Melamine formaldehyde 
(MFR) solution was  added and blended, by using an 
electrical blender while heating at about 80 °C, over a 
water bath,  taking care to stop the process just before it 
forms a thick ball like mass. At this stage the blend is 
ready to be cast into a film or a coating.  
For making films the blend was poured and spread 
uniformly, on a plastic Petri dish and dried in hot air oven 
at about 70 – 80 °C for 2 h. After evaporation of the 
solvent at ambient temperature, film was peeled off and 
stored in Ziploc bags. To prepare blank PVA-MFR film, 
20 ml of (10 wt %) PVA aqueous solution was used in the 
place of 20 ml of AgNP solution. The active composite 
blend could also be coated on a whatman paper or a thin 
strip of polyvinyl foam can be soaked into it. PVA-MFR-
Silver films with varying concentration of AgNPs, 
labelled Ag0 to Ag6 shown in Table 1, were prepared by 
varying the dilution of AgNP solution taken. Film 
labelled Ag0 has no silver and is only a PVA-MFR blank 
film.  
Table 1. PVA-MFR-AgNP films of different concentration of AgNP 
Name Ag0 Ag1 Ag2 Ag3 Ag4 Ag5 Ag6 
X 10-7 mol AgNO3 film area in cm-2 0 0.4 0.8 1.2 2 3 4 
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RESULTS AND DISCUSSION 
Characterization of AgNPs 
The four AgNP solutions prepared under similar 
conditions but with different stabilisers were compared by 
UV-Visible spectral analysis carried out in the range 250-
750 nm and the characteristic absorption (SPR) peaks 
obtained in the visible regions at 412 nm.  Absence of 
peak at 560 nm in Figure 1 confirms no agglomeration of 
AgNP and they are highly dispersed in nature. 
Considering absorbance at wavelength 412 nm, is 
indicative of concentration of AgNPs formed, the yield of 
the AgNP is higher when starch or PVA are used as 
stabilisers. Further on comparison starch stabilised AgNP 
solution showed better antimicrobial efficacy than the rest 
of the stabilisers.  
Thus AgNP solution prepared by combination of citrate 
and starch as described was preferred for use in further 
work. Very small concentration of AgNPs is formed with 
starch alone or with citrate alone. Our previous work14 on 
starch stabilised AgNPs discusses at length the role of 
starch as stabiliser as well as reducing agent. 
 
 
 
 
 
 
 
Figure 1. UV-Visible studies of AgNPs prepared using different 
protective colloids as stabilizers 
Reaction parameters for the process have been 
standardized to obtain uniform size AgNPs that are stable 
for months at room temperature even after a year.  Silver 
nanoparticles show a small gap between the conduction 
band and valence band where electron moves freely that 
are responsible for Surface Plasmon peak.15, 16 This 
absorption strongly depends on the particle size, dielectric 
medium and chemical surroundings.17 TEM studies were 
performed on the samples so as to access size and 
morphology. The TEM image of AgNP prepared using 
different protective colloids as stabilizers is shown in 
Figure 2 and as can be seen the size of the nanoparticles is 
less than 40 nm.  The inset shows the SAED images and 
as can be seen the observed Debye Scherer concentric 
rings assigned to (111), (200), (220), and (311) planes 
consistent with the fcc phase of AgNPs. 
FTIR spectrum of PVA film in Figure 3 shows typical 
strong hydroxyl bands for free alcohol (non bonded –OH 
stretching band at 3313cm-1 and also PVA film reveals 
major peaks like C–H broad alkyl stretching band (2850-
3000 cm-1).18 An important absorption peak was verified 
at 1245cm-1 for –C-O stretching bond and 1090 cm-1 for 
C-O-H bending vibration. These bands have been used as 
characteristic bands for assessing the semi-crystalline 
nature of PVA structure that is expected due to different 
process parameters.19, 20  
 
 
 
 
 
 
 
 
Figure 2. TEM images of silver nanoparticles prepared using 
different protective colloids as stabilizers 
By cross linking PVA with MFR, the intensity of the –
OH peaks reduced and became broad when compared to 
pure PVA that suggests hydrogen bonding becomes weak 
in cross linked PVA as shown in the FTIR spectrum of 
PVA-MFR. In addition to that, the C-O stretching at 1090 
cm-1 is reduced in cross linked PVA to a broader 
absorption band PVA-MFR (1000 -1300 cm-1) as can be 
seen in Figure 3. 
The peak at 813 cm-1 is characteristic of triazinyl ring 
of melamine moiety. A slight change in the IR spectrum 
of the PVA-MFR composite was observed for the band 
peaking at 1300-1200 cm-1. These changes are more 
pronounced for the Ag-PVA-MFR nanocomposite with 
the blending of inorganic phase.  The decrease in the ratio 
of intensities of this band upon incorporation of the Ag 
nanofiller indicates interaction of Ag nanoparticles and 
the free OH groups of cross linked polymer and 
decoupling of corresponding vibrations.  This is further 
noticed 21.22,23,24 by the decrease in intensity of symmetric 
CH bend in the region 1000-850 cm-1.  
 
 
 
 
 
 
 
 
Figure 3.  FTIR spectra of plain PVA film, PVA-MFR 
composite film and PVA-MFR-Ag nanocomposite film 
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Results of antimicrobial studies done on prepared PVA-
MFR composite and PVA-MFR-Ag composite films, in 
Table 2, show that the PVA-MFR composite film is 
antimicrobial but efficacy is more in comparison for the 
Ag composite film.  
Antimicrobial activity due to silver is thus clearly 
superimposed over the activity due to the polymer. 
Concentration of silver, MFR, and film thickness can be 
varied easily and studied.  
Studies on films prepared with different concentration 
of AgNP from Table1 show antimicrobial property of the 
films increases with increasing concentration of silver. 
All organisms studied in Table 2 were studied to see the 
trend, but for convenience only S. Aureus results are 
shown here. 
 Table 2. Zone of inhibition diameter in cm for composite 
and Ag composite film 
Organism AgNP-composite film Composite film 
E.coli 1.8 1 
K.pneumonia 2 1.2 
P.aeruginosa 2.5 1.2 
P.vulgaris 2.7 1.3 
S. aureus 3.3 1.1 
B.subitilis 3 1.3 
Antimicrobial activity in all the films containing silver 
(Ag1-Ag6) was more compared to the film Ag0 
containing no silver, where the activity is only due to 
PVA-MFR, as is seen in Figs 4 and 5. Activity increased 
with increasing concentration of silver used, in films Ag1 
to Ag3 and levelled off thereafter in Ag4-Ag6.  
 
 
 
 
 
 
 
Figure 4. Zone of inhibition diameter in cm.  Increasing S. 
aureus antimicrobial activity of Ag-Composite films with 
increasing concentration of silver in film  
Thus, antimicrobial property of the film can be 
increased by using more of nanosilver concentration and 
less of MFR if so desired for any medical applications. At 
the same time if cost is a criteria and if MFR has no 
harmful effect, concentration of MFR in the film can be 
increased with lesser or no silver at all. The film Ag6 in 
this study, for example was prepared by using 20 ml of as 
prepared nanosilver solution, dissolving 2g of PVA 
powder into it, to get 10 wt. % PVA solutions with the 
silver containing 0.04 millimol of silver. 
 
 
 
 
 
 
 
Figure 5. Increase in zone of inhibition for S.Aureus studies, 
with increase in silver content in silver composite films from 
Ag1 to Ag6 
To this 2 ml of MFR was added and proceeded as 
described earlier. This composite so prepared gave about 
100 sq cm of film, having about 4 x 10-7 mol of silver cm-
2 of film area. The films are found to be stable and do not 
lose their efficacy with storage. The composite and Ag-
composite films have been studied, in immediate use and 
eight months after they have been prepared.  
 
 
 
 
 
 
 
Figure 6. Zone of inhibition diameter in mm; P. Aeruginosa 
studies demonstrating the stability and antimicrobial efficacy of 
film over time period 
Results in Figure 6, represent antimicrobial activity 
with P. aeruginosa only, though trend is same with other 
organisms also. Within experimental errors there is a 
marginal fall in activity of both the films over period of 
eight months. In fact, the films are stable and effective 
even two years after they have been prepared. 
Bacterial Identification of microorganisms from foot 
infections of patients 
Tissues from the wounds of five diabetic patients with 
deep foot infections were collected to isolate and identify 
the microorganism responsible for causing foot ulcers in 
diabetic patients.  The samples from patients labelled as 
case 1 to 5, were subjected to tissue culture and  the 
organism present in them identified.25  The organism 
identified in the wound of case 1 to 5 proved to be in case 
1-Staphylococus aureus, case 2-Proteus vulgaris, in case-
3 and 5-Pseudomonas aeruginosa and case 4 -
Enterobacter cloacae (Table 3). 
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Antibiotic susceptibility of microorganisms from foot 
infections of patients 
Antibiotic susceptibility testing (AST) is usually carried 
out to determine which antibiotic will be most successful 
in treating a bacterial infection in vivo. World Health 
Organisation (WHO) has recognised the spread of 
multiple antimicrobial –resistant pathogenic as a serious 
global human and animal health problem. The 
development of bacterial antimicrobial resistance is not a 
new phenomenon, but a troublesome situation because of 
the frequency with which it is emerging. Selection of an 
appropriate agent from a variety of available 
antimicrobial agents has made doctors more dependent on 
in-vitro antimicrobial susceptibility testing. Antibiotic 
susceptibility in all five cases (Table 4) was checked 
using disk diffusion technique to identify the 
susceptibility of the organisms to various antibiotics.25 
In-vitro testing of susceptibility of microorganisms from foot 
infections to PVA-MFR-Ag composites  
The microbes isolated from the foot ulcers of five 
different patients identified above are, case 1-
Staphylococus aureus, case 2-Proteus vulgaris, case-3,5-
Pseudomonas aeruginosa and case- 4 Enterobacter 
cloacae. The antibiotic studies above showed the 
expected pattern, that the microbes often are found to be 
resistant to many antibiotics.26  The polymer sensitivity 
was studied with PVA-MFR and PVA-MFR-Ag 
composites to establish the sensitivity of isolated 
microbes in cases 1 to 5. Composites are found to be 
antimicrobial against S. Aureus, P. Vulgaris, 
Pseudomonas and Enterobacter species in these samples. 
In each case, antimicrobial activity is found in PVA-MFR 
and the activity is enhanced in the corresponding PVA-
MFR-Ag composite. Tests were done to study the 
composite in solution, films, coatings on paper and foam 
and each one found to be antimicrobial towards the 
isolated microbes. 
Susceptibility to Composites in solution  
The solutions tested were (1) on as prepared solution of 
AgNP (2) 10 Wt% solution of PVA in as prepared AgNP 
solution (3) PVA-MFR-Ag solution that was obtained by 
diluting the active composite blend with an equal volume   
of water before casting into films.  The dilution of the 
composite needs to be done to avoid solidification, and 
the dilution can be done with methanol also.  
Figure 7 shows zone of inhibition diameter in mm for 
different microorganisms from foot infections of the five 
cases studied.  It can be seen from Figure 7, AgNP 
solution in water and AgNP solution in PVA are equally 
effective. This goes to prove that Ag in Ag/PVA solution 
is as active as in pure AgNP solution. In comparison the 
antimicrobial activity in all the cases is enhanced in the 
case PVA-MFR-Ag solution which is due to 
antimicrobial contribution from MFR, over and above the 
contribution from AgNPs. This novel composite offers 
the flexibility of increasing the contribution from MFR or 
from AgNP if we so desire by merely increasing their 
concentration in the reaction mixture.  
 
 
 
 
 
 
 
Figure 7. Zone of inhibition diameter in mm.  Susceptibility of 
microorganisms from foot infections of patients to AgNPs, 
Ag/PVA, PVA-MFR-Ag in solution form 
Susceptibility to composite films  
Susceptibility of all the five cases with PVA-MFR and 
PVA-MFR-AgNP composite films was studied. PVA-
MFR is antimicrobial in all the cases.  Figure 8 shows a 
relative increase in the antimicrobial efficacy of  PVA-
MFR-AgNP composite as compared to PVA-MFR only, 
due to contribution by AgNP in the film. This clearly 
corroborates the role of AgNP and MFR in the film as 
PVA by itself has absolutely no antimicrobial activity.  
Enterobacter species is not as sensitive as the rest of the 
microbes. The polymeric silver films are far more 
effective as compared to the solution form. 
 
 
 
 
 
 
 
Figure 8. Zone of inhibition diameter in mm. Susceptibility of 
microorganisms from foot infections of different patients to 
composite and Ag –composite films. 
Susceptibility to nanocomposite coatings  
The polymeric composite has good binding properties 
forming stable chemically resistant coatings on fabric, 
paper, glass, polyester etc, rendering them antimicrobial. 
These films and coatings retain their antimicrobial 
activity over long period of time.  The composite 
absorbed in polyvinyl foam and coated on paper have 
been tested in similar manner as the films. Effectiveness 
of the prepared nanocomposite foams towards different 
organisms is well demonstrated in Figure 9.  The zone of 
inhibition diameter in mm is plotted.  It is possible to soak 
more nanocomposites in the foam and increase its 
antimicrobial efficacy. 
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Table 3. Bacterial identifications and the observations from various test performed 
Case 1 Staphylococcus aureus Case 2 Protens vulgaris 
 Catalase  positive Motile bacilli Indole positive 
Coagulase positive Mannitol fermentative  Urease positive Phenyl alanine deaminase 
positive 
Beta Haemolysis on blood 
agar 
Golden yellow colonies Swarming growth on blood agar  
Case 3, 5 Pseudomonas aeruginosa Case 4 Enterobacter cloacae 
Motile bacilli Oxidase positive Motile bacilli Indole negative 
Citrate positive Non lactose fermenting 
colonies 
MR negative VP positive 
  Citrate positive Aesculine hydrolysis negative 
  Arginine dihydrolase positive  
 
Table 4. Antibiotic susceptibility of microorganisms from foot infection of patient cases 1 to 5 
Case 1 Staphylococcus aureus Case 2 Protens vulgaris 
Sensitive Sensitive 
Cefazolin Cefotaxime Amoxicillin clavulanic 
acid 
Amoxicillin clavulanic acid Piperacillin tazobactam 
Oxacillin Linezolid Amikacin Imipenem  
Vancomycin   Resistant 
Intermediate Sensitive Ciprofloxacin Ofloxacin 
Ciprofloxacin Ofloxacin Levofloxacin Levofloxacin Ceftazidime 
Resistant Cefepime Cefotaxime 
Azithromycin Erythromycin Co Trimoxazole Amikacin Gentamicin 
Gentamicin   Tobramycin  
Case 4 Enterobacter cloacae Case 3, 5 Pseudomonas aeruginosa  
Sensitive Sensitive 
Imipenem  Amikacin Tobramycin 
Resistant Piperacillin tazobactam imipenem 
Ciprofloxacin Ofloxacin Resistant 
Levofloxacin Ceftazidime Ciprofloxacin Ofloxacin 
Cefepime Cefotaxime Levofloxacin Ceftazidime 
Ceftriaxone Amikacin Cefepime Gentamicin 
Gentamicin Tobramycin   
Piperacillin tazobactam Amoxicillin clavulanic acid   
 
 
 
 
 
 
 
 
 
Figure 9.  Zone  of inhibition diameter in mm. Demonstrating 
effectiveness of foams coated with composite to 
microorganisms from foot infections of patients case 1 to 5  
 
 
 
 
 
 
 
 
Figure 10. Zone of inhibition diameter in mm.  Demonstrating 
susceptibility of microorganisms from foot infections of patients 
case 1 to 5 towards composite and Ag-composite coated paper  
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Results of studies on paper coatings in Figure 10 
corroborate the results seen with foams. The efficacy in 
the case of foams and paper coatings is low as compared 
to that with corresponding films. The antimicrobial 
efficiency can be improved by making thicker coating of 
PVA-MFR-Ag composite if the need be. What is 
common with solution, film and coatings is that all the 
forms are antimicrobial towards all the organisms.   
 
 
 
 
 
 
 
 
Figure 11.  Zone of inhibition diameter in mm for organism P. 
Vulgaris Comparison of effectiveness of different forms of 
PVA-MFR-AgNP Composite - in Solution, on Paper, Foam and 
Films  
The PVA –MFR is less effective while PVA-MFR-Ag 
has higher level of antimicrobial efficacy due to 
contribution from nanosilver immobilised on 
antimicrobial PVA-MFR. Comparative studies on 
solution, film and coatings in Figure 11 show that 
microorganisms are most sensitive to the Ag-composite in 
films than the corresponding solution or coatings. 
CONCLUSION 
The study shows that the PVA-MFR-Ag composite 
films are able to kill microorganisms isolated from foot 
ulcers in case 1 to 5, where they were resistant to many 
antibiotics. Considering the results, it is obvious that as 
compared to solution form, it is PVA-MFR-Ag film 
which is most effective form of the Ag - composite. 
Further it is possible to increase the efficacy of the films 
and the coatings either by increasing the concentration of 
MFR in the acceptable limits or else by increasing the 
loading of AgNPs. An interesting observation with film is 
that it does not leach out all its silver in one use. A piece 
of film once used  for antimicrobial studies was washed, 
dried in oven and tested  again, was found to be 
antimicrobial though with reduced efficacy. The films, 
coatings and solution form of the composite are stable 
over months and do not lose the antimicrobial efficacy. 
We hope that the PVA-MFR-Ag films can possibly 
become safe, effective and affordable wound dressing 
material for patients with foot ulcers, that are resistant to 
conventional antibiotics and antimicrobial dressings.  
Also modification of surface of medical devices by giving 
them a coating with this silver Nanocomposite, so that no 
bacterial adhesions may occur, could probably be a step 
in the direction to help decrease the incidence of medical 
device related infection. 
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SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME NEW 
1,2,3-TRIAZOLE HYDRAZONE DERIVATIVES 
Bakr F. Abdel-Wahab,[a]* Hanan A. Mohamed[a] and Ghada E.A. Awad[b] 
 
Keywords: 1,2,3-triazoles; hydrazones; hydrazonoyl chlorides; antimicrobial activity; MIC. 
A family of novel 1,2,3-triazoles 3-7 were prepared by one pot reaction of 1,2,3-triazol-4-carbohydazides 1 with different reagents such as 
hydrazonoyl chlorides and methyl ketones. The novel compounds were evaluated for their antimicrobial activity. The results of
antimicrobial screening showed that, compound 5 has the highest inhibitory effects on the growth of a wide range of the tested microbes
due to the presence of sulphonyl moiety in its structure. 
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INTRODUCTION 
Recently 1,2,3-triazoles, have found a wide range of 
important applications in the agrochemical, pharmaceutical, 
polymer, and materials field.1,2 In addition, several 
compounds of the 1,2,3-triazole family have shown a broad 
spectrum of biological properties such as antibacterial,3 and 
anti-HIV activity.4 In addition, hydrazones have been 
reported as useful as antibacterial,5  whereas arylhydrazones 
inhibited the replication of HIV-1.6 Because of our interest 
in the synthesis of new 1,2,4-triazole derivatives of 
biological interest,7-10 we decided here to synthesize the title 
compounds for evaluation of their antimicrobial activity. 
RESULTS and DISCUSSION 
The synthesis of 2-(2-(1,2,3-triazole-4-carbo-
nyl)hydrazono)-N'-propanehydrazonoyl chlorides 3a-c, the 
necessary intermediate for the production of N'-(4-(4-
fluorophenyl)-1-(hydrazono)-1-(piperidin-1-yl)but-3-en-2-
ylidene)- 1,2,3-triazole-4-carbohydrazide 4 and N'-(1-(2-
arylhydrazono)-1-(phenylsulfonyl)propan-2-ylidene)- 1,2,3-
triazole-4-carbohydrazide 5, is easy and is shown in Scheme 
1. Condensation of 1,2,3-triazol-4-carbohydrazides 1a-c 
with hydrazonoyl halide 2 in ethanol afforded the 
bishydrazones 3. 
 
 
 
 
When chloro bis-hydrazones 3b were allowed to react 
with a molar ratio of both 4-fluorobenzaldehyde and 
piperidine in refluxing ethanol, they furnished compound 4. 
On the other hand, when compound 3b was treated with 
sodium benzenesulfinate under the same experimental 
conditions, it afforded 5 in good yield (Scheme 2). 
 
 
 
 
 
 
 
 
The structure of 4 and 5 was confirmed on the basis of 
their spectroscopic data. For example, the IR spectrum of 4 
showed absorption bands in the region 3380–3130 cm–1 of 
two NH groups, and the band of the carbonyl group at 1680 
cm–1. Its 1H-NMR spectrum revealed two D2O exchangeable 
singlet signals (three NH) at δ 10.78, 11.12 ppm, whereas its 
mass spectrum showed a peak corresponding to its 
molecular ion at m/z: 582 [M+]. 
The 3-acetyl-1,2,3-triazoles 6 condensed with 1,2,3-
triazol-4-carbohydrazide 1a,c  in absolute ethanol and acetic 
acid as catalyst to give the bis-1,2,3-triazoles 7a-c (Scheme 
3). 
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Table  1.  Antimicrobial activity  (mm) of chemical compounds   
Gram positive bacteria Gram negative bacteria Yeast Compd. 
Staphelococcus 
aureus 
ATCC 29213 
B. subtilis 
ATCC6633 
B. 
megaterium 
ATCC 9885 
 
Sarcina 
lutea 
Klebseilla 
peneumoniae 
ATCC13883 
Pseudomonas. 
Aeroginosa 
ATCC27953 
E. 
coli 
ATCC 
25922 
Saccharomy-
ces cervesia 
Candida 
Albicans 
NRRL Y-477 
3a 32 24 20 29 N.A. N.A. N.A. 30 30 
3b 32 13 14 30 15 16 17 24 22 
3c 34 18 14 28 19 19 18 20 18 
4 35 N.A. 12 33 N.A. 16 17 30 26 
5 36 27 28 38 35 33 34 31 32 
7a 32 15 16 27 29 28 26 30 28 
7b 35 34 32 28 32 28 30 29 28 
7c 30 30 24 32 27 24 27 28 25 
Ciprofloxacin 20 22 24 20 25 24 23 N.A. N.A. 
Ketoconazole N.A. N.A. N.A. N.A. N.A. N.A. N.A. 23 22 
 
 
Table 2.   Minimum inhibitory concentration (µg mL-1 )  
Gram positive bacteria Gram negative bacteria Yeast Compd. 
Staphelococcus 
aureus ATCC 
29213 
B. subtilis 
ATCC6633 
B. 
megate-
rium 
ATCC 
9885  
 
Sarcina 
lutea 
Klebseilla 
peneumoniae 
ATCC13883 
Pseudomonas. 
Aeroginosa 
ATCC27953 
E. 
coli 
ATCC 
25922 
Saccharomyces 
cervesia 
Candida 
Albicans 
NRRL 
Y-477 
3a 50 100 200 50 - - -. 50 50 
3b 50  - 50 -  - - 50 100 
3c 25 200 - 50 200 200 - 100 - 
4 25 - - 50 - - - 50 100 
5 25 50 50 25  50 50 50 50 
7a 50 - - 50 50 50 50 50 50 
7b 25 25 50 25 32 50 50 50 100 
7c 50 50 50 50 50 50 50 100 50 
Ciprofloxacin 25 25 25 25 25 25 25 - - 
Ketoconazole -. - - -. - - - 25 25 
 
The 1H NMR spectra of the latter products showed one 
signal in the regions δ 10.77  ppm assigned to the NH group. 
whereas the mass spectra of compounds 7a-c showed a 
peaks at m/z 418, 432 and 436 corresponding to their 
molecular ions respectively. 
Antimicrobial activity 
The antimicrobial activity of the new compounds has been 
evaluated by filter paper disc method.7 The novel 
compounds have been tested for their antibacterial activity 
against Gram positive bacteria (Staphylococcus aureus 
ATCC 29213, Bacillus subtilis ATCC6633, and Bacillus 
megaterium ATCC 9885); Gram negative bacteria 
(KlebseillapeneumoniaeATCC13883, Pseudomonas. 
Aeroginosa ATCC27953 and Echerichia coli ATCC 25922) 
and fungal (Saccharomyces cervesia, Candida Albicans 
NRRL Y-477 and Aspergillus niger) and two yeast 
(Saccharomyces cervesia and Candida Albicans NRRL Y- 
477). at a concentration of 100µg/mL in DMSO. 
Ciprofloxacin and Ketoconazole were respectively used as 
standard antibacterial and antifungal reference, respectively. 
Minimal inhibitory concentration (MIC)  
The minimum inhibitory concentration (MIC) of the 
synthesized compounds against highly inhibited organisms 
is reported in Table 2. 
Compounds 5 revealed the lowest MIC (25 µg/ml) against 
Staphelococcus Aureus ATCC 29213 and SarcinaLutea. 
While  7b exhibited low MIC (25 µg mL-1) against 
Staphelococcus aureus ATCC 29213 and B. subtili 
ATCC6633 and SarcinaLutea (Table 2). 
From the above results, we can say that, the hydrazone 
moiety is responsible for the antimicrobial activity and the 
compound bearing sulfonyl group (compound 5) is more 
effective than the other tested compounds.  
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EXPERIMENTAL 
All melting points were taken on Electrothermal IA 9000 
series digital melting point apparatus. Elemental analytical 
data were carried from the microanalytical unit, Cairo 
University, Giza, Egypt. The IR spectra were recorded in 
potassium bromide disks on a JASCO FT/IR-6100. 1H-
NMR spectra were run on JOEL-ECA 500MHz in 
deuterated dimethylsulphoxide (DMSO-d6). Chemical shifts 
values (δ) are given in parts per million (ppm). The mass 
spectra were performed using mass Varian MAT CH-5 
spectrometer at 70eV. 1,2,3-Triazol-4-carbohydrazides 1a-
c,11 hydrazonoyl halide 2,12  and 3-acetyl-1,2,3-triazoles 613 
were prepared according to literature.   
Synthesis of compounds 3a-c 
A mixture of 5-methyl-1-aryl-1H-1,2,3-triazole-4-
carbohydrazide 1a-c (10 mmol) and N'-(4-fluorophenyl)-2-
oxopropanehydrazonoyl chloride 2 (2.4g, 10 mmol) in absolute 
ethanol (30 mL) was refluxed for 4 h. The formed solid was 
filtered off, washed with ethanol to afford the corresponding 
propanehydrazonoyl chlorides 3a–c, respectively. 
(1Z,2E)-N'-(4-Fluorophenyl)-2-(2-(5-methyl-1-phenyl-1H-1,2,3-
triazole-4-carbonyl)hydrazono)propanehydrazonoyl chloride 
(3a) 
Yield 68 %; m.p. 222-223°C; IR (KBr) νmax/cm-1 1686 (C=O), 
3322, 3185 (2 NH); 1H NMR (DMSO-d6) δ 2.35, 2.49 (2s, 6H, 
2CH3), 7.01-7.54 (m, 9 H, Ar-H),  10.22, 10.70 (2s, 2H, NH, D2O 
exchangeable); MS m/z (%): 413 (M+, 12), 91(100); Anal. Calcd 
for  C19H17ClFN7O (413.84): C, 55.14; H, 4.14; N, 23.69 %. 
Found: C, 55.23; H, 4.28; N, 23.82% .    
(1Z,2E)-N'-(4-Fluorophenyl)-2-(2-(5-methyl-1-p-tolyl-1H-1,2,3-
triazole-4-carbonyl)hydrazono)propanehydrazonoyl chloride 
(3b) 
Yield 69 %; m.p. 200-201 °C; IR (KBr) νmax/cm-1 1682 (C=O), 
3320, 3181 (2 NH); 1H NMR (DMSO-d6) δ 2.35, 2.49, 2.51 (3s, 
9H, 3CH3), 7.13-7.55 (m, 8 H, Ar-H),  10.21, 10.70 (2s, 2H, 2 NH, 
D2O exchangeable); MS m/z (%): 427 (M+, 16), 91(100); Anal. 
Calcd for  C20H19ClFN7O (427.86): C, 56.14; H, 4.48; N, 22.92;  %. 
Found: C, 56.21; H, 4.51; N, 22.80% .    
(1Z,2E)-N'-(4-Fluorophenyl)-2-(2-(1-(4-fluorophenyl)-5-meth-
yl-1H-1,2,3-triazole-4-carbonyl)hydrazono)propanehydrazo-
noyl chloride (3c) 
Yield 71 %; m.p. 218-220 °C; IR (KBr) νmax/cm-1 1680 (C=O), 
3317, 3183 (2 NH); 1H NMR (DMSO-d6) δ 2.35, 2.49 (2s, 6H, 
2CH3), 7.12-7.54 (m, 8 H, Ar-H),  10.20, 10.69 (2s, 2H, 2 NH, D2O 
exchangeable); MS m/z (%): 431 (M+, 13), 91(100); Anal. Calcd 
for  C19H16ClF2N7O (431.83): C, 52.85; H, 3.73; N, 22.71 %. 
Found: C, 52.91; H, 3.83; N, 22.89% .    
(E)-N'-((1Z,3E)-4-(4-Fluorophenyl)-1-(2-(4-fluorophenyl)-hyd-
razono)-1-(piperidin-1-yl)but-3-en-2-ylidene)-5-methyl-1-p-to-
lyl-1H-1,2,3-triazole-4-carbohydrazide (4) 
To a solution of propanehydrazonoyl chloride 3a–c (1 mmol) in 
ethanol (20 mL), piperidine (0.34 g, 4 mmol) and the 4-
fluorobenzaldehyde (0.13g, 1 mmol) were added. The reaction 
mixture was refluxed for 6 h. The precipitated product was filtered 
off to afford 4. 
Yield 52 %; m.p. 147-148 °C; IR (KBr) νmax/cm-1 1680 (C=O), 
3381, 3236 (2 NH); 1H NMR (DMSO-d6) δ 1.61 (m, 6H, 3CH2 of 
piperidine), 2.34, 2.50 (2s, 6H, 2CH3), 3.31 (m, 4H, 2CH2 of 
piperidine), 6.91, 6.96 (2d, 2H, olefinic-CH, J = 12 Hz) ,7.13-7.98 
(m, 12 H, Ar-H),  10.78, 11.12 (2s, 2H, 2 NH, D2O exchangeable); 
MS m/z (%): 582 (M+, 40), 91(100); Anal. Calcd for  C32H32F2N8O 
(582.65): C, 65.96; H, 5.54; N, 19.23%. Found: C, 66.21; H, 5.67; 
N, 19.50% .    
(E)-N'-((Z)-1-(2-(4-Fluorophenyl)hydrazono)-1-(phenylsulfo-
nyl)propan-2-ylidene)-5-methyl-1-p-tolyl-1H-1,2,3-triazole-4-
carbohydrazide (5). 
To a solution of the appropriate propanehydrazonoyl chloride 3c 
(0.43g, 1 mmol) in absolute ethanol (20 mL), sodium 
benzenesulphinate dihydrate (0.4 g, 2 mmol) was added. The 
mixture was refluxed for 12 h, then left to cool. The reaction 
mixture was poured into cold water and the solid product filtered 
off, washed with water, dried to afford the corresponding sulphone 
5. 
Yield 52 %; m.p. 180-181 °C; IR (KBr) νmax/cm-1 1683 (C=O), 
3386, 3230 (2 NH); 1H NMR (DMSO-d6) δ  2.20, 2.41, 2.49 (3s, 
9H, 3CH3), 6.92-7.98 (m, 8 H, Ar-H),  11.75, 14.45 (2s, 2H, 2 NH, 
D2O exchangeable); MS m/z (%): 534 (M++1, 56), 533 (M+, 53), 
91(100); Anal. Calcd for  C26H24FN7O3S (533.58): C, 58.53; H, 
4.53; N, 18.38%. Found: C, 58.64; H, 4.62; N, 18.42% .    
Synthesis of compounds 7 
A mixture of appropriate carbohydrazide 1  (1 mmol) and 1-(5-
methyl-1-aryl-1H-1,2,3-triazol-4-yl)ethanones 6 (1 mmol) in 
absolute ethanol (50 mL) and acetic acid (0.5 mL) was refluxed for 
5 h. The formed solid was filtered off, washed with ethanol, to 
afford the corresponding hydrazones 7a-c. 
(E)-N'-(1-(1-(4-Fluorophenyl)-5-methyl-1H-1,2,3-triazol-4-yl)-
ethylidene)-5-methyl-1-phenyl-1H-1,2,3-triazole-4-carbohyd-
razide (7a) 
Yield 76 %; m.p. 224-225 °C; IR (KBr) νmax/cm-1 1670 (C=O), 
3198 (NH); 1H NMR (DMSO-d6) δ  2.43, 2.47, 2.48 (3s, 9H, 
3CH3), 7.43-7.76 (m, 9 H, Ar-H), 10.75 (s, H, NH, D2O 
exchangeable); MS m/z (%): 418 (M+, 90), 95(100); Anal. Calcd 
for  C21H19FN8O (418.43): C, 60.28; H, 4.58; N, 26.78 %. Found: 
C, 60.34; H, 4.63; N, 26.87% .    
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(E)-1-(4-Fluorophenyl)-5-methyl-N'-(1-(5-methyl-1-p-tolyl-1H-
1,2,3-triazol-4-yl)ethylidene)-1H-1,2,3-triazole-4-carbohydra-
zide (7b) 
Yield 78 %; m.p. 220-221 °C; IR (KBr) νmax/cm-1 1668 (C=O), 
3199 (NH); 1H NMR (DMSO-d6) δ  2.43, 2.47, 2.48, 2.50 (4s, 12H, 
4CH3), 7.46-7.75 (m, 8 H, Ar-H), 10.76 (s, H, NH, D2O 
exchangeable); MS m/z (%): 432 (M+, 92), 95(100); Anal. Calcd 
for  C22H21FN8O (432.45): C, 61.10; H, 4.89; N, 25.91 %. Found: 
C, 61.24; H, 4.94; N, 26.06% .    
(E)-1-(4-Fluorophenyl)-N'-(1-(1-(4-fluorophenyl)-5-methyl-1H-
1,2,3-triazol-4-yl)ethylidene)-5-methyl-1H-1,2,3-triazole-4-car-
bohydrazide (7c) 
Yield 78 %; m.p. 240-241 °C; IR (KBr) νmax/cm-1 1672 (C=O), 
3280 (NH); 1H NMR (DMSO-d6) δ  2.41, 2.45, 2.47 (3s, 9H, 
3CH3), 7.46-7.76 (m, 8 H, Ar-H), 10.77 (s, H, NH, D2O 
exchangeable); MS m/z (%): 436 (M+, 88), 95(100); Anal. Calcd 
for  C21H18F2N8O (436.42): C, 57.79; H, 4.16; N, 25.68 %. Found: 
C, 57.83; H, 4.26; N, 25.75% .    
Antimicrobial activity 
Novel compounds were tested against a panel of gram positive 
and gram negative bacterial pathogens, yeast and fungi using the 
reported agar well diffusion method.7 
Minimal inhibitory concentration (MIC) measurement 
The bacterio-static activity of the active compounds (having 
inhibition zones (IZ) ≥ 16 mm) was then evaluated using the two 
fold serial dilution technique.7 
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SERENDIPITOUS SYNTHESIS OF A Cu(OAc)2 COMPLEX VIA 
CuCl2 CATALYZED OXIDATION OF 2-BUTANONE:  
SYNTHESIS, CRYSTAL STRUCTURE, AND MAGNETIC     
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 (5-NAP=2-AMINO-5-NITROPYRIDINE) 
 
Andrew G. Bellesis[a], Christopher P. Landee[b], Matthew Polson[c], Mark M. Turnbull[a]* 
and Jan L. Wikaira[c]  
 
Keywords: copper complex, XRD, IR, magnetization. 
A copper (II) catalyzed Baeyer-Villiger reaction of 2-butanone in the presence of oxygen and 2-amino-5-nitropyridine produced crystals of 
bis(2-amino-5-nitropyridine)tetraacetatedicopper(II) dehydrate, (1). 1 and its anhydrous form, (bis-2-amino-5-nitropyridine)tetra-
acetatedicopper(II), (2), were then synthesized directly from Cu(CH3COO)2·H2O and 2-amino-5-nitropyridine. Crystals of both compounds 
were grown using slow evaporation, and characterized using IR, combustion analysis, X-ray powder diffraction, single crystal X-ray 
diffraction, and temperature-dependent magnetic susceptibility measurements. 1 and 2 are both monoclinic and crystallize in the space 
groups P21/c and C2/m, respectively. 2 exhibits 2-fold disorder in the 2-amino-5-nitropyridine molecule that arises due to symmetry. Both 
compounds pack in sheets of isolated dimers, and exhibit strong antiferromagnetic interactions within the dimers (J = -442(5) and -471(5) 
K for 1 and 2 respectively). 
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INTRODUCTION 
The structure and magnetic properties of copper(II) 
acetate monohydrate has been of interest in the magnetism 
community for over half a century. Guha1 first observed the 
unexpected antiferromagnetic behavior of copper(II) acetate 
monohydrate in 1951 when he detected a decrease in 
magnetic moment that corresponded to a decrease in 
temperature. The precise physical and chemical phenomena 
explaining the magnetic properties of copper(II) acetate 
monohydrate were elucidated by Bleaney and Bowers2 the 
following year; their experiments showed very strong 
antiferromagnetic coupling between isolated pairs of copper 
ions due to exchange interactions, thus explaining Guha’s 
results. The magnetic and structural properties of copper II 
acetate monohydrate3 and its derivatives,4,5 have been 
closely studied to explain the findings of Bleaney and 
Bowers, as it was an early description of a compound with 
strong antiferromagnetic exchange.   
Currently, we are involved in a project to synthesize and 
characterize copper coordination compounds of the type 
L2CuX2, where L is a substituted pyridine ligand and X is a 
halide ion.  We have previously prepared members of this 
family such as Cu(2-X-3CH3py)2X2 (X=Cl, Br),6 Cu(2-
amino-5-trifluoromethylpyridine)2(X)2 (X=Cl, Br),7 and 
Cu(2-amino5-chloro-3-fluoropyridine)2X2 where (X=Cl, 
Br).8 In the course of our synthesis of Cu(2-amino-5-
nitropyridine)Cl2 (2-amino-5-nitropyridine=5-NAP), we 
serendipitously produced the compound (5-
NAP)2(CH3COO)4Cu2·2H2O (1). The previously unreported 
anhydrous form, (5-NAP)2(CH3COO)4Cu2 (2) was 
synthesized as well, through direct methods. It was 
determined that an unexpected reaction with 2-butanone 
produced acetate ions through Cu(II) catalyzed air-oxidation 
followed by hydrolysis. Here, we present the synthesis, 
crystal structure, and magnetic behaviors of both 
compounds and propose a reaction mechanism for the 
production of acetate ions from 2-butanone during the 
synthesis.  
EXPERIMENTAL 
Copper(II) chloride dihydrate was purchased from Allied 
Chemical Corporation.  2-Amino-5-nitropyridine (5-NAP) 
was purchased from Fluka Chemie, a subsidiary of Sigma 
Aldrich. Copper(II) acetate monohydrate was purchased 
from Matheson Coleman & Bell Corporation. 1-Butanol was 
purchased from Mallinckrodt, Inc. and 2-butanone was 
purchased from Alfa Aesar. All materials were used as 
received. IR spectra were recorded via ATR on a Perkin-
Elmer Spectrum 100. X-Ray powder diffraction was carried 
out on a Bruker AXS-D8 Powder Diffractometer. Elemental 
analyses were carried out by Marine Science Institute, 
University of California, Santa Barbara, 93106. 
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Synthesis of (5-NAP)2(OAc)4Cu2·2H2O (1) 
Compound 1 was previously synthesized by Yan and 
Wang.9  
Method A: 1 was originally synthesized in an attempt to 
crystallize (5-NAP)2CuCl2, which has been characterized by 
IR, X-ray powder diffraction, single-crystal X-ray 
diffraction, and SQUID magnetometry. 1  0.1032 g (0.250 
mmol) of (5-NAP)2CuCl2 was dissolved in 45 mL of 2-
butanone by heating to reflux, forming a clear, emerald 
green solution. The beaker was mostly covered and the 
solution was allowed to cool. Crystals began forming after 
seven days of slow evaporation. A mixture of large, dark 
green rectangular prisms with well defined-faces and a pale 
green crystalline solid were isolated by vacuum filtration, 
rinsed with cold 2-butanone, and allowed to air-dry. The two 
solids were separated manually and characterized by IR and 
combustion analysis. The odor of the filtrate indicated the 
presence of acetic acid. The dark green crystals proved to be 
(5-NAP)2(OAc)4Cu2·2H2O. The yield of 1 could not be 
calculated, because the pale green crystalline byproduct 
could not be completely separated. Only the larger crystals 
of 1 could be manually separated. The pale green crystalline 
solid has not been conclusively characterized at this time. 
For compound 1: IR (ν in cm-1): 3531 (vw), 3491 (vw), 
3347 (vw), 3202 (vw), 1650 (m), 1624 (s), 1604 (s), 1574 
(m), 1493 (w), 1431 (m), 1343 (m), 1296 (s), 1158 (vw), 
1125 (w), 1078 (vw), 1010 (vw), 974 (vw), 847 (w), 833 (w), 
767 (w), 687 (s), 625 (m), 577 (m), 544 (m). CHN found 
(calculated): C: 32.3 (31.9), H: 3.21 (3.88), N: 12.4 (12.4).  
Method B: 1.00 mmol (0.1989 g) of Cu(CH3COO)2·H2O 
was dissolved in 52 mL of 2-butanone by heating to 60 °C. 
A small amount of solid impurity was removed by filtration. 
In a separate beaker, 1.05 mmol (0.1463 g) of 5-NAP were 
dissolved in 20 mL of 2-butanone at room temperature. The 
two solutions were combined, stirred, and heated to 65 °C 
for 10 minutes before allowing the solution to cool to room 
temperature. Dark green rectangular prisms with well-
defined faces formed on the bottom of the beaker after six 
days of slow evaporation (0.1149 g, 33.9 % yield). The IR 
spectrum was the same as that described in method A. The 
product was also shown to be the same as that from Method 
A via comparison of the powder X-ray diffraction pattern to 
the predicted spectrum from the single crystal data. 
Synthesis of (5-NAP)2(OAc)4Cu2 (2) 
0.1996 g (1.000 mmol) of Cu(CH3COO)2·H2O was 
dissolved in 50 mL of 1-butanol by heating to ~ 60 °C  
0.1465 g (1.05 mmol) 5-NAP was dissolved in 20 mL of 1-
butanol by heating to ~ 50 °C. The 5-NAP solution was 
added to the copper acetate solution; the combined solution 
was stirred and heated until it reached 75 °C. The solution 
was allowed to cool and was partly covered. After 8 days of 
slow evaporation, small crystals with well-defined 
rectangular faces were harvested by vacuum filtration, 
washed with 1-butanol, and allowed to air dry. The crystals 
are dichroic; clover green and sky blue. Yield: 0.2225 g; 
                                                 
 
1 Bellesis, A. G., Turnbull, M.M., manuscript in preparation. 
 
69.4 %. IR (ν in cm-1): 3440 (w), 3352 (w), 3242 (vw), 1650 
(m), 1626 (m), 1602 (s), 1573 (m), 1493 (w), 1429 (m), 
1338 (s), 1295 (s), 1129 (w), 1015 (vw), 838 (w), 766 (w), 
682 (m), 643 (vw), 625 (w), 539 (w), 521 (m). CHN found 
(calculated): C: 33.9 (33.7), H=3.32, (3.46) N=13.0 (13.1).  
 
Table 1. X-Ray Data for 1 and 2 
 Compound 1 Compound 2 
Empirical 
formula  
C18H26Cu2N6O14 C18H22Cu2N6O12 
Formula weight  677.55 641.50 
Temperature  120(2) K 120(2) K 
Wavelength  1.54178 Å 1.54184 Å 
   
Crystal system  Monoclinic Monoclinic 
Space group  P 21/c  C2/m  
a 8.3062(3) Å 7.2797(3) Å 
b 19.9736(7) Å 15.6618(5) Å 
c 8.0082(3) Å 10.8921(3) Å 
β 97.394(4)° 102.684(3)° 
Volume 1317.55(8) Å3 1211.55(6) Å3 
Z 2 2 
Density 
(calculated) 
1.708 Mg/m3 1.758 Mg/m3 
   
Absorption 
coefficient 
2.712 mm-1 2.849 mm-1 
F(000) 692 652 
Crystal size 0.17x0.16x0.06 
mm3 
0.14x0.14x0.11 
mm3 
θ range for data 
collection 
4.43 to 74.50°. 4.16 to 76.34° 
Index ranges  
 
 
 
 
Reflections 
collected 
8602 10020 
Independent 
reflections 
2617  
[R(int)=0.0535] 
1317 
[R(int)=0.0542] 
Completeness to 
θ = 74.50° 
97.1 %  99.4% 
Absorption 
correction 
Semi-empirical 
from equivalents 
Gaussian 
Max. and min. 
transmission 
1.00000 and 
0.86607 
0.812 and 0.714 
Refinement 
method 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Data / restraints / 
parameters 
2617 / 0 / 195 1317 / 0 / 146 
Goodness-of-fit 
on F2 
1.087 1.061 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0350, wR2 = 
0.0905 
R1 = 0.0364, wR2 = 
0.0948 
R indices (all 
data) 
R1 = 0.0402, wR2 = 
0.0942 
R1 = 0.0416, wR2 = 
0.0993 
Largest diff. 
peak and hole 
0.427 and -0.660 
e.Å-3 
0.411 and -0.462 
e.Å-3 
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X-Ray Structure Analysis 
Data for 1 and 2 were collected on an Agilent 
Technologies Gemini Eos CCD-Xray diffractometer using 
the CrysAlisPro software package with CuKα radiation (λ = 
1.5418 Å) via ω-scans at 120(2) K employing a graphite 
monochromator. Cell parameters were determined and 
refined using CrysAlisPro10 and absorption corrections were 
made using SADABS.11 The structure was solved by direct 
methods and refined via least-squares analysis using 
SHELXS97-2.12 All non-hydrogen atoms were refined 
anisotropically. Hydrogen atoms bonded to carbon atoms 
were added in calculated positions and refined using a riding 
model with fixed isotropic thermal parameters. The 
positions of hydrogen atoms bonded to nitrogen and oxygen 
atoms were located and refined anisotropically. 
Crystallographic information and details of the data 
collection can be found in Table 1.  
Magnetic Susceptibility Data Collection  
Magnetic data were collected using a Quantum Design 
MPMS-XL SQUID magnetometer. Finely ground samples 
of the crystals were packed in gelatin capsules. The moment 
was measured using magnetic fields from 0 to 50 kOe at 1.8 
K. Several data points were collected as the field was 
brought back to 0 kOe to check for hysteresis; none was 
observed. Magnetization was then measured from 1.8 to 310 
K in a 1 kOe field. The contributions from the sample holder 
were measured independently and subtracted from the data 
set. The data was also corrected for the temperature 
independent paramagnetism of the Cu(II) ions (60 × 10–6 
emu mol-1Oe-1 per ion) and for the diamagnetism of the 
constituent atoms (–226.5 × 10–6 emu mol-1Oe-1) estimated 
from Pascal’s constants.13  
RESULTS  
Syntheses 
Compound 1 was initially synthesized serendipitously in 
an attempt to recrystallize (5-NAP)2CuCl2 (Figure 1) from 2-
butanone which yielded crystals of 1.  
 
 
 
 
 
 
 
 
 
Figure 1. Proposed synthesis of 1, via Method A. 
A direct synthesis of 1 was then successfully carried out 
using copper(II) acetate monohydrate and 5-NAP in 2-
butanone (Figure 2). Both synthesis techniques described 
here were previously unreported, as Yuan and Wang used a 
different pathway.9 When using 1-butanol as a solvent, the 
previously unreported anhydrous form, 2, was synthesized 
(Figure 3).  
 
 
 
 
 
 
 
Figure 2. Method B for the synthesis of 1.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Synthesis of 2 
Crystal Structure 
Compound 1 crystallizes in dimeric units in the 
monoclinic space group P21/c. The asymmetric unit 
comprises one Cu(II) ion, one coordinated 5-NAP molecule, 
two acetate ions, and one H2O molecule. There is a 
crystallographic inversion center at (0,0,0) (dCu…Cu = 
2.6484(6) Å which generates the other half of the dimer 
(Figure 4). The copper coordination sphere has five-
coordinate geometry in which the N-atom of the 5-NAP ring 
coordinates in the axial position. The Addison Parameter is 
τ=0.0033, indicating a very slightly distorted square 
pyramidal geometry.14 The continuous symmetry (CSM) 
parameter further quantifies the geometry;15 the CSM value 
for square pyramidal is 0.192, whereas the value for trigonal 
bipyramidal is 5.70 (a lower value indicates less distortion 
from the idealized geometry).  Selected bond lengths and 
angles are given in Tables 2 and 3 respectively. All bond 
angles of 1 are unremarkable when compared to the 
previously published structure of 1.9  The O-Cu-O angles are 
slightly distorted from the idealized 90 and 180  found in a 
perfect square pyramid, ranging from 88.53(8) to 90.24  and 
167.85(7) to 168.05 , respectively. The 5-NAP molecule is 
canted by 8.16° relative to the Cu1-N1 bond making the C2-
N1-Cu1 bond angle 128.68(16)° and the C6-N2-Cu1 bond 
angle 113.56(14)°. 
When the crystal lattice of 1 is viewed parallel to the a-
axis of the unit cell, it is seen to pack as stacked, pleated 
sheets (Figure 5). The sheets are held together by hydrogen 
bonding network between nitro group oxygen atoms, water 
molecules, and oxygen atoms on the acetate ions (Table 4). 
The amino group acts as a hydrogen bond donor through 
both H-atoms, one of which bonds to an acetate oxygen (dN2-
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H2A...O22#1=2.855(3)Å) and the other to a water molecule 
(dN2...O1W#2 = 2.903(3) Å). The water molecules also act as 
hydrogen bond donors. One H-atom forms a H-bond to an 
acetate oxygen atom in an adjacent dimer (dO1W-
H1W...O12#3=2.858(3) Å; the other hydrogen atom forms a 
hydrogen bond to a nitro group oxygen atom on an adjacent 
dimer (dO(1W)-H(2W)...O(1)#4 =2.859(3) Å). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The thermal ellipsoid plot of the dimer of (1) showing 
50% probability ellipsoids. Only the copper coordination sphere 
and the asymmetric unit are labeled for clarity.  
 
 
 
 
 
 
 
 
 
Figure 5. The unit cell of 1 viewed parallel to the a-axis, such that 
the origin is in the back right corner of the unit cell, shows how 1 
packs in pleated sheets. Dotted lines show intermolecular H-
bonding. 
 
Compound (2) crystallizes in dimeric units, similar to 1, in 
the monoclinic space group C2/m. The 5-NAP molecule is 
canted due to steric interactions between neighboring 5-
NAP molecules on adjacent dimers. The copper ion sits on a 
two-fold rotation axis with direction [0, 1, 0] at [0, y, 0]. An 
inversion center exists at the origin, equidistant between the 
two copper II ions (dCu…Cu = 2.6047(8) Ǻ). The asymmetric 
unit comprises one bridging acetate ion, one copper (II) ion, 
and one 5-NAP molecule; the bridging tetraacetate dimer is 
produced through the combination of the inversion center 
and two-fold axis (Figure 6). The inversion center and 2-
fold rotation axis produce the symmetry-equivalent 5-NAP 
ring and copper II ion. Compound 2 exhibits static two-fold 
disorder in the 5-NAP molecule that arises due to a 
crystallographic mirror (Figure 7).  
 
 
 
 
 
 
Figure 6. The thermal ellipsoid plot of (2) showing 50% 
probability ellipsoids. Only the copper coordination sphere and the 
asymmetric unit are labeled for clarity. 
 
 
 
 
 
 
 
 
Figure 7. Two-fold disorder of the 5-NAP ring in 2.  One position 
is shown as shaded spheres and solid bonds, while the other is 
show as open spheres and hollow bonds. 
The 5-NAP molecule is canted at an angle of 10.55° 
relative to the line of the Cu1-N1 bond; the mirror plane 
bisects N1, thus generating the disorder. In the discussion of 
the local structure, the 5-NAP ring will be restricted to one 
position because both positions are symmetry equivalent. 
The copper coordination sphere exhibits five-coordinate 
geometry. The symmetry operations require the Addison 
parameter to be exactly 0.00 and therefore it is not a helpful 
measure of the geometry. However, the CSM parameter has 
a value of 0.21 for a square pyramidal geometry and a value 
of 5.70 for a trigonal bipyramidal geometry. Therefore, 2 is 
best viewed as having a slightly distorted square pyramidal 
geometry around the copper ions. Selected bond lengths and 
angles are given in Tables 2 and 3, respectively. The O-Cu-
O angles are slightly distorted from the idealized 90 and 
180° found in a perfect square pyramid, ranging from 
88.52(12) to 89.25(9)° and 168.96(7), respectively. The C2-
N1-Cu1 bond is 131.7(3)° and the C6-N2-Cu1 bond is 
111.6(3)°. 2 packs as flat sheets of isolated dimers held 
together by hydrogen bonding (Table 4) and, unlike 1, -
stacking (Figure 8). The lack of water molecules 
significantly limits the hydrogen bonding between layers. 
An amino group acts as an H-bond donor through one 
hydrogen which bonds to an adjacent nitro group oxygen 
atom (dN2-H2B...O2#5=2.957(7) Å).  The distance between the 
mean planes of the rings is 3.29(1)Å with a slip angle of 
17.5(1)° between the line connecting the ring centroids and 
the planes of  the rings. 
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Figure 8. 2 viewed parallel to the b-axis. Sheets of isolated dimers 
interact through  stacking between 5-NAP molecules, and to a 
lesser extent through H-bonding between amino groups and nitro 
groups. 
Table 2. Selected bond lengths 
Compound 1 Compound 2 
Bond Length (Å) Bond Length (Å) 
Cu1…Cu1a  2.6484(6) Cu1…Cu1a  2.6047(8) 
Cu1-N1 2.2282(18) Cu1-N1  2.214(3) 
Cu1-O11 1.9633(18) Cu(1)-O(11)  1.9672(17) 
Cu1-O12a 1.9741(17) Cu1-O12a     1.9687(17) 
Cu1-O21 1.9652(16)   
Cu1-O22a 1.9642(17)   
Table 3. Selected bond angles 
Compound 1 Compound 2   
Atoms Angle (°) Atoms  Angle (°) 
C2-N1-Cu1  128.68(16) C2-N1-Cu1 131.7(3) 
C6-N1-Cu1  113.56(14) C6-N1-Cu1 111.6(3) 
O11-Cu1-N1 96.45(7) O11-Cu1-N1 95.96(7) 
O21-Cu1-N1   94.36(7)   
O22a-Cu1-N1 97.79(7) O12-Cu1-N1 95.00(7) 
O12a-Cu1-N1 95.40(7)   
O11-Cu1-O21 88.53(8) O11-Cu1-O12c 89.25(9) 
O11-Cu1-O22a 90.24(8) O12a-Cu1-
O12c 
88.52(12) 
O22a-Cu1-O21 167.85(7) O11b-Cu1-
O12c 
168.96(7) 
O11-Cu1-O12a 168.05(6)   
C2-N1-C6  117.71(19) C2-N1-C6   116.6(6) 
N1-C2-C3    121.5(2) N1-C2-C3 126.7(7) 
C2-C3-C4   119.9(2) C2-C3-C4 117.5(6) 
C3-C4-C5  117.7(2) C3-C4-C5 118.7(5) 
C4-C5-C6   120.3(2) C6-C5-C4   119.3(6) 
N1-C6-C5   122.8(2) N1-C6-C5   121.2(7) 
Symmetry Transformations to generate equivalent atoms for (1): 
#1 -x,-y+1,-z+2 For (2) #1 x,-y+1,z    #2 -x+1,-y+1,-z    #3 -x+1,y,-
z  #4 -x+1/2,-y+1/2,-z+1 
Magnetic Data 
Magnetic data for 1 and 2 were collected in a 0.1 T field 
from 1.8 K to 310 K. Data for 2 are shown in Figure 9. 
(Data for 1 are very similar) The data for both compounds 
were fit to the Bleaney-Bowers equation, where ρ represents 
a paramagnetic impurity, and Nα  represents the temperature 
independent paramagnetism (Eqn. 1).2 The form of the 
Hamiltonian used was H=-JΣS1 S2. The data were fit per 
mole of dimer.  
In 1, the best fit yielded J = –442(5) K, Curie constant = 
1.09(16) emu(K) mol(Oe)-1, and ρ = 1.70(10) %. In 2, the 
best fit yielded J = –471(5) K, Curie constant = 0.970(16) 
emu(K) mol-1(Oe)-1, and ρ = 1.62(10) %. In each 1 and 2, χ 
reaches a maximum near 278 K (1), or 294 (2). As the 
temperature decreases, the susceptibility steadily decreases 
as a result of the antiferromagnetic interactions, until near 
77 K (1 and 2) where the dimer is in the singlet state and 
only trace impurities contribute to the moment. At 
temperatures below 77 K, the χT value remains constant as 
would be expected for a sample with a small paramagnetic 
impurity.  
The magnetization was measured at a constant 
temperature of 1.8 K in a field varying from zero to 50 kOe. 
For a Cu(II) ion, a saturation magnetization near 6000 emu 
mol-1 is expected.13 The saturation magnetization was 100 
emu mol-1 (1) and 45 emu mol-1 (2). Saturation 
magnetization of this magnitude is in agreement with the 
presence of a small paramagnetic impurity with the bulk 
sample in a singlet state. A small increase in moment at 50 
K in both compounds indicates the presence of a trace of O2. 
 
 
 
 
Equation 1.  The Bleany-Bowers Equation 
 
 
Figure 9. χmT vs. T plot for 2 in a 0.1 T field. The solid line 
represents the best fit to a dimer model with a paramagnetic 
impurity term. 
12 2
m
2 2
2 1 21 exp (1 )
3 3
N g
4kT
N g J
kT kT
N
βχ ρ
β ρ α
−  = + − − +    
+
Synthesis and structure of binuclear 2-amino-5-nitropyridine-Cu(OAc)2 complexes    Section A-Research paper 
Eur. Chem. Bull., 2015, 4(2), 110-116   DOI: 10.17628/ecb.2015.4.110-116 115
Table 4. Hydrogen-bonding of 1 and 2.  
D-H…A   d(D-H) (Ǻ) d(H...A) (Ǻ) d(D...A) (Ǻ) <(DHA) 
 
1 
    
N2-H2A...O22 #1 0.85(3) 2.02(4) 2.855(3) 165(3) 
N2-H2B...O1W #2 0.87(3) 2.05(3) 2.903(3) 170(3) 
O1W-H1W...O12 #3 0.85(4) 2.04(4) 2.858(3) 162(3) 
O1W-H2W...O1 #4 0.88(4) 2.00(4) 2.859(3) 168(3) 
 
2 
    
N(2)-H(2B)...O(2)#5 0.82(7) 2.14(7) 2.957(7) 171(6) 
Symmetry transformations to generate equivalent atoms for (1): #1 -x,-y+1,-z+2; #2 -x,y-1/2,-z+3/2; #3 x,y,z-1; #4 -x+1,-y+1,-z+1. For (2) 
#1 x,-y+1,z    #2 -x+1,-y+1,-z    #3 -x+1,y,-z #4 -x+1/2,-y+1/2,-z+1    #5 -x+1/2,y+1/2,-z+1 
 
DISCUSSION 
Copper(II) is known to act as a Baeyer-Villiger catalyst 
capable of oxidizing ketones to esters16 and lactones17 in the 
presence of molecular oxygen. Punniyamurthy and Rout 
have recently written a review on copper-catalyzed 
oxidation.18 Other transition metal complexes, including 
platinum-, iron-, and nickel-based systems, have been 
widely studied as well.19 A Baeyer-Villiger reaction occurs 
when the ketone is protonated and then undergoes a 
nucleophilic attack by an oxygen species, forming the 
“Criegee intermediate.”20 This unstable species allows for 
the insertion of an oxygen atom next to the carbonyl group, 
forming an ester21-23. The Cu(II) serves the role of a Lewis 
acid in this reaction and must coordinate to carbonyl oxygen 
atom. The structure of the catalytic complex is likely to be 
Cu(5-NAP)xCly(2-butanone) although this has not been 
demonstrated. If water is present, hydrolysis can 
subsequently occur, forming a carboxylic acid and an 
alcohol (acetic acid and ethanol in this instance) which 
provides the necessary acetate ions for the formation of 1.   
Compounds 1 and 2 have strong local structural 
similarities, despite having different space groups and thus 
different symmetry. The greatest difference in the local 
structures between the two compounds is the existence of 
disorder in 2. However, there are nuanced differences 
between the two structures, and some considerable 
differences appear when they are compared to known crystal 
structures of similar, previously reported Cu(II) carboxylate 
dimers. The O-Cu-O angles are unremarkable when 
compared to the published structure of copper acetate 
monohydrate.3 In compounds 1 and 2, the bond lengths in 
the copper coordination sphere are within experimental error 
compared to the Cu-O and Cu-N bonds found in 
bis(pyridine)tetraacetatedicopper(II)24 and less than 0.03 Ǻ 
different than the Cu-O bonds in copper (II) acetate 
monohydrate.3 Each analogous bond in 1 and 2 in the copper 
coordination sphere is the same length within experimental 
error. The distance between the Cu(II) ions in each dimer, 
2.648(4) Ǻ in 1 and 2.605(8) Ǻ  in 2, are distinctly different, 
but are comparable to the Cu-Cu distances in 
bis(pyridine)tetraacetate-dicopper(II) which is 2.641 Ǻ and 
in copper(II) acetate monohydrate, which is 2.616  Ǻ It is 
unclear why the Cu…Cu distance differs so greatly between 
1 and 2, although differences in packing are almost certainly 
important.  
Analogous bond angles differ greatly between compounds 
1 and 2 and show distortion, especially in the case of 2. The 
C6-N1-Cu1 and C2-N1-Cu1 bonds are distorted away from 
12° in both compounds due to the steric hindrance provided 
by the amino group present at the 2-position in 5-NAP. The 
steric hindrance between the acetate ions and the amino 
group causes the 5-NAP molecule to be canted relative to 
the Cu-N bond, and therefore the C2-N1-Cu1 is larger than 
120°. The C6-N1-Cu1 bond is distorted an equal amount 
less than 120° in both 1 and 2 in order to compensate and 
distribute the steric strain The C2-N1-Cu1 bond angle in 
both 1  and 2 is larger than the analogous bond angle in 
bis(pyridine)-tetraacetatedicopper(II) by 7.5° and 10.5°, 
respectively.24 The pyridine molecule is not canted because 
there is no unsymmetrical steric hindrance, unlike in the 5-
NAP compounds, and therefore the Cu-N-C bonds are both 
121.5°. The bond angles of the 5-NAP ring in 1 do not differ 
from the published crystal structure of 5-NAP by more than 
1.4°.25 However, in 2, the N(1)-C(2)-C(3) bond is 3.7° larger 
than the crystal structure of pure 5-NAP, and  is 5.2° larger 
than the analogous angle in 1.   
The magnetic behavior of 1 and 2 was unsurprising. 
Copper acetate compounds and their derivatives have long 
been known to exhibit very strong antiferromagnetic 
interactions.1,2 The exchange constants reported for Cu(II) 
acetate monohydrate26 and pyridine27 complexes are 
comparable to those observed here with values of 2J=-409 
and –466 K respectively.  
In conclusion, we have observed the Cu(II)-catalyzed 
Baeyer-Villiger oxidation of 2-butanone to produce acetate 
ions and ethanol. Cu(II) and 5-NAP coordinated to the 
acetate ions, forming bis-5-NAPtetraacetatecopper(II) which 
was also prepared by direct synthesis along with its 
anhydrous analogue. Both compounds crystallize in a 
monoclinic space group, and the anhydrous compound 
exhibits static disorder of the 5-NAP. Both compounds form 
isolated dimers, leading to strong antiferromagnetic 
interactions. 
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APPENDIX.  
Supplementary Data: CCDC (1049172) and CCDC 
(1026255) contain the supplementary crystallographic data 
for 1 and 2, respectively. This data can be obtained free of 
charge via from http://www.ccdc.cam.ac.uk/conts/ 
retrieving.html, or from the Cambridge Crystallographic 
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; 
fax: (+44) 1223-336-033; or e-mail: deposit@ccdc.cam. 
ac.uk. 
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